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In order to equally segregate their genetic material into daughter cells during mitosis, 
it is essential that chromosomes undergo major restructuring to facilitate compaction. 
However, the process of transforming diffuse, entangled interphase chromatin into 
discrete, highly organised chromosomal structures is extremely complex, and 
currently not completely understood.   
  
The complexes involved in chromatin compaction and sister chromatid decatenation 
in preparation for mitosis include condensins I and II. Mutations in condensin subunits 
have been identified in human tumours, reflecting the importance of accurate cell 
division in the prevention of aneuploidy and tumour formation. Most mutations 
described in TCGA (The Cancer Genome Atlas) and COSMIC (Catalogue of Somatic 
Mutations in Cancer) are missense, and therefore likely to only partially affect 
condensin function. Most functional genetic studies of condensin, however, have used 
loss of function systems, which typically cause severe chromosome segregation 
defects and cell death.   
  
Mice carrying global hypomorphic mutations within the kleisin subunit of the 
condensin II complex develop T cell lymphomas. The Caph2nes/nes mouse model is 
therefore a good system for understanding how condensin dysfunction can influence 
tumourigenesis. However, little is known about which cellular processes are affected 
in mutant cells before transformation. I therefore set out to use the Caph2nes/nes mouse 
model to study the consequences of the condensin II deficiency on cell cycle regulation 
in several different hematopoietic lineages. The Caph2nes/nes mice are viable and fertile, 
with no obvious abnormalities other than the thymus, which is drastically reduced in 
size. Previous studies reported greater than a hundred-fold reduction in the number of 
CD4+ CD8+ thymocytes. I set out to understand why the alteration of a ubiquitously 
expressed protein which functions in a fundamental cellular process would result in 
such a cell-type specific block in development. To achieve this, I investigated the 
possibility that condensin II is involved in interphase processes as well as in mitosis. 
In addition, I studied the aspects of T cell development that may make this lineage 
particularly vulnerable to condensin II deficiency. Finally, I carried out a preliminary 






















investigation into the biochemical properties of the condensin complexes.  
 
During my PhD., I found strong evidence to suggest that the Caph2nes/nes T cell-specific 
phenotype arises due to abnormal cell division. However, I was unable to find any 
evidence to support the hypothesis that the phenotype is a consequence of abnormal 
interphase processes. Upon systematic analysis of several stages of hematopoietic 
differentiation, I found that at a specific stage of T cell development, the mutation 
results in an increased proportion of cells with abnormal ploidy, followed by a drastic 
reduction in cell numbers. Erythroid cells revealed a similar increase in the frequency 
of hyperdiploid cells, but no reduction in cell numbers. B cells and hematopoietic 
precursors did not reveal an increase in hyperdiploidy, or a reduction in cell numbers 
in wildtype relative to mutant. Subsequently, I found preliminary evidence to suggest 
that the T cell-specificity may be due to more rapid progression of CD4+ CD8+ T cells 
from S phase to M phase, relative to other hematopoietic stages. Finally, a preliminary 
investigation into the biochemical properties of the condensin complex revealed 
apparent imbalances in the expression of condensin subunits in T, B and erythroid 
cells. The sedimentation profile of CAP-H2 from whole-thymus extract did not 
exclude the possibility that condensin subunits might be forming heavier-weight 
complexes with non-SMC proteins. Further work must be carried out to determine 




Each cell in our bodies has been estimated to contain approximately 2 metres of DNA, which 
must be compacted into nuclei that can be less than 10 microns in diameter. Before cell 
division, DNA is compacted still further. This compaction is facilitated by several proteins, 
including two complexes called condensin I and condensin II. The compaction of chromatin 
must be carried out correctly before cell division takes place. Mistakes in this process result 
in abnormal cell division, which can lead to tumour formation. Despite its importance, 
currently our understanding of the process of chromosome condensation and remodelling is 
limited. I therefore set out to better understand the role of the condensin complexes in the 
physical restructuring of DNA using a mouse model which carries a mutation in one of the 
condensin complexes.  
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CHAPTER 1: INTRODUCTION 
 
1.1 Genome organization and chromosome structure 
 
Each diploid cell in our bodies has been estimated to contain approximately 2 metres 
of DNA, which must be compacted into nuclei that can be less than 10 microns in 
diameter. This is achieved through the action of DNA binding proteins that associate 
with DNA to form chromatin, thereby compacting the genome down to a manageable 
size while maintaining functionality. This compaction acts to protect the DNA from 
damage, while also playing a role in transcription and DNA replication. Genomic 
regions located within more compact chromatin (heterochromatin) tend to be less 
transcriptionally active than those located on more open chromatin (euchromatin). 
 
The organisation of interphase chromatin shows both commonalities and differences 
between cell types. During interphase, chromosomes occupy distinct areas within the 
nucleus: certain areas are preferentially occupied by certain chromosomes. These are 
known as “chromosome territories”. In almost all cells, transcriptionally repressed 
chromatin is enriched at the nuclear periphery in association with the nuclear lamina 
(Peric-Hupkes et al., 2010). At the molecular level, interphase chromosomes are 
compartmentalized into discrete domains; loci within the same domain interact more 
frequently than loci that are located in neighbouring domains (Dixon et al., 2012; 
Lieberman-aiden et al., 2010). Within such topologically associated domains (TADs), 
the linear DNA is thought to be folded to facilitate interactions between gene 
promoters and distal regulatory elements such as enhancers, which can be separated 
by many hundreds of kilobases (Lettice, 2003). Conversely, interactions are less 


























1.1.1 The histones 
 
The basic unit of chromatin is the nucleosome, which comprises two copies each of 
the core histones: H2A, H2B, H3 and H4, around which approximately 147 base pairs 
of DNA are wrapped. When nucleosomes are subjected to increasing salt 
concentrations, the DNA dissociates from the histones, indicating that the interactions 
between core histones and DNA are primarily electrostatic in nature (Andrews & 
Luger, 2011). Studies that made use of high-salt concentrations and chemical cross-
linking revealed that in the absence of DNA, histones H2A and H2B form a stable 
dimer, while H3 and H4 form a tetramer (Kornberg, 1974). 
 
Histone-histone and histone-DNA interactions occur at the C-terminus of the histone, 
comprising three alpha-helices. Each histone molecule also has a basic tail region 
which is exposed to the periphery of the nucleosome, and is targeted by a wide variety 
of post-translational modifications that can alter nucleosomal biochemistry and affect 
the functional state of the associated DNA. In addition, acetylation in the globular 
domain of histones is also very important (Cerbo et al., 2014; Tropberger et al., 2013). 
Acetylation of histones H3 and H4 results in decondensed chromatin, while other 
modifications, such as methylation and ubiquitination, can result in either compaction 
or decompaction of the chromatin, depending on which residue is modified. Whilst 
acetylation can alter nucleosome structure directly through alteration of charge, effects 
of other modifications are indirect: i.e. they rely on the activities of other proteins that 
“read” the histone modification, such as polycomb or HP1. The amino-acid sequences 
of both the C-terminal and charged N-terminal are highly conserved, reflecting their 
crucial roles in higher-order chromatin structure. Histone variants, e.g. H3.3 and the 
acidic patch on H2A versus H2A.Z (Bönisch & Hake, 2012), are also very important 
for structure. The histone variant H2A.Z causes chromosome to become more open, 
and is associated with active transcription (Fan, Gordon, Luger, Hansen, & 
Tremethick, 2002; Xu et al., 2012), whereas chromatin condensation is facilitated by 
the binding of H4K16 histone tail to the acidic patch on H2A (discussed in Section 
1.1.2.4). 
 
Chromatin is further compacted by the linker H1, which binds to the nucleosome and 
to the linker DNA (Zhou et al., 2015) to generate higher order structures. Traditionally, 






















these structures were thought to comprise a 30nM fibre (Gilbert & Allan, 2001; 
Greulich, Wachtel, Ausio, Seger, & Eisenberg, 1987), although recent evidence using 
methods such as electron spectroscopic imaging and tomography, has called into 
question whether such a structure is prevalent in vivo (Fussner et al., 2012; Nishino et 
al., 2012). 
 
During mitosis, chromosomes undergo dramatic changes in morphology involving 
further condensation into discrete rod shaped structures. This process serves at least 
two purposes: to remove entanglements between sister chromatids and to provide the 
rigidity necessary to withstand forces exerted by the spindle. Mitotic chromosome 
structure is discussed in more detail in Section 1.1.3. 
 
1.1.2 Chromosome dynamics during the cell cycle 
 
The cell cycle is comprised of events that take place within the cell, including the 
duplication of DNA, as well as cell division into two daughter cells. The accurate 
segregation of genetic material into daughter cells during mitosis is essential for 
normal proliferation. Mistakes in cell division can lead to DNA damage, aneuploidy 
and cancer. Accurate cell division is also dependant on processes that are carried out 
in S phase and G2, prior to progression into M phase. These include DNA replication, 
the establishment and maintenance of sister chromatid cohesion between S phase and 
anaphase, and centrosome replication. In order for accurate cell division to occur, 
faithful replication of the genome must first take place. Sources of error in DNA 
replication, known as replication stress, can result in DNA damage and genetic 
instability (Mazouzi, Velimezi, & Loizou, 2014). 
 
DNA replication is initiated during early G1 in a process known as “origin licensing” 
at specific sequences known as replication origins which occur, on average, every 
100kb in the mammalian genome.  
 
Origin licensing requires the binding of the Origin recognition complex (ORC), which 
recruits CDC6 and the hexameric MCM2-7 helicase complex to double-stranded (ds) 
DNA. During G1 the complex is dormant, but some complexes are activated during 






















G1-S phase (Symeonidou, Taraviras, & Lygerou, 2012) and begin to unwind the DNA 
strands in front of the replication fork (Coster, Frigola, Beuron, Morris, & Diffley, 
2014) in preparation for DNA synthesis.  
 
Before entry into S phase, the cell must pass through the G1 checkpoint, which ensures 
genomic integrity before entry into S phase. The p53 tumour suppressor protein is 
known to have a role at the G1 checkpoint (as well as maintaining a damage-induced 
G2 arrest). A downstream target of p53, p21, also plays a role at the G1 to S phase 
transition. This involves the activation of the retinoblastoma protein (pRb) which binds 
to and inhibits E2F transcription factors (which act to advance the cell into S phase). 
Once the requirements of the checkpoint have been met, pRb is phosphorylated by the 
cyclin dependent kinases Cdk2, Cdk4 and Cdk6, thereby liberating the E2F 
transcription factors. This drives the expression of cyclin E and cyclin A as well as 
Cdk1 and Cdk2, resulting in the beginning of S phase, and the start of replication 
(Neganova & Lako, 2008). Different CDKs and cyclins act in different cell types, for 
example CDK4 and 6 appear to be more important in the thymus in comparison to 
CDK2. Similarly, cyclin D3 appears to be most important in the thymus (Sicinska et 
al., 2003). The role of cyclin-dependent kinases during S phase is discussed in more 
detail below. Finally during G2, any remaining S phase replication errors are corrected 
before the cell enters mitosis. The major cell cycle checkpoints are illustrated in Figure 
1.1. 
 
1.1.2.1 S phase 
 
Replication of the genome during S phase requires all sections of DNA to be accurately 
synthesized exactly once, with no duplications (areas replicated more than once) or 
omissions. In eukaryotes, once the origins of replication have been licensed in G1, a 
subset of the replication origins are initiated (this process is also known as “origin 
firing”) by the activation of the Mcm2-7 helicase complex.  
 
Approximately 10% of licensed origins will initiate replication (Ge & Blow, 2010). 
The excess Mcm2-7 complexes that are loaded but not activated provide additional 
support should the cell undergo replication stress. The additional origins of replication 
will then become activated, and replication of the entire genome can take place, even 






















in the presence of replication stress (Woodward et al., 2006). 
 
The number of origins that are licensed in G1, and subsequently, the proportion of 
these sites that are initiated determines the length of S phase (Sansam, Goins, Siefert, 
Clowdus, & Sansam, 2015). More activated origins results in an increase in the 
number of replication forks.























Assuming fork velocity is constant, the increased number of replication forks will 
replicate the genome more quickly, since each will have less DNA to replicate. 
Through a combination of RNAi to knockdown regulators of histone assembly 
together with analysis of DNA replication, it was shown that new histone supply 
controls replication fork speed (Mejlvang et al., 2014). 
 
The replisome is formed from DNA replication proteins at the replication fork. These 
proteins are responsible for two main tasks: the helicase complex unwinds the DNA 
to form separate leading and lagging strand templates (taking the shape of a “fork”), 
while the DNA polymerase synthesizes new DNA using the template strand. 
Following initiation and elongation (DNA synthesis), termination takes place. This 
occurs when two converging replication forks meet. Several processes take place 
during termination, including the removal of double stranded (ds)DNA catenations 
and replisome dissassembly. However, due to the difficulty in predicting termination 
sites, the exact sequence of termination events requires further research. In contrast, a 
recently published study reveals that the strands of converging replication forks in 
Xenopus egg extracts freely pass each other, with no evidence of stalling (Dewar, 
Budzowska, & Walter, 2015). 
 
One of the most important questions in the field of replication is the exact relationship 
between replication fork progression and genome stability. Since replication and 
transcription both occur along the same template, collisions between the replication 
and transcription machinery are inevitable. However, the consequences of these 
collisions are poorly understood. It is generally considered that the 
transcription/replication interference is a major cause of DNA damage and replication 
fork stalling (Mirkin & Mirkin, 2005; Skourti-Stathaki & Proudfoot, 2014). In 
contrast, a recently published study reveals that the strands of converging replication 
forks in Xenopus egg extracts freely pass each other, with no evidence of stalling 
(Dewar et al., 2015). 
 
During S phase, the cohesin complex establishes sister chromatid cohesion at the 
replication fork by forming a ring structure which entraps both sister chromatids. The 
role of cohesin is discussed in more detail in Section 1.2.1.  






















1.1.2.2 M phase 
 
Mitosis is typically broken down into five cytologically distinct stages: prophase, 
prometaphase, metaphase, anaphase and telophase (Figure 1.2). To facilitate faithful 
segregation of daughter cells, the interphase chromatin is further compacted at the start 
of mitosis (prophase) into discrete cylindrical structures. At this stage, the two 
centrosomes move to opposite sides of the cell, where they will become the poles of 
the spindle apparatus. Microtubules are nucleated at the centrosomes and begin to 
spread out into the cell. Sister chromatid cohesion is removed along chromosome arms 
during prophase (Waizenegger, Hauf, Meinke, & Peters, 2000),  when cohesin 
subunits and associated proteins are phosphorylated by the mitotic kinases PLK1, 
Aurora B and CDK1 (Dreier, Bekier, & Taylor, 2011; Hauf et al., 2005) allowing the 
removal of cohesin from the chromosome arms by Wapl (Tedeschi et al., 2013). 
Centromeric cohesin is protected by SGO1 (Shugoshin), which recruits PP2A to 
dephosphorylate sororin, thereby ensuring that sororin remains active at the 
centromeres. Sororin binds to acetylated SMC3, keeping the cohesin ring closed (Liu, 
Rankin, & Yu, 2013). Additionally, SGO1 prevents Wapl binding to cohesin by 
competitive binding (Hara et al., 2014). 
 
During prometaphase the nuclear membrane breaks down. Microtubules connect to 
the kinetochores at the centromeres of each chromatids. Each sister chromatid of a pair 
will attach to kinetochore microtubules (k fibres) originating from opposite spindle 
poles in a process called bi-orientation (Walczak, Cai, & Khodjakov, 2010). This 
ensures that at anaphase sister chromatids are distributed evenly to daughter cells. 
Uneven distribution of chromatids can result in tumourigenesis, as described in 
Chapter 3, Section 3.1.1.1. 
 
During metaphase, chromosomes align at the equator of the mitotic spindle (the 
metaphase plate), which is equidistant from the two spindle poles, and are held there 
under tension. Sister chromatid cohesion is removed at the centromeres following the 
cleavage of centromeric cohesin by separase, triggering the onset of anaphase. The 
kinetochore microtubules separate the sister chromatids, by pulling each of the sister 
chromatids towards opposite poles (Walczak et al., 2010). 
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During telophase the nuclear membrane is reformed, and the spindle apparatus is 
broken down. Maximum condensation of chromatin occurs in telophase. Finally, 
cytokinesis occurs. This requires the precise bisection of the metaphase plate by the 
cleavage furrow: a process controlled by actin and myosin, as well as other 
cytoskeletal proteins. It is also vital that the daughter cell acquires one centrosome 
each. 
 
The processes involved in M phase are regulated by different checkpoints to ensure 
accurate segregation of the sister chromatids. 
 
1.1.2.3 Kinases and cell cycle checkpoints  
 
In order to ensure that the cells maintain a correct chromosome complement, the cell 
must pass several checkpoints at various stages of the cell cycle. Failure to remove 
cells with an incorrect number of chromosomes from the cell cycle can lead to the 
accumulation of further abnormalities and tumourigenesis. 
 
1.1.2.3.1 Cyclin- and Dbf4-dependent kinases during S phase 
 
Cyclin–dependent kinases and Dbf4-dependent kinases (DDKs) are important in the 
initiation of DNA replication during S phase (Tanaka & Araki, 2013). DDKs activate 
the replicative helicase by phosphorylating MCM2-7 subunits (Sheu, Kinney, 
Lengronne, Pasero, & Stillman, 2014). Despite being necessary for initiation of 
replication, the role of S phase CDKs is less well understood - particularly in 
vertebrates. In yeast, S phase CDKs phosphorylate Sld2 and Sld3, allowing them to 
physically interact with the scaffolding protein Dpb11. Sld2 is homologous to the 
vertebrate DNA helicase RecQL4, which physically interacts with the vertebrate 
homolog of Dpb11: TopBP1. However, unlike in yeast, this process does not occur as 
a result of CDK phosphorylation (Matsuno, Kumano, Kubota, Hashimoto, & 
Takisawa, 2006), and so the necessity for CDKs in vertebrate replication initiation 
remained unclear. 
 
A screening for TopBP1 interactors revealed TICRR (TopBP1-interacting checkpoint 






















and replication regulator)/TRESLIN, which is phosphorylated by CDKs and shares 
some sequence similarity with Sld3 (Kumagai, Shevchenko, Shevchenko, & Dunphy, 
2010; C. L. Sansam et al., 2010). TRESLIN phosphorylation allows interaction with 
TopBP1, and this is essential for initiation of replication (Boos et al., 2011; Kumagai, 
Shevchenko, Shevchenko, & Dunphy, 2011). Levels of phosphorylated Treslin control 
the length of S phase,by altering replication initiation (i.e. the number of replication 
forks) (Sansam et al., 2015).  
 
1.1.2.3.2 DNA structure checkpoints 
 
Entry into M phase is dependent on dephosphorylation of Cdk1. This occurs when 
Cdc25C (a phosphatase) is more active than the kinases Wee1 and Myt1. DNA 
structure checkpoints mediate the activity of these enzymes, so that the cell doesn’t 
progress through the cell cycle if its DNA is not replicated faithfully, or if the DNA is 
damaged (Perry & Kornbluth, 2007). Later during late metaphase, the APC (anaphase 
promoting complex) ubiquitin ligase targets Cdk1-cyclin B for destruction following 
satisfaction of the spindle assembly checkpoint, resulting in exit from M phase. 
However, there are also many other mitotic kinases involved in this process, which 
has been simplified in the description above (Abrieu, Fisher, Simon, Dorée, & Picard, 
1997; Sudakin, Chan, & Yen, 2001). 
 
1.1.2.3.3 The spindle assembly checkpoint (SAC) 
 
The spindle assembly checkpoint (SAC) inhibits sister-chromatid separation (and thus 
progression to anaphase) until all microtubules are correctly attached to the 
kinetochores and there is tension across the bi-oriented sister kinetochores. The SAC 
inhibits progression to anaphase by binding Mad2 and BubR1 directly to Cdc20, 
thereby preventing the activation of APC/C-Cdc20 (Hwang, 1998; Kim, 1998). 
Experiments in yeast identified the Mitotic Checkpoint Complex (MCC), which 
includes BubR1, Bub3, Mad2 and Cdc20 (Hardwick, Johnston, Smith, & Murray, 
2000). The complex was later identified in HeLa cells (Sudakin et al., 2001). The MCC 
is produced when kinetochores are unattached during prometaphase. Because Cdc20 
is bound in this complex, it is unable to activate APC/C. However, once all 






















kinetochores are attached correctly, the MCC is no longer produced – allowing Cdc20 
to be released to activate APC/C (Kulukian, Seok Han, & Cleveland, 2009). The 
primary targets of activated APC/C are Cyclin B, degradation of which allows 
dephosphorylation of Cdk substrates which triggers mitotic exit, (Zachariae, Schwab, 
Nasmyth, & Seufert, 1998; Sullivan & Morgan, 2007) and securin, degradation of 
which removes centromeric cohesin to trigger chromosome segregation. 
 
Degradation of Cyclin B in the absence of chromosome segregation leads to a process 
known as “mitotic slippage”, where cells exit mitosis without reducing their DNA 
content and become tetraploid (Brito, Yang, & Rieder, 2008). The process of “mitotic 
slippage” is distinct from “mitotic skippage” which occurs when a cell enters G1 
without having entered mitosis, and consequently will contain 4N DNA content.  The 
products of these two processes may be distinguished by the presence or absence of 
sister chromatid cohesion, since cells in G2 (unlike G1), will be subject to sister 
chromatid cohesion. Additionally, cells that have skipped mitosis can be distinguished 
from cells that have undergone mitotic slippage, since they accumulate Cdt1 (a DNA 
replication factor expressed during G1) but lack mitotic regulators, and do not enter 
mitosis (as determined by the lack of Cdk1 expression). Mitotic skippage can be 
caused by the transient activation of p53 at G2, and results in senescence, both in vivo 
and in vitro (Dikovskaya et al., 2015; Johmura et al., 2014). 
 
1.1.2.4 Mitotic kinases and chromatin condensation 
 
The most visually dramatic event in the cell cycle is the condensation of chromatin 
during prophase. The phosphorylation of histone H3 serine 10 by Aurora B kinase is 
associated with mitotic chromosome condensation. However, how this leads to 
chromatin condensation is unclear. To investigate the consequences of the 
phosphorylation of H3S10, Wilkins et al. studied protein-protein interactions in yeast 
(Wilkins et al., 2014). They found that histone H3 serine 10 phosphorylation results 
in the deacetylation of H4 lysine 16, which allows the histone tail to interact with 
adjacent nucleosomes – thereby encouraging condensation. H4K16 binds to the acidic 
patch on H2A (discussed previously). 
 
Aurora B - the catalytic subunit of the chromosomal passenger complex (CPC) which 






















coordinates mitotic processes through phosphorylation of key regulatory proteins - is 
recruited to centromeric chromatin by the action of another kinase – haspin which 
phosphorylates H3 on threonine 3. Protein phosphatase 1 (PP1)/Repo-Man acts 
antagonistically to Haspin, dephosphorylating H3T3ph on chromosome arms. Aurora 
B phosphorylates Repo-Man at S893, preventing its recruitment. This is counteracted 
by PP2A - a mitotic interactor of Repo-Man that dephosphorylates S893 and thereby 
promotes the targeting of Repo-Man to chromosomes and the dephosphorylation of 
H3T3ph by PP1. Thus, Repo-Man-associated PP1 and PP2A collaborate to oppose the 
chromosomal targeting of Aurora B (Qian, Beullens, Lesage, & Bollen, 2013).  
 
The Mps1 protein kinase, known to be involved in several mitotic processes including 
the spindle assembly checkpoint (SAC) and cytokinesis, also facilitates prophase 
chromatin condensation by associating with the condensin II complex (Kagami et al., 
2014). Cyclin dependent kinases, particularly Cdk1, have also been shown to induce 
mitotic chromosome organization by phosphorylating subunits of condensins I and II 
(Abe et al., 2011; Kagami et al., 2014; Shintomi, Takahashi, & Hirano, 2015), as well 
as other mitotic proteins (Olsen et al., 2010). However, despite some progress being 
made, the essential process of transforming diffuse, entangled interphase chromatin 
into discrete, highly organized chromosomal structures is not currently very well 
understood.  
 
1.1.2.5 Phosphatases and chromatin decondensation on mitotic exit 
 
The process of chromosome decondensation on exit from mitosis has been visualised 
in living cells (Müller, Boyle, Singer, Bickmore, & Chubb, 2010). This study revealed 
through quantitative measurements that the volume and morphology of interphase 
chromosomes are generated very quickly after mitosis. A key role in chromatin 
decondensation is carried out by the nuclear protein, Repo-Man, which is involved in 
the dephosphorylation of histone H3 during mitotic exit (Vagnarelli et al., 2011). 
Repo-Man activity is inhibited by the phosphorylation of the residue threonine 412 
(T412) until anaphase onset. At this point, Repo-Man targets protein phosphatase 1 γ 
(PP1γ) to chromatin, casing the dephosphorylation of Thr3, Ser10 and Ser28 of histone 
H3 (Vagnarelli et al., 2011). 
 






















1.1.3 The structure of mitotic chromosomes 
 
The purpose of mitotic chromosome condensation and mitotic chromosome structure 
is firstly, to ensure chromatin is kept away from the cleavage furrow (failure to do so 
results in the “cut” phenotype) and secondly, to provide the chromosomes with 
sufficient structural rigidity to survive the forces of mitosis.  
 
1.1.3.1 The chromosome scaffold 
 
It has been postulated that the increased level of condensation during mitosis is 
achieved through the “scaffold-and-loop” model whereby the 30nm fibre is organised 
into loops which are attached to a scaffolding structure (Gasser, Amati, Cardenas, & 
Hofmann, 1989). In order to identify non-histone stabilizers of mitotic chromosome 
condensation, Laemmli et al. carried out histone depletion experiments, whereby 
histones were removed from metaphase chromosomes using dextran sulphate and 
heparin as competitors. They discovered that histone depletion resulted in 
chromosomes that remained highly folded due to the presence of non-histone proteins 
(Laemmli et al., 1978). These proteins make up the “mitotic chromosome scaffold” – 
a structure which can be isolated using sucrose gradient sedimentation, illustrated in 
Figure 1.3 (Adolph, Cheng, & Laemmli, 1977).  
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The two major protein components of the mitotic chromosome scaffold were initially 
thought to be ScI (topoisomerase II) and ScII (a protein belonging to the family of 
SMC “structural maintenance of chromosomes” protein complexes). Topoisomerase 
II (topo II) is an enzyme that can relax supercoils through the use of transient double-
strand breaks, and it is also required to “untangle” (decatenate) DNA, prior to mitosis. 
Immunofluorescence on gently centrifuged mitotic chromosomes indicated that topo 
II was localized towards the centre of the expanded chromatids, specifically on the 
chromosome axes, rather than in the surrounding chromosome loops (Earnshaw & 
Heck, 1985). Although these data may not directly relate to the localization of topo II 
in condensed chromosomes in vivo, they suggest that topo II is involved in maintaining 
the structure of condensed mitotic chromosomes, by anchoring DNA to the mitotic 
scaffold.   
 
However, inhibiting topo II by either immunodepletion or antibody blocking did not 
alter chromosome structure once mitotic condensation had taken place. In addition, 
immunofluorescence indicated that topo II was located throughout the condensed 
chromosome, rather than being restricted to the chromosomal axis (Hirano & 
Mitchison, 1993). Finally, extraction of topoisomerase II under mild conditions did 
not alter the shape of mitotic chromosomes. Together, this evidence suggests that 
while topo II is vital for successful chromosome condensation in preparation for 
mitosis, once this has been achieved it is not required to maintain chromosome 
structure, and therefore does not play an architectural role in maintaining the mitotic 
chromosome scaffold (Hirano & Mitchison, 1993). 
 
Several studies suggested that certain DNA sequences might directly associate with 
the axial region of the chromosome, defined as the chromosome scaffold (Cook, 1994; 
Gasser et al., 1989; Razin et al., 1993), to form the base of the loops in the “scaffold-
and-loop” model of mitotic condensation. Using multicolour fluorescence in situ 
hybridization (FISH), Bickmore and Oghene provided the first visual evidence for the 
existence of the scaffold-and-loop model, since their data showed that specific DNA 
sequences do indeed preferentially bind to the axial region of chromosomes (Bickmore 
& Oghene, 1996). This data was supported by Saitoh and Laemmli, who suggested 
that the banding patterns observed in native chromosomes using the AT-specific 
fluorochrome daunomycin, was a consequence of AT-rich regions of DNA interacting 






















with the chromosome axis of metaphase chromosomes (Saitoh & Laemmli, 1994). 
These specific DNA sequences were termed Scaffold Associated Regions (SARs). 
Originally characterized in Drosophila (Mirkovitch, Spierer, & Laemmli, 1986), 
SARs have since been identified in several other model organisms, often localized near 
regulatory domains such as enhancers (Cockerill & Garrard, 1986; Gasser & Laemmli, 
1986; Kas & Chasin, 1987).  
 
However, this hypothesis remained controversial, as other researchers suggested that 
the sequences associated with the scaffold were due to artefacts resulting from harsh 
extraction procedures (Jackson, Dickinson, & Cook, 1990; Okada & Comings, 1980). 
They argued that the scaffold-associated proteins may not interact in vivo, but associate 
with each other non-specifically after removal of chromatin. Under this assumption, 
the highly folded structures observed after the removal of the histones is due to the 
formation of a precipitate consisting of the non-histone proteins. Hudson et al. 
provided the first biochemical evidence that the scaffold components associate with 
each other as a result of specific interactions. The study revealed that removal of one 
of the scaffold proteins (SMC2/ScII) resulted in improper localization of other 
scaffold-associated proteins such as topo II (Hudson, Vagnarelli, Gassmann, & 
Earnshaw, 2003).  
 
Using the chromosome conformation capture methods 5C and Hi-C, Naumova et al. 
showed that the organisation of metaphase chromatin is dramatically different to that 
of interphase chromatin. The folding of chromatin into domains (both large-scale 
compartments and sub-megabase TADs) was lost and loci within 10Mb of each other 
could come into regular contact. However, metaphase chromatin is linearly organized 
at distances above 10Mb; i.e. loci more than 10Mb apart rarely come into contact. 
Their proposed model of mitotic chromosome organization involves linear 
condensation by the formation of consecutive loops, followed by axial compression – 
resulting in linear organization above 10Mb (Naumova et al., 2013). There is some 
evidence from Drosophila to suggest the structure of mitotic chromosomes is 
determined by DNA-protein interaction: using high resolution fluorescence 
microscopy, actively transcribed, dosage compensated Drosophila genes were shown 
to be located along the periphery of mitotic chromosomes, indicating that there is an 
underlying radial organization (Strukov, Sural, Kuroda, & Sedat, 2011). 























Chromatin is generally considered to undergo a continuous, smooth condensation in 
preparation for mitosis. However, new evidence suggests that this might not be the 
case: instead chromatin may undergo discrete stages of condensation and expansion 
from mid-prophase to metaphase (Figure 1.4) (Liang et al., 2015). Chromosome 
volumes in HeLa and living muntjac cells were shown to expand from mid- to late-
prophase, and then contract into metaphase. Additionally, chromosome density was 
measured, and found to diminish from mid- to late-prophase, before shifting to 
considerably higher values during metaphase. This chromosome expansion during late 
prophase was shown to be a consequence of increased chromosome width, rather than 
increased length. Chromosome lengths were dramatically reduced during 
prometaphase, resulting in condensation in metaphase. However, during this 
compaction phase, chromosome widths continued to increase, indicating that the 
chromosomes are compressed in a length-wise direction (Liang et al., 2015). 
 
During mid-prophase, Liang et al. detected a single topoisomerase II signal along the 
length of the chromosome. However, during the expansion phase at late prophase, this 
signal was found to split in two, perhaps reflecting sister chromatid individualisation. 
This occurred concomitantly with loss of cohesin along the chromatid arms. These 
chromosome morphology changes were sensitive to topoisomerase II inhibition and 
the phases of expansion and contraction were suggested to be a consequence of the 
expansion and formation of tethers (either mediated by DNA catenations or proteins), 
respectively. Removal of linkages by topoisomerase II and release of cohesin during 
late prophase results in chromosome expansion which allows the chromosome 
structure to be altered. Unconstrained sister loops are able to expand and push each 
other apart – causing sister chromatid individualisation. These morphological changes 
are “locked in” by the subsequent stages of condensation (Liang et al., 2015). 
 
  













































1.2 Experiments leading to the discovery of Condensin 
 
In order to better understand the processes involved in restructuring higher-order 
chromatin during cell division, Hirano et al. used a biochemical procedure to isolate 
proteins from mitotic chromosomes. Two novel polypeptides, XCAP-C (SMC4) and 
XCAP-E (SMC2), were identified and found to associate with each other, forming a 
heterodimer. They were subsequently shown to be involved in the condensation of 
chromatin in Xenopus egg mitotic extracts (Hirano & Mitchison, 1994). XCAP-C and 
XCAP-E are recruited to chromosomes during prophase, at the point when mitotic 
chromosome structure is being established. By the time the cell has reached telophase, 
XCAP-C no longer localizes to the chromosomes, but is uniformly distributed 
throughout the nucleus. Immunodepletion experiments using anti-XCAP-C antibody 
showed that XCAP-C is necessary for both assembly and maintenance of mitotic 
chromosomes in vitro (Hirano & Mitchison, 1994). 
 
During this time, whilst investigating the protein composition of the mitotic 
chromosome scaffold in chicken cells, Saitoh et al. characterised the second most 
abundant protein of the scaffold (after topoisomerase II), which they named ScII (now 
known as SMC2) (Saitoh, Goldberg, Wood, & Earnshaw, 1994). ScII was found to 
associate only very loosely with interphase nuclei, indicating that it plays a part in 
mitotic chromosome condensation, perhaps alongside topoisomerase II. Using two 
different preparation techniques, ScII was found to localize to the axis of the 
hypotonically swollen mitotic chromosomes (Saitoh et al., 1994) in a nearly identical 
distribution to that of topoisomerase II (Earnshaw & Heck, 1985). 
  
XCAP-C and XCAP-E/ScII are now known to belong to a family of chromosomal 
ATPases called SMC (structural maintenance of chromosomes) proteins conserved 
from bacteria to human. In prokaryotes there is only one SMC protein, whereas 
eukaryotes have six. SMC2 and SMC4 form the core subunits of condensin: a complex 
that uses energy from ATP hydrolysis to mediate various different aspects of 
chromosome dynamics. Condensin subunits were also independently identified by 
members of the Meyer lab, whilst investigating the mechanism of X chromosome 
dosage compensation in C. elegans (Chuang, Albertson, & Meyer, 1994). Condensin 
is homologous to cohesin (Figure 1.5a), and a third class of complex termed SMC5/6 






















(not shown). In yeast, a temperature sensitive mutation of SMC4 was found to result 
in chromosome segregation errors and chromosome decondensation (Strunnikov, 
Hogan, & Koshland, 1995). 
 
1.2.1 Cohesin: a homolog of condensin 
 
Considerable research effort has focused on the cohesin complex, which is 
homologous to condensin. The two complexes are structurally very similar, and both 
restructure chromatin before cell division. Cohesin maintains sister chromatid 
cohesion between S phase and anaphase, by entrapping sister chromatids within a ring-
like structure (Gruber, Haering, & Nasmyth, 2003). Cohesin is removed from 
chromosomes via two distinct pathways (as discussed in Section 1.1.2.2). Cohesin is 
removed from the chromosome arms during prophase by a pathway involving Wapl, 
but Shugoshin 1 (Sgo1) and PP2A are thought to prevent removal of centromeric 
cohesin at this stage, by counteracting phosphorylation and preventing binding of 
Wapl to cohesin located at the centromeres (Hara et al., 2014; Kitajima et al., 2006). 
Anaphase begins with the proteolytic cleavage of SCC1, the kleisin subunit of cohesin, 
by separase (Hauf, Waizenegger, & Peters, 2001). This triggers the release of cohesin 
from sister chromatid centromeres, enabling the sister chromatids to be separated into 
daughter cells (Oliveira & Nasmyth, 2010). 
 
Heterozygous mutations in cohesin subunits and in NIPBL (Scc2 in yeast) - a protein 
implicated in the loading of cohesin (and condensin), have been identified in patients 
with Cornelia de Lange-like syndromes (Gil-Rodríguez et al., 2015; Liu & Krantz, 
2010). Cornelia de Lange syndrome is a developmental disorder affecting the physical 
and intellectual development of patients and is characterized by a number of traits 
including microcephaly, vision and hearing impairments, and small stature (Gil-
Rodríguez et al., 2015). Like condensin, cohesin carries out an important role in cell 
division (although perhaps to different degrees in different cell types) and it is 
therefore surprising that reduced cohesin function does not appear to impact all 
dividing cells. This might indicate that only a small amount of functional cohesin is 
required to provide cohesion. 
  
















































Cohesin is implicated in additional processes beyond sister chromatid cohesion, 
including promoting interactions between enhancers and promoters (Ong & Corces, 
2011). Cohesin binding sites often coincide with those of CCCTCF-binding factor 
(CTCF) in human cells and such sites have been suggested to form the base of 
chromatin loops and the boundaries of topological domains (TADs) to assist in 
enhancer-promoter communication (Gil-Rodríguez et al., 2015). Thus, accumulating 
evidence suggests that cohesin is involved in the formation of links between non-
homologous sequences in cis, as well as between sister chromatids (Wood, Severson, 
& Meyer, 2010). It is thought that this secondary function is impaired in patients with 
Cornelia de Lange syndrome, as sister chromatid cohesion is not obviously affected in 
patient-derived cell lines (Strachan, 2005; Vrouwe et al., 2007).  
 
1.2.2 The structure of SMC proteins 
 
Each SMC protein contains motifs - “Walker A” at the amino-terminus and the 
carboxy terminal “Walker B” motif, which are important for ATPase activity, (Figure 
1.5b). These are connected via two coiled-coil domains separated by a central hinge 
region, which allows the molecule to fold back upon itself bringing N and C termini 
into contact. All eukaryotic SMC complexes contain a heterodimer of SMC proteins, 
which interact through the hinge domain to form a V-shape, while prokaryotic 
complexes are formed from a homodimer. ATP binding, but not hydrolysis is essential 
for the association of condensin with chromosomes (Hudson et al., 2008). 
 
The SMC proteins associate with kleisins, which bridge interactions between the head 
domains of the different SMC proteins (Figure 1.5a). The kleisin subunit of cohesin is 
cleaved during anaphase by a protease called separase, allowing chromatid separation. 
Whether proteolytic cleavage of the condensin-associated kleisin is required to remove 
condensin from chromosomes is not known.  
 
As well as kleisins, the SMC2/4 heterodimer of condensin also associates with two 
different HEAT repeat-containing proteins (Capg/Capg2 and Capd2/Capd3) to the 






















complex. HEAT repeats form rod-like helical structures which, in other contexts, have 
been shown to mediate protein-protein interactions (Nasmyth & Haering, 2005). The 
subunit composition of condensin is highly conserved from yeast to humans, 
indicating its fundamental role in the physiology of eukaryotic cells. 
 
1.2.3 Two distinct complexes: condensin I and II 
 
There are at least two different condensin complexes in most eukaryotes. Evidence for 
a second condensin complex was identified (Schleiffer et al., 2003), through searches 
to identify homologs of the B. subtilis SMC-interacting protein ScpA. Schleiffer et al. 
characterized a superfamily of SMC-interacting proteins, called kleisins. This family 
included the Barren/CAP-H-kleisin (a known subunit of condensin I) and a novel 
protein, which was termed kleisin-β (Schleiffer et al., 2003). In addition to condensin 
I and condensin II, a third distinct condensin I-like complex binds specifically to X 
chromosomes in C. elegans.  This complex is known as the dosage compensation 
complex (DCC), as it is involved in the regulation of transcription levels in 
hermaphrodites (Csankovszki et al., 2009). 
 
Vertebrate condensin II was discovered through searches for homologs of condensin I 
subunits (Ono et al., 2003). Condensin II contains the same SMC subunits as 
condensin I (SMC2 and SMC4), but is comprised of different non-SMC subunits (Ono 
et al., 2003; Ono, Fang, Spector, & Hirano, 2004). While the SMC2/SMC4 dimer in 
condensin I associates with a Barren/CAP-H-kleisin, the condensin II dimer associates 
with the kleisin identified by Schleiffer et al., - Kle-2/CAP-H2-kleisin (Schleiffer et 
al., 2003). Different pairs of HEAT repeat-containing proteins associate with 
condensin I (CAP-D2 and CAP-G) and condensin II (CAP-D3 and CAP-G2) 
(Nasmyth & Haering, 2005) (Figure 1.5a). The gene duplications that gave rise to these 
paralogs apparently predate the radiation of modern day eukaryotes (Tatsuya Hirano, 
2012). 
 
Despite their conserved subunit composition, condensin I and condensin II exhibit 
different cell cycle localization patterns. Immunostaining of a condensin I subunit 
shows it to be cytoplasmic during interphase, and only associated with chromosomes 
after breakdown of the nuclear membrane during prometaphase. In contrast, the 






















condensin II complex is both nuclear and cytoplasmic throughout the cell cycle (Ono 
et al., 2004). Fluorescence recovery after photobleaching (FRAP) was used to assess 
the association of the condensin complexes with chromatin and revealed that 
condensin II binding to mitotic chromatin is stable, whereas condensin I binding is 
dynamic (Gerlich, Hirota, Koch, Peters, & Ellenberg, 2006). Given their different 
spatial localization and binding affinities, it seemed likely that the functions of 
condensin II would be distinct from those of its condensin I counterpart. 
 
1.2.3.1 Functions of condensin I and II 
 
It is becoming apparent that different cell types, species, and experimental systems 
have different degrees of requirement for condensins I and II - the reasons for which 
are not yet known.  Using gene disruption, Fujiwara et al. demonstrated that condensin 
II is not essential for mitosis in the model organism Cyanidioschyzon merolae, which 
was chosen because the localization of the condensin complexes throughout the cell 
cycle is similar to that of vertebrate cells, and also because it is one of the most basal 
eukaryotes known to have two condensin complexes (Fujiwara, Tanaka, Kuroiwa, & 
Hirano, 2013). Using immunodepletion experiments, Shintomi and Hirano showed 
that Xenopus egg extract chromosomes were less severely impacted by depletion of 
condensin II compared to condensin I. They found that the ratio of condensin I to 
condensin II in Xenopus egg extracts is 5:1, which implies that the contribution of 
condensin II to chromosomal architecture is far less important than that of condensin 
I in this organism (Shintomi & Hirano, 2011). In DT40 chicken cells, the ratio of 
condensin I to II is even more extreme at 10:1 (Green et al., 2012; S. Ohta et al., 2010). 
Finally, condensin II is known to function during interphase in several organisms 
(Bauer, Hartl, & Bosco, 2012; Haeusler, Pratt-hyatt, Good, Gipson, & Engelke, 2008; 
Hartl, Smith, & Bosco, 2008; Wood et al., 2010). Taken together, this data suggests 
that the role of condensin II may not be as vital as that of condensin I in mitosis. 
 
Despite this, there is increasing evidence to suggest that condensins I and II have 
distinct, as well as overlapping functions in some model systems. A recent study 
investigated the roles of condensins I and II using mouse strains containing floxed 
alleles of Caph1 (condensin I) and Caph2 (condensin II). Caph1 and Caph2 were 
inactivated specifically in meiosis using Cre recombinase (Houlard et al., 2015) which 






















revealed that condensin II, but not condensin I, is essential for meiosis since Caph1 
deletion did not result in a pronounced effect, while Caph2 deletion caused sterility. 
In addition, condensin II depletion was shown to affect chromosome morphology, with 
stretching of pericentric sequences occurring during spindle attachment, and delayed 
bi-orientation of chromosomes. No such effect was observed as a consequence of 
Caph1 deletion. However, deletion of both Caph1 and Caph2 resulted in failure to 
form pericentric foci, and stretching of the pericentric sequences was more severe than 
that observed for the Caph2 single mutant (Houlard et al., 2015), indicating that some 
of the functions of condensins I and II overlap. 
 
Nishide and Hirano (Nishide & Hirano, 2014) found that condensin I and II are both 
essential for accurate chromosome segregation in mouse neuronal stem cells (NSCs), 
and contribute to chromosome re-structuring and maintenance in distinct, as well as 
overlapping ways. Using strains of conditional knockout (cKO) mice that were 
depleted for condensin subunits, they found that defects in cortical development were 
most severe in animals depleted of both CAP-H and CAP-H2 (i.e. both condensins I 
and II) or depleted of SMC2 (a subunit common to both condensin complexes), 
supporting the hypothesis that condensins I and II carry out overlapping functions.  
However, NSC numbers were also significantly reduced in strains depleted of both 
CAP-H (condensin I) and CAP-H2 (condensin II) individually, indicating that both 
complexes also perform distinct roles that are essential for cortical development 
(Nishide & Hirano, 2014). 
 
Conditional knockouts of the genes encoding CAP-H (condensin I subunit) and CAP-
D3 (condensin II subunit) in chicken cells showed that condensin I depleted mitotic 
chromosomes were wider and shorter, whereas condensin II depleted chromosomes 
seemed to lack axial rigidity, as indicated in Figure 1.6. The results suggested that 
condensin II plays a vital role in the construction of an initial chromosome axis, 
thereby providing rigidity. Interestingly, the results indicate that condensin I deficient 
cells are better able to condense and divide appropriately than condensin II depleted 
cells. Anaphase bridges were observed in both condensin mutants, but were 
considerably more severe for cells that were depleted of condensin II. Additionally, 
condensin I depleted cells were considerably more successful in maintaining 
chromosome rigidity (Green et al., 2012). The main consequence of condensin 






















depletion (through the conditional knock out of SMC2) in chicken DT40 cells was 
revealed to be loss of rigidity, or stiffness (Ribeiro et al., 2009). 
 
Consistent with this, Hudson et al. found that altering the ratio of condensin I and II 
in DT40 cells via disruption of a conserved Cdk1 phosphorylation site within CAP-
D3 changed the shape of mitotic chromosomes (Bakhrebah, Zhang, Mann, Kalitsis, & 
Hudson, 2015). This was the first evidence indicating that manipulation of the ratio of 
condensin I to II alters mitotic chromosome shape in vivo. This is also supported by 
the fact that chromosomes formed in Xenopus egg extract are long and thin, with a 
ratio of condensin I to condensin II of approximately 5:1. In HeLa cells however, 
where the ratio is closer to 1:1, the chromosomes are generally shorter and thicker. 
Indeed, Shintomi and Hirano found that when the ratio of condensin I to condensin II 
in Xenopus egg extracts was experimentally manipulated by quantitative 
immunodepletion to give a 1:1 ratio, the chromosomes became shorter and thicker 
(Shintomi & Hirano, 2011). However, the molecular mechanisms through which 
condensins impact chromosome morphology still remain poorly understood. 
 
Ono et al., using siRNAs to knockdown CAP-G (condensin I) and CAP-G2 (condensin 
II) in HeLa cells, reported dramatic differences in the structure of mitotic 
chromosomes depleted of condensin I relative to condensin II (Ono et al., 2004). 
Depletion of CAP-G resulted in localisation of SMC2 away from the central 
chromosome axis, and a slight swelling of the chromosomes. Depletion of CAP-H2, 
however, resulted in dramatic morphological changes, with SMC signal localised 
along a “wavy” central chromatid axis. The sister chromatid arms were also often no 
longer positioned close to one another, but became splayed (Ono et al., 2003). These 
data support the hypothesis that condensin II contributes to the structural rigidity of 
metaphase chromosomes, in a role that is distinct from that of condensin I.   
 
In their study, Nishide and Hirano found that depletion of SMC2 and simultaneous 
depletion of condensin I and II subunits in mNSCs resulted in severe chromosomal 
abnormalities and apoptosis as a result of p53 accumulation (Nishide & Hirano, 2014).  
 













































However, RNAi-mediated depletion of SMC2 in mouse embryonic stem cells 
(mESCs) was reported to result in cell cycle arrest during metaphase (Fazzio & 
Panning, 2010). These differences may indicate that the response to condensin-
deficient mitosis is cell type dependent. Nishide and Hirano further investigated a 
possible cell type-dependent consequence of condensin depletion using an alternative 
cell line – the human retinal pigment epithelial cell line (RPE-1) – and demonstrated 
that unlike mouse NSCs, abnormal RPE-1 cells accumulate nuclear p21 and became 
senescent, rather than either undergoing G1/S phase arrest, or p53 nuclear 
accumulation leading to apoptosis (Nishide & Hirano, 2014). 
 
1.2.4 The role of condensins in organising chromosome structure 
 
Hirano and Mitchison carried out some of the earliest investigations relating 
condensins to mitotic chromosome structure, using Xenopus egg extracts to 
demonstrate that a heterodimeric coiled-coil protein (later shown to be condensin) is 
essential for proper condensation of chromatin into typical rod-shaped chromosomes 
(Hirano & Mitchison, 1994). As well as being required for the final stages of Xenopus 
chromatin condensation, condensin is also essential for the maintenance of 
condensation, unlike topoisomerase IIa, which can be extracted without altering the 
chromosome structure (Ono et al., 2003).  
 
DNA condensation is necessary before mitosis for two main reasons. Firstly, 
uncondensed chromosomes are larger than the diameter of the mitotic cell and so 
would be broken by the cleavage furrow at cytokinesis (a so-called cut phenotype). 
Secondly, the condensed chromosomes are structurally rigid, and are therefore less 
likely to be damaged when they are subjected to the opposing forces which separate 
the sister chromatids during anaphase. Homologs of condensin subunits are important 
for chromosome condensation in many model organisms, including S. cerevisiae 
(Alexander, Hogan, & Koshland, 1995), and Drosophila (Bhat, Philp, Glover, & 
Bellen, 1996). 
 
However, other studies have indicated that condensin depletion has only a very subtle 
effect on chromosome condensation (Charbin, Bouchoux, & Uhlmann, 2014; Coelho, 
Queiroz-Machado, & Sunkel, 2003; Steffensen et al., 2001). This has been most 






















extensively characterised in chicken DT40 cells in which knockout of SMC2 results 
in cells that are able to form mitotic chromosomes, albeit not entirely normal ones 
(Hudson et al., 2003). This could indicate that the role of condensin in the formation 
of condensed mitotic chromosomes is not universal, and may vary between cell types 
or organisms. In fact, rather than chromosome decondensation, loss of condensin is 
most commonly associated with anaphase defects such as the presence of anaphase 
bridges, leading to abnormal chromosome segregation.  
 
1.2.4.1 Mechanisms of condensin 
 
Very little is known about the mechanism by which condensin might condense 
chromatin. Given the structural similarity of condensin and cohesin, it has been 
suggested that condensin might encircle DNA, causing distal DNA segments to be 
brought into close proximity, in the same way that cohesin is thought to encircle sister 
chromatids during S phase. This hypothesis is supported by experiments showing that 
either linearization of circular mini chromosomes, or opening the ring structure of 
condensin using engineered protease cleavage sites, results in disassociation of 
condensin from chromosomes (Cuylen, Metz, & Haering, 2011).  
 
This mechanism would facilitate the condensation of chromosomes, but could also 
inhibit the formation of sister chromatid catenations formed during replication by 
contracting the newly replicated DNA away from their sister DNA (Gruber et al., 
2014). However, unlike in bacterial cells where replication and segregation occur 
concomitantly, metazoan chromosome condensation does not begin until long after 
replication has finished. In the presence of topoisomerase, condensin is known to be 
involved in DNA supercoiling (Kimura, Rybenkov, Crisona, Hirano, & Cozzarelli, 
1999), which is thought to play a significant role in the restructuring of chromatin in 
preparation for mitosis. 
 
  
























During replication or transcription, the double-stranded DNA must be unwound at a 
certain location, in order that polymerases can gain access to single-stranded DNA and 
begin replication or transcription. This unwinding causes the DNA to become 
overwound (positively supercoiled) in front of the polymerase, and underwound 
(negatively supercoiled) behind it (Gilbert & Allan, 2013; Liu & Wang, 1987). 
Supercoiling arises due to an inability to rotate “free ends” of the DNA around one 
another, and the inability of the polymerase to turn with the pitch of the helix, due to 
its size. This restriction of DNA can occur in several ways. For example, ends of the 
DNA may attach to one another forming a closed circle: a shape that is representative 
of bacterial circular plasmids. Supercoiling can also occur in linear DNA perhaps due 
to restriction of free rotation at supercoil boundaries (discussed below) or due to the 
rapid introduction and slow dissipation of torsion (Kouzine, Liu, Sanford, Chung, & 
Levens, 2004). 
 
Positive supercoiling is the process of over-winding a DNA strand, which imposes 
strain on the strand, and alters its shape. The level of supercoiling is determined by the 
number of twists relative to a relaxed strand, and the number of times the strand crosses 
over itself, which is known as writhe. Writhe can form two types of supercoils: 
solenoidal supercoiling involves the curving of DNA into spirals around a ring (for 
example when DNA wraps around a protein, Figure 1.7a, left and Figure1.7b), while 
plectoneme supercoiling occurs when the strand crosses above and below itself: Figure 
1.7a, right and Figure 1.7b (Calladine, Drew, Luisi, & Travers, 1994). Topoisomerase 
enzymes have the ability to relieve helical stress by cutting one or both DNA strands 
thereby introducing “free ends” and allowing the strands to unwind and relieve tension, 
before topoisomerase repairs the breaks. Topoisomerase I enzymes cleave single 
stranded DNA, while topoisomerase II cleaves double stranded DNA. It is likely that 
topoisomerase II works on most DNA strand crossovers during plectonemic writhe, 
and has been shown to be involved in sister chromatid separation and decatenation of 
circular chromosomes (Baxter et al., 2011). However, the different roles of 
topoisomerases I and II in relieving supercoils generated by polymerases are somewhat 
unclear. 
 















































The linking number (Lk) is the sum of twist (Tw) and writhe (Wr). The Lk remains 
constant – unless the strand is cut by, for example, topoisomerase (Figure 1.7c). DNA 
in its relaxed state has a linking number of zero. By convention, if the DNA is 
overwound it is assigned a positive value for Lk, and underwound DNA is assigned a 
negative value.  
 
Generally, DNA that is not being replicated (relaxed) is underwound, i.e. it has a 
negative Lk0 (Champoux, 2001). In vitro studies have demonstrated that, in the 
presence of bacterial or eukaryotic topoisomerase I, condensins can alter DNA 
topology by forming positive supercoils (Kimura & Hirano, 1997). This change in 
DNA structure requires mitotic condensin, specifically. In contrast, condensin purified 
from interphase extracts does not introduce positive supercoils into the circular DNA 
(K Kimura, Hirano, Kobayashi, & Hirano, 1998).  
 
Following the discovery that condensin acts in concert with bacterial or eukaryotic 
topoisomerase I to introduce positive supercoils into Xenopus DNA (Kimura & 
Hirano, 1997), work was carried out to determine how condensin might achieve this 
topological change. The structure of condensin provided some clues: the anti-parallel 
confirmation of SMC proteins (Figure 1.5a) results in the ability of condensins to bind 
both ATP via the C terminus, and DNA via the N terminus. ATP hydrolysis could 
power the complex to alter the DNA structure between the bound globular heads 
(Lammens, Schele, & Hopfner, 2004) thereby resulting in a more compact chromatin 
configuration. 
 
Xenopus 13S condensin restructures DNA by introducing global positive writhe into a 
circular plasmid in the presence of topoisomerase I. This might occur when multiple 
condensin complexes bind to DNA and introduce a right-handed bend - Figure 1.8a 
(Kimura et al., 1999). This hypothesis is supported by the fact that proteins that bend 
DNA often preferentially bind to four-way junctions (Bhattacharyya et al., 1991): a 
property shared by condensin (Kimura & Hirano, 1997). 
  













































The introduction of global positive writhe by condensin is an efficient way of 
compacting chromosomes since it causes chromosome structure to alter directly, rather 
than relying on the introduction of compensatory negative supercoils to bring about 
condensation. Therefore, it seems likely that condensin induces chromosome 
condensation via the introduction of global positive writhe, rather than positive 
supercoiling on a more local level (Kimura et al., 1999). 
 
In agreement with previous studies (Kimura et al., 1998), mitotic condensin was found 
to be able to introduce topological changes to Xenopus DNA (supercoiling and 
knotting), while interphase condensin was not (Kimura et al., 1999). This stage 
specific nature of condensin mediated supercoiling is phosphorylation dependent, 
since the ability of interphase condensin to introduce positive supercoils and knots is 
greatly enhanced by Cdc2-cyclin B (Kimura et al., 1998; Kimura et al., 1999).  
 
There are Cdc2 phosphorylation sites in the C-terminus of the condensin II subunit 
CAP-D2 in Xenopus, leading Kimura et al. to speculate that Cdc2 induces chromatin 
condensation by phosphorylating (and thereby activating) condensin (Kimura et al., 
1998). However, inhibiting protein phosphatase 1 from localizing to mitotic 
chromosomes rescues condensation defects in cells depleted of condensin subunits 
(Vagnarelli et al., 2006), which may indicate that Cdc2-cyclin B and condensin 
reconfigure chromatin via distinct mechanisms. Vagnarelli et al. suggest that since 
chromosomes can undergo condensation and mitosis until the onset of anaphase in the 
absence of condensin in some model organisms (Charbin et al., 2014; Coelho et al., 
2003; Steffensen et al., 2001), a system other than condensin must exist to compact 
chromosomes. This system was termed the “regulator of chromosome architecture” 
(RCA). It was hypothesised that the RCA system may be regulated by CDK1 
phosphorylation, which induces chromosome condensation. Subsequently, condensin 
maintains and stabilizes the condensed state (Vagnarelli et al., 2006). 
 
1.2.4.3 Disentangling DNA catenations  
 
In order for supercoiling to have any impact on the structure of DNA, it was thought 
that the ends of the strands must be constrained, such that the tension produced as a 
consequence of unravelling the sister strands does not dissipate, i.e. the DNA strands 






















must be prevented from rotating relative to each other. DNA rotation might be 
prevented by physical barriers, which would bind to the DNA strands and constrain 
them. As mentioned above, however, some evidence exists to suggest that transient 
supercoiling might arise in linear DNA without the presence of barriers due to the 
rapid introduction and slow dissipation of torsion (Kouzine et al., 2004), or 
alternatively as a consequence of increased friction due to higher order chromatin 
organisation (Kouzine, Levens, & Baranello, 2014). 
 
DNA is organized into topological supercoiling domains (Worcel & Burgi, 1972). 
Supercoiling domains were initially investigated in prokaryotes (Hardy, Crisona, 
Stone, & Cozzarelli, 2004), but have also been characterised in higher eukaryotes 
(Naughton et al., 2013). Supercoiling domains of higher eukaryotes are large areas 
(approximately 100kb) of overwound and underwound DNA, and are distinct from 
TADs  (Gilbert & Allan, 2013). Experiments using psoralen, which preferentially 
binds to underwound DNA, indicates that supercoiling domains are approximately a 
tenth of the size of TADs (Bermúdez, García-Martínez, Pérez-Ortín, & Roca, 2010; 
Pezzulo et al., 2013) – i.e. approximately the size of a replicon.  
 
In order to carry out semi-conservative DNA replication, the linking number must be 
reduced to zero (Hardy et al., 2004). Division of the genome into domains allows this 
reduction of linking number to occur across the smaller DNA segments: something 
that would be impossible across whole genomes. In addition, the barriers isolate the 
production of supercoils and precatenanes to limited areas. This may result in the 
ability to decondense and replicate a single domain followed by topoisomerase 
mediated removal of some of the resulting supercoils and precatenanes before 
progressing to the next domain in a systematic manner - Figure 1.8b (Hardy et al., 
2004). This hypothesis is only applicable when chromosome condensation occurs 
concomitantly with DNA replication. 
 
If topoisomerase enzymes do not relieve the tension almost immediately, the positive 
supercoiling in front of the fork will increase as the fork progresses along the strand. 
As the fork approaches the place at which the strands are constrained (e.g. the domain 
barrier), less space will be available to contain the supercoils. Additionally, less space 
will be available for topoisomerases to act to remove the supercoils (Postow, Crisona, 






















Peter, Hardy, & Cozzarelli, 2001). However, the tension caused by the fork 
progression may be dissipated along the DNA strand if the fork is able to rotate. This 
rotation would result in the introduction of precatenanes between daughter strands (J. 
Champoux & Been, 1980). Convincing evidence exists indicating that precatenanes 
arise in circular plasmids both in vitro and in vivo (Adams, Shekhtman, Zechiedrich, 
Schmid, & Cozzarelli, 1992; Khodursky, Zechiedrich, & Cozzarelli, 1995; Peter, 
Ullsperger, Hiasa, Marians, & Cozzarelli, 1998; Sundin & Varshavsky, 1981). Due to 
the difficulty in observing catenations in linear DNA, however, there is no direct 
evidence for the presence of inter-strand catenations. However, the high incidence of 
anaphase bridges in topoisomerase mutants indicates that sister catenations may also 
arise in higher eukaryotes (DiNardo, Voelkel, & Sternglanz, 1984; Sundin & 
Varshavsky, 1980). 
 
Processes other than fork rotation may also introduce precatenanes into sisters, 
including aberrant topoisomerase activity or perhaps replication fork collisions, as has 
been shown in SV40 cells (Sundin & Varshavsky, 1980). 
 
Studies in the yeast S. cerevisiae have shown that the complete removal of catenations 
by topoisomerase II is dependent on the presence of mitotic spindles (Baxter et al., 
2011; Holm, Goto, Wang, & Botstein, 1985; Uemura et al., 1987). Additionally, 
topoisomerase II activity is required as late as anaphase in budding yeast (Baxter & 
Diffley, 2008), implying that the cell must progress through M phase for all catenations 
to be resolved. However, the process of decatenation is known to begin during 
replication, very quickly after the catenations are introduced (Charbin et al., 2014; 
DiNardo et al., 1984; Sundin & Varshavsky, 1981) and several studies have concluded 
that sister DNA molecules are completely decatenated before the sisters are separated 
by the spindle (Baxter et al., 2011; Oliveira, Hamilton, Pauli, Davis, & Nasmyth, 
2010). As discussed previously, however, investigations into sister catenations have 
generally been carried out using circular chromosomes, and therefore the relevance of 
these results to open-ended eukaryotic chromosomes is unclear. 
 
Depletion of condensin in yeast resembles the phenotype of topoisomerase II depletion 
(Bhalla, Biggins, & Murray, 2002; Uemura et al., 1987), suggesting that the two 
proteins act in concert to resolve catenations. This is supported by the direct interaction 






















of the E.coli condensin homolog MukB with topoisomerase IV (Li et al., 2010), which 
is a homolog of eukaryotic topoisomerase II. Using electrophoresis assays, it was also 
shown that MukB can stimulate topoisomerase IV to relax plasmid DNA in a dose 
dependent manner (Li et al., 2010). However, the magnitude of the effects was not 
large.  
 
Several studies have been carried out to investigate the role of supercoiling in the 
decatenation of prokaryotic chromosomes, and concluded that sister chromatid 
catenations are reduced by the introduction of intra-chromosomal supercoils (Hardy et 
al., 2004; Martínez-Robles et al., 2009; Zechiedrich, Khodursky, & Cozzarelli, 1997). 
Consequently, Baxter et al. set out to investigate whether decatenation of eukaryotic 
sister chromosomes is also facilitated by the introduction of positive supercoils. Using 
circular yeast plasmids depleted of functional topoisomerase II, they demonstrated that 
the conformation of eukaryotic circular chromosomes changes from being negatively 
supercoiled before mitosis, to being positively supercoiled during mitosis. Usually, 
however, topoisomerase II rapidly relaxes the positive supercoils. The transition from 
negative to positive supercoils is dependent on the presence of mitotic spindles, since 
it does not take place when the cells are treated with nocodazole, a microtubule-
depolymerizing drug (Baxter et al., 2011).  
 
It was hypothesised that the conformational changes to DNA during mitosis (i.e. the 
introduction of positive supercoils) might be necessary for topoisomerase II mediated 
decatenation. Interestingly, it was found that DNA enriched for positive supercoils was 
more easily decatenated by topoisomerase II than negatively supercoiled DNA (Baxter 
et al., 2011). In agreement with previous results (Kimura & Hirano, 1997; Kimura et 
al., 1999), condensin was found to be necessary for the formation of positive 
supercoils (Baxter et al., 2011). This indicates that condensin, alongside 
topoisomerase II, plays an important role in decatenation of sister-strands, at least in 
S. cerevisiae minichromosomes. Indeed, it has been suggested that positive 
supercoiling of DNA by condensin might be necessary to provide directionality to the 
decatenating activity of topoisomerases and thereby minimize inter-chromosomal 
bridging (Baxter & Aragón, 2012). Without the ability to direct topoisomerases to 
introduce breaks in the appropriate places, topoisomerases might introduce as many 
catenations as they resolve. Condensin depletion has been shown to affect the 






















localisation of topoisomerase II on mitotic chromosomes (Coelho et al., 2003; Hudson 
et al., 2003), further indicating that topoisomerase II binding is influenced by the 
presence of positive supercoils introduced into the DNA by condensin. However, work 
carried out by Vagnarelli et al. in chicken DT40 cells using an SMC2 conditional 
knock out did not reveal differential topoisomerase II activity as a consequence of 
condensin depletion (Vagnarelli et al., 2006).  
 
In budding yeast, a recent study addressing the process of sister chromatid 
decatenation on circular chromosomes of different sizes, discovered that most 
catenanes were resolved quickly, while S phase was ongoing. However, condensin 
was required to complete the process of decatenation and remove all remaining 
catenanes. This was most evident in the largest chromosomes (Charbin et al., 2014). 
 
The vast majority of studies into whether condensin acts to resolve catenations have 
been carried out in prokaryotes, or on circular mini-chromosomes in yeast, because 
catenations between linear DNA strands is lost after DNA extraction. A major 
challenge facing the field is to ascertain the extent to which these findings are 
applicable to the linear chromosomes found in eukaryotes, which can be hundreds of 
megabases in size and subject to a distinct set of topological constraints. 
 
1.2.5 Condensin's role in organizing the interphase genome in preparation for mitosis 
 
While condensin I is cytoplasmic during interphase, condensin II is nuclear (Gerlich 
et al., 2006; Tatsuya Hirano, 2012; Ono et al., 2004). This differential localization 
might indicate that condensin II-mediated condensation begins before prometaphase, 
when condensin I gains access to the chromosomes. This implies that chromosome 
condensation is a carefully timed process: first condensation by condensin II provides 
rigidity, and only then do chromosomes undergo lateral condensation by condensin I 
after breakdown of the nuclear membrane.   
 
 
Consistent with the prediction that condensin II begins to restructure chromosomes 
prior to breakdown of the nuclear membrane during prometaphase, siRNA knockdown 






















studies of CAP-G or CAP-G2 levels suggested that condensin II could be important 
during the early stages of chromosome assembly, during prophase or prometaphase 
(Ono et al., 2004), or perhaps even as early as S phase (Ono, Yamashita, & Hirano, 
2013). Most CAP-H2 was found to be detergent extractable from G1/S phase HeLa 
cells, but became increasingly detergent resistant as cells progressed through S to G2. 
This data was used to support the hypothesis that condensin II begins to associate with 
chromatin during S/G2, before chromosome compaction becomes evident. 
 
Next, Ono et al. artificially induced chromosome condensation of early, mid and late 
S phase cells (determined using EdU incorporation) (Ono et al., 2013). G1 and G2 
(EdU negative) stage cells were determined on the basis of their appearance, and 
number of chromosomes. The prematurely condensed early S phase chromosomes 
were “pulverised” into a number of small fragments, whereas the structure of the late 
S phase chromosomes were drastically different: in fact, discernible paired sister 
chromatids were observed in the early replicating regions (as judged by EdU). The 
researchers then carried out premature chromosome condensation in HeLa cells 
depleted of condensin subunits. When CAP-G (a condensin I subunit) was depleted, 
only minor changes to the structure of the prematurely condensed chromosomes were 
observed. However, drastic morphological changes were observed in the cells depleted 
of CAP-G2 (a condensin II subunit): the sister chromatids were no longer easily 
discernible, and interestingly, the chromosomes were “wavy” in appearance. The 
researchers inferred from this data that condensin II, rather than condensin I is crucial 
for PCC-driven chromosome condensation. 
 
In addition, the researchers used FISH as an independent method to investigate the 
role of condensin II in the resolution of sister chromatids during S phase. To achieve 
this, the distance between FISH probes situated on sister chromatids was measured in 
late S phase cells depleted of either a condensin I (CAP-G2), condensin II (CAP-G) or 
a cohesin (Rad21) subunit. The cells depleted of condensin I showed no change in the 
distance between probes with respect to wildtype. However, the distance between 
probes increased in cells depleted of cohesin (as expected due to a loss of sister 
chromatid cohesion) and significantly decreased in cells depleted of condensin II. 
These data provide additional support to the theory that condensin II plays a role in 
the individualisation of sister chromatids during late S phase, before entry into mitosis 






















(Ono et al., 2013). 
 
1.2.5.1 Condensin as a regulator of gene expression 
 
An alternate explanation for the location of condensin II in the nucleus could be that 
it also functions during processes that are completely independent of cell division, 
such as transcription (Bauer et al., 2012; Fazzio & Panning, 2010; Haeusler et al., 
2008; Kruesi, Core, Waters, Lis, & Meyer, 2013; Li et al., 2015). The possibility that 
condensin could be a regulator of gene expression was originally suggested by studies 
on Caenorhabditis elegans dosage compensation: a process that controls gene 
expression across a whole chromosome. The purpose of dosage compensation is to 
ensure that the genes located on the X-chromosome are equally expressed in males 
(XO) and hermaphrodites (XX). In C. elegans, this occurs by the condensin I-like 
dosage compensation complex (DCC) binding to both X chromosomes and reducing 
transcriptional output to half the level of the single male X-chromosome.  
 
The mechanism by which the DCC controls transcription is not completely 
understood, but is thought to involve the reduction of RNA Pol II recruitment to 
promoters (Kruesi et al., 2013). C. elegans have three, rather than two condensin 
complexes, of which two are orthologues of condensin I (Csankovszki et al., 2009). 
As discussed previously, the DCC is almost identical in structure to condensin I, and 
only differs by one subunit: SMC4 is replaced by DPY-27 (Csankovszki et al., 2009). 
The DCC is involved in the restructuring of the X chromosome with the formation of 
a series of regularly spaced topologically associated domain (TAD) boundaries (Crane 
et al., 2015). The conformation of the X chromosome is distinct from that of autosomes 
since X chromosomes consist of more pronounced and more regularly spaced TAD 
boundaries. Interestingly, the boundaries were shown to be enriched within areas of 
high-affinity DCC binding sites. DCC-defective mutants caused a reduction in the 
number of TAD boundaries, resulting in chromosome topology that closely resembled 
that of autosomes (Crane et al., 2015). 
 
Condensins have also been implicated in other interphase processes. Condensin 
promotes physical clustering of tRNA genes in the yeast nucleus, despite their being 






















encoded on different chromosomes (Haeusler et al., 2008). It has also been 
demonstrated that condensin II acts to inhibit transvection in flies: an interaction 
between homologous alleles, resulting in either gene activation or repression. The 
same study also demonstrated that polytene chromosomes fail to disassemble during 
Drosophila nurse cell development in condensin mutants (Hartl, Smith, et al., 2008). 
Thus, condensin complexes may serve to prevent associations between different 
chromosomes during both interphase and mitosis (Hartl et al., 2008; Wood et al., 
2010). 
 
The possibility that condensin may be important for the formation or maintenance of 
interphase chromosome territories is supported by a study of polytene chromosomes 
in condensin-deficient nurse cells in Drosophila. This study revealed that condensin II 
promotes the axial compaction of interphase chromosomes, thereby sequestering 
chromatin into discrete areas or “territories” (Bauer et al., 2012). However, 
mammalian chromosomes don’t generally exist in a polytene configuration, so 
whether these findings would apply to mammals is not currently clear. Since the 
majority of the work into the roles of condensins in regulating gene expression had 
thus far focused on simpler eukaryotes, Heale et al. used HeLa cells to better 
understand the interphase roles of condensin I in higher eukaryotes (Heale et al., 
2006).  While the vast majority of condensin I is sequestered within the cytoplasm 
during interphase (Ono et al., 2003), evidence exists to suggest that a subpopulation 
of condensin I associates with chromatin during interphase (Li et al., 2015; 
Schmiesing, Gregson, Zhou, & Yokomori, 2000). Heale et al. discovered that 
mammalian condensin I interacts with DNA nick-sensor poly(ADP-ribose) 
polymerase 1 (PARP-1) and base excision repair (BER) machinery to rapidly repair 
single stranded breaks. Additionally, it was shown using conditional knockout DT40 
cells that condensin I depletion compromises single strand, but not double strand break 
repair (Heale et al., 2006). 
 
The diversity of the roles of condensin complexes in both chromosome segregation 
and interphase gene regulation indicate their adaptability: altering one subunit results 
in multiple complexes that are able to carry out diverse biological functions. 
 
 






















1.2.6 Genome instability and chromosome missegregation as a consequence of 
condensin mutation  
 
Mutations in condensin can impede both chromosome resolution and condensation. 
Failures in either of these processes could lead to abnormal mitosis with an increased 
incidence of anaphase bridges (Vagnarelli et al., 2006; Hartl, Sweeney, Knepler, & 
Bosco, 2008), abnormal ploidy (Cobbe & Heck, 2000; Green et al., 2012; Hardy et al., 
2004), and ultimately, cancer. An investigation into the potential causes of lymphoma 
revealed mutations in condensin subunits in multiple leukaemia-lymphoma patient-
derived cell lines (Ham et al., 2007). Three of the eight pyothorax-associated 
lymphoma (PAL) cell lines tested revealed either SMC2 or SMC4 heterozygous 
missense mutations, suggesting that mutations in condensin are reasonably frequent in 
PAL. Additionally, condensin I or condensin II subunit mutations have been detected 
in 4.2% of tumours tested by Leiserson et al. This represents a statistical enrichment, 
and therefore supports the hypothesis that these complexes play an important role in 
preventing chromosomal instability and tumourigenesis (Leiserson et al., 2015). 
 
1.2.6.1 Interlinked sister chromatids as a consequence of the absence of condensin I 
in B. subtilis 
 
A study into the importance of condensin for accurate sister chromatid segregation in 
B. subtilis found that condensin deficient bacterial cells did not undergo successful 
chromosome segregation when grown in rich medium. This was investigated by 
labelling the origin of replication, oriC, with GFP during spore outgrowth. A second 
GFP signal quickly appeared in control cells, followed by a third and a fourth, until 
multiple GFP signals were observed uniformly throughout the cell. Multiple GFP 
signals were generally absent in condensin mutant cells. However, the intensity of the 
signal gradually increased, leading the researchers to conclude that multiple oriC 
regions are generated, but are unable to segregate efficiently from one another (Gruber 
et al., 2014). 
 
Using small-molecule inhibitors to slow the growth rate of B subtilis, and treatment 
with either chloramphenicol or streptolydigin (which inhibit translation and 
transcription respectively), the researchers investigated the possibility that rapid cell 






















growth rates were the cause of the condensin deficient lethality. However, under slow 
cell growth conditions, condensin depleted cells were still unable to grow and divide 
accurately. Further investigation revealed that lowering replication fork velocity, 
specifically, by the addition of either hydroxyurea (HU) or arginine hydroxamate 
(Rhx) rescued the phenotype of condensin deficient cells. The researchers concluded 
that condensin is essential in rapidly dividing bacterial cells with replication forks that 
progress quickly, but that chromosome segregation occurs almost normally in 
condensin mutants when the replication fork velocity is artificially slowed (Gruber et 
al., 2014). 
 
This suggested that fast DNA replication might result in more pressure being placed 
on topoisomerase to untangle chromosomes, resulting in an increase in chromosomal 
bridging. However, Rudner et al. have shown that inactivation of topoisomerase IV 
does not hinder segregation at replication origins in B. subtilis (Wang, Tang, Riley, & 
Rudner, 2014). This implies that fast DNA replication may result in long swathes of 
replicated DNA situated alongside its sister DNA. Nucleoid-associated proteins may 
more readily bridge these sisters, resulting in an inability to separate efficiently during 
segregation. Gruber et al. suggest that condensin may be involved in contracting the 
newly replicated DNA away from its sister, thereby minimizing the potential for 
catenations. Whether these findings also apply to mammals is, as yet, unknown. 
However, this study does provide further support for a possible role of condensin in 
the restructuring of chromatin during genome duplication, specifically during rapid 
fork progression, as well as during segregation. 
 
1.3 Chromosomal Instability (CIN) 
 
Chromosomal instability is an increased likelihood of the duplication or loss of either 
whole or subsections of chromosomes. Mistakes in chromosome segregation can lead 
to chromosomal instability, resulting in the production of aneuploid cells. There is a 
consensus that the acquisition of an aneuploid karyotype is an early event in cancer 
formation, likely due to loss of chromosomes carrying tumour suppressor genes or 
gain of chromosomes carrying growth promoting genes, providing a selective 
advantage. Genome instability may also arise as a consequence of incorrect 
chromosome segregation resulting in lagging chromosomes, which may eventually 






















form micronuclei. These micronuclei undergo inefficient defective replication, leading 
to chromosome rearrangement in the following cell division (Crasta et al., 2012; 
Ganem & Pellman, 2012). In support of these hypotheses, Van Deursen et al. showed 
that defects in SAC genes accelerate thymic lymphomas in heterozygous p53 mutant 
mice, and colonic tumours in Apc mutant mice (Baker, Jin, Jeganathan, & Van 
Deursen, 2009). In almost all cases, the non-mutated tumour suppressor allele was 
absent in these tumours and had been replaced by a second copy of the mutant allele 
due to a mitotic non-disjunction event promoted by the CIN phenotype.  
 
1.3.1 Mouse models of CIN 
 
Model systems to study the consequences of CIN during development have been 
hampered by the essential role of mitotic genes in cell division, meaning that animals 
in which the function of these genes is perturbed typically die early in gestation. This 
has also been shown to be true in available mouse models of condensin mutation 
(Houlard et al., 2015; Nishide & Hirano, 2014). SAC and other mouse models of 
chromosomal instability have generally used reduction- or gain-, rather than loss-of-
function systems. A recent study has indicated that haploinsufficiency for a cohesin 
subunit can cause defective telomere replication resulting in CIN – with accelerated 
tumourigenesis and high levels of aneuploidy (Remeseiro et al., 2012). This is further 
evidence of the crucial role of chromosome structure in chromosomal stability.  
 
Many studies have shown that reducing levels of mitotic checkpoint proteins (Mad1, 
Mad2, Bub1, BubR1 etc.) results in a higher rate of chromosome missegregation in 
murine embryonic fibroblasts - “MEFs” (Baker et al., 2004; Weaver, Silk, Montagna, 
Verdier-Pinard, & Cleveland, 2007). However, the consequences of these mutations 
in terms of tumour formation were inconsistent. Li et al. expressed a dominant 
mutation in Cdc20, which prevents it being repressed by the mitotic checkpoint. The 
experiments showed that these mice exhibit high levels of aneuploidy and tumours (Li, 
Fang, Wei, York, & Zhang, 2009). However, other mouse models of CIN have shown 
that, in some cases, high levels of aneuploidy can result in decreased levels of tumour 
formation. For example, Rao et al. (2005) showed that mice carrying mutations in the 
Apc tumour suppressor displayed reduced levels of tumour formation in the small 
intestine when BubR1 was reduced (Rao et al., 2005). In addition, Jeganathan et al. 






















showed that reducing BubR1 further resulted in fewer spontaneous liver tumours 
(Jeganathan, Malureanu, Baker, Abraham, & van Deursen, 2007). 
 
One hypothesis is that low levels of CIN – a low but still elevated frequency of 
chromosome missegregations per cell division – provides the increased mutation rate 
associated with tumourigenesis, whereas higher CIN often causes apoptosis and 
tumour suppression due to the more severe perturbation of cellular physiology. Highly 
aneuploid tumour cells may be the consequence of a gradual accumulation of 
missegregations over multiple cell divisions (Holland & Cleveland, 2009). 
 
Several studies have also implicated condensin II in maintaining a stable karyotype to 
suppress tumourigenesis; however the current available evidence is indirect. 
Longworth et al. investigated the Drosophila retinoblastoma protein RBF1. Mutations 
or loss of pRB, the human ortholog of RBF1, are known to result in a variety of cancers 
including non-small-cell lung cancer, T cell acute lymphoblastic leukaemia and 
pancreatic and breast cancers. In their study Longworth et al. showed using 
biochemical techniques that RBF1 interacts with a subunit of condensin II (CAP-D3), 
and is involved in directing condensin II to DNA (Longworth, Herr, Ji, & Dyson, 
2008). Another study revealed that depletion of the retinoblastoma protein (pRB) 
results in an increase in lagging chromosomes, delayed mitosis and whole-
chromosome gains and losses (Manning, Longworth, & Dyson, 2010). In addition, 
Coschi et al. used gene targeted mutant mice to show that mutations in Rb1 crossed 
into a Tp53-/- background result in the development of tumours more quickly than 
Tp53-/- controls. The double mutant mice also developed more aggressive tumours, 
with more frequent metastases (Coschi et al., 2010). Although there are numerous 
examples of CIN influencing aging-associated phenotypes such as cancer, there are 
few, if any examples in the literature of CIN inducing developmental phenotypes in 
non-aged mice other than embryonic lethality. 
 
Previous studies have, for the most part, utilised loss of function alleles in order to 
understand the roles of the condensin complexes (Green et al., 2012; Houlard et al., 
2015; D. F. Hudson et al., 2003; Nishide & Hirano, 2014). There is an enrichment of 
condensin mutations in the COSMIC (Catalogue of Somatic Mutations in Cancer) 
(Forbes et al., 2014) and TCGA (The C ancer Genome Atlas) (Leiserson et al., 2015) 






















datasets, and the majority of these are missense (Figure 1.9). Therefore, a missense or 
partial loss of function mouse model may be a more relevant model of human disease. 
 
  






















1.3.1.1 The “nessy” mouse model 
 
The nessy mutation originated from a forward genetic screen and arises due to a single 
nucleotide change (a T to A substitution) within the evolutionarily conserved N-
terminus of the kleisin-β subunit (CAP-H2) of condensin II (Figure 1.10), a ~1Mb 
region on Chromosome 15 containing no previously identified T cell differentiation 
genes (Gosling et al., 2007; Bürmann et al., 2013; Piazza et al., 2014). The mutation 
results in an Ile to Asn amino acid substitution within the long isoform of Caph2, i.e. 
a conserved hydrophobic amino acid is substituted for a polar residue.  
 
The mutation results in a developmental block: peripheral T cell numbers are reduced 
by approximately two to threefold in Caph2nes/nes mutants, but the most pronounced 
defects occur in the thymus where the developmental block results in a more than one 
hundred-fold decrease of CD4+ CD8+ double positive (DP) thymocytes.  
 
Since forward genetic screens can result in the introduction of multiple point 
mutations, it was necessary to determine that the identified nucleotide change within 
the condensin II complex was the cause of the nessy phenotype. This was achieved by 
transducing haematopoietic stem cells with wildtype Caph2 long isoform cDNA. The 
researchers showed that untransduced nessy cells exhibited the nessy developmental 
phenotype, while cells successfully transduced with the wildtype allele did not, thereby 
proving that the T cell specific block in development is caused by the mutation to 
condensin II (Gosling et al., 2007). 
 
The Ile to Asn substitution is not present in either the short or intermediate isoforms. 
A different substitution is encoded in the intermediate isoform. However the long 
isoform is thought to be the most important because it is highly conserved, and because 
cDNA encoding the long form was sufficient to rescue the developmental phenotype. 
 
 













































Caph2nes/nes homozygotes are viable and fertile, with no major morphological 
abnormalities, with the exception of the thymus: there is a noticeable reduction in the 
size of the Caph2nes/nes thymus, and a reduction in cellularity within the cortex. Since 
the cortex contains mostly CD4+ CD8+ double positive (DP) thymocytes, this decrease 
in cellularity is to be expected given the reduction in DP Caph2nes/nes thymocytes. The 
observable phenotype is highly T cell specific, with B cell numbers apparently 
unaffected. This is somewhat surprising, considering T cells and B cells undergo 
similar processes (i.e. stages of proliferation interspersed with stages of VDJ 
recombination) during development. In addition, since the condensin complexes are 
thought to be ubiquitous and perform vital roles in all dividing cells, the T cell specific 
phenotype is highly unexpected.  
 
Several potential causes for the reduction in numbers of Caph2nes/nes DP thymocytes 
were considered. The mutant CD4+ CD8+ DP thymocytes showed high levels of 
annexin V staining, causing the researchers to question whether the nessy mutation 
affects expression of IL-7Rα (an essential protein, necessary for T cell survival) 
resulting in increased apoptosis of the Caph2nes/nes thymocytes. IL-7Rα was, however, 
found to be expressed on the mutant thymocytes, ruling out deficiency of the 
interleukin as a possible cause of the reduction in cell numbers. 
 
Pre-rearranged TCR transgenes (which eliminate the requirement for VDJ 
recombination) were used to test whether defective VDJ recombination could be the 
cause of the T cell specific developmental block in nessy. Abnormal VDJ 
recombination could prevent the expression of functional T cell receptor subunits that 
are necessary to receive signals that facilitate developmental progression. It was found 
that the transgenes failed to rescue the block in development in Caph2nes/nes cells, 
suggesting that VDJ recombination is not the primary cause of the nessy phenotype, 
and that the block occurs after the β selection checkpoint, during the proliferative 
expansion of β-selected cells (Figure 1.12, Table 1.1). 
 
Finally, in order to test the hypothesis that the Caph2nes/nes thymocytes are less able to 
proliferate resulting in an overall reduction in numbers, the researchers used BrdU 
incorporation to study the rates of proliferation of Caph2nes/nes cells relative to wildtype 
at various stages of T cell differentiation. However, Gosling et al. did not find reduced 






















levels of Caph2nes/nes proliferation at the CD4+ CD8+ DP stage of development: the 
stage at which the block in nessy development becomes apparent. 
 
Given the cell lineage-specific phenotype of the nessy condensin mutant mice, the 
researchers concluded that the T cell specific defect in Caph2nes/nes mice is most likely 
caused by a separation of function allele of kleisin β. This mutation was suggested to 
alter the proposed role of condensins in transcriptional regulation, (known to take place 
in yeast and Drosophila through interactions with either a histone deacetylase or a 
polycomb group protein (Hirano, 2005)), rather than its well-known role in mitosis 
(Gosling et al., 2007). However, neither possibility was tested empirically. 
 
Further analysis into the Caph2nes/nes mouse was carried out by Rawlings et al. who 
deduced the degree of chromatin compaction using several techniques, including the 
ability of antibodies to access the histones (Rawlings, Gatzka, Thomas, & Ihle, 2011). 
The researchers discovered that the histones of wildtype mouse T cells were readily 
detectable at the CD4- CD8- double negative (DN) stage (implying that the chromatin 
was decondensed at this stage) whereas they were unable to detect the histones at either 
the CD4+ CD8+ double positive (DP) or CD4+/CD8+ single positive (SP) stages 
(indicating a more condensed chromatin state). Further evidence of decompaction at 
specific stages of development was inferred from flow cytometry forward scatter data 
(a marker for cell size) and electron micrograph images. The researchers inferred from 
this evidence that chromatin decompaction occurs at a very specific stage of T cell 
development to allow activation of naïve T cells. Prior to this, the cells must remain in 
a compact state, in order to avoid premature activation.  The researchers concluded 
that the compaction of chromatin is dependent on condensin II, since Caph2nes/nes 
mutants revealed a decompacted chromatin state, according to their assays (Rawlings 
et al., 2011). In agreement with the previous study into the Caph2nes/nes mutation, 
Rawlings et al. concluded that the mutation within condensin II most likely impacts 
epigenetic processes: specifically, the compaction of interphase chromatin. 
 
  






















1.4 The haematopoietic system 
 
I have used various haematopoietic populations to investigate the consequences of 
condensin II deficiency on cell cycle regulation. There are many advantages to using 
this system: haematopoiesis is a paradigm for the differentiation of multiple cell types 
from a single stem cell precursor – as a result, the consequences of condensin 
perturbation may be investigated in many different, but related cell types. 
Haematopoietic development generates a diverse range of functionally specialised cell 
types, many of which undergo extensive cellular proliferation during the 
differentiation process. In addition, this system offers convenient cellular phenotyping 
using flow cytometry to assess developmental stage and cell cycle parameters in 
individual cells in a high throughput manner. Throughout this thesis, I have focused 
on early haematopoietic progenitors, T cells, B cells and erythroid cells. I will 
therefore introduce only these lineages here. 
 
In adult mice, haematopoietic stem cells reside in the bone marrow, where they 
differentiate into multipotent progenitor cells that divide and give rise to all mature 
blood cell types (Figure 1.11). The concept of self-renewing multipotential 
haematopoietic precursors was initially put forward when it was discovered that mice 
that had undergone lethal levels of irradiation could be saved when they were injected 
with healthy bone marrow (Micklem & Loutit, 1966). These haematopoietic 
progenitors do not express the lineage markers characteristic of the later stages of 
differentiation: B220 (B cells), CD4 and CD8 (T cells), Ter119 (erythroid cells), Gr-1 
(granulocytes) and Mac-1 (myelomonocytic cells). It was discovered that the 
haematopoietic stem cell population can be further purified based on the expression of 
Sca-1 (stem cell antigen-1) (Spangrude, Heimfeld, & Weissman, 1989) and the mouse 
receptor, c-kit, also known as CD117 (Ikuta & Weissman, 1992).  It should be noted, 
however, that Sca-1 can only be used as a stem cell marker in certain mouse strains, 
such as C57BL/6 (Wognum & Szilvassy, 2013). This population of haematopoietic 
progenitor cells are known as LSK (Lin-Sca-1+c-kit+) cells, which contains both the 
true haematopoietic stem cells and their direct derivatives. The LSK population can 
thus generate all haematopoietic cell types. 
  













































Blood cells can be divided into two major lineages: myeloid (including erythrocytes, 
megakaryocytes and macrophages), and lymphoid (including T and B cells). Once the 
lymphoid and myeloid progenitors have been formed in the bone marrow, they migrate 
to other locations (for example, the liver, the thymus or the spleen) to proliferate and 
differentiate further. 
 
1.4.1 αβ-T cell development 
 
The adult thymus consists primarily of two cell types, lymphoid and epithelial. Thymic 
epithelial cells develop first, and play a role in the generation and subsequent selection 
(self-antigen presentation) of developing T cells (Anderson & Takahama, 2012). From 
approximately embryonic day E15.5 onwards, small numbers of lymphoid progenitors 
seed the thymus where they mature and commit to the T cell lineage (Koch & Radtke, 
2011). At this stage, the cells are double negative (DN) for the major T cell lineage 
markers, CD4 and CD8. The cells then begin to undergo VDJ recombination, and 
rearrange their T cell receptor genes. The α/β T cell receptor comprises two variable 
chains: α and β, encoded by two distinct loci. The β locus is the first to rearrange, and 
at this point the cells exit the cell cycle. Alternatively, cells may rearrange their gamma 
and delta chains and differentiate along the TCRγδ, rather than the TCRαβ lineage. 
 
Cells which generate out-of-frame rearrangements at the T cell receptor β locus are 
unable to assemble pre-T cell receptor complexes, and thus do not proliferate, but 
instead undergo apoptosis. TCR-β rearrangements that have occurred in-frame, 
however, pass the β selection checkpoint, proliferate rapidly in response to signalling 
via the pre-T cell receptor and downregulate CD25 expression to progress from DN3 
to DN4 stage cells (Ho, Tai, & Pai, 2009). Later, these cells upregulate the CD4 and 
CD8 cell surface markers to become CD4+ CD8+ double positive (DP) and relocate to 
the thymic cortex. There are two major signalling pathways responsible for driving 
αβ-T cell development to the DP stage. Notch is important in early thymic T cell 
precursors for T cell lineage commitment. At the DN3 stage, pre-TCR signalling plays 
a more prominent role and is responsible for the selective expansion of cells that have 
undergone successful VDJ recombination. 
 
Upon cell cycle exit, CD4+CD8+ (DP) cells downregulate the transferrin receptor 






















CD71 and rearrange the α-chain locus. The cells that successfully rearrange their α-
chains then undergo two rounds of selection. In the first round, T cells are tested for 
their ability to bind the major histocompability complex (MHC – “positive selection”), 
which is essential for their function in an adaptive immune response. This process is 
termed “positive selection”. The cells that have successfully passed positive selection 
proceed to downregulate either CD4 or CD8 to become single positive thymocytes. 
Next, T cells are tested for their ability to interact with self-peptides, and those which 
do so too strongly are removed by apoptosis, in order to prevent autoimmune 
responses.  
 
Of the approximately 50 million CD4+ CD8+ DP thymocytes generated in the mouse 
thymus each day, approximately 90% - 95% will fail to progress past positive and 
negative selection (Kyewski & Klein, 2006). The expression of cell surface markers 
used to determine stages of T cell development is illustrated in Figure 1.12 and the 
relationship between stage of development and VDJ recombination is presented in 
Table 1.1. 
 
The single positive cells then relocate to the periphery, where they remain in a G0, 
quiescent state, with reduced transcription levels until they are stimulated to proliferate 
when they are presented with their cognate antigen by the MHC complex on dendritic 
cells. The cells proliferate rapidly, and facilitate the destruction of the invading 
pathogen. 
 
TCR activation is a tightly controlled process, in order to prevent premature activation 
of T cells and so autoimmunity does not occur. Stimulation via the TCR of naïve single 
positive CD4 cells results in the upregulation of the transcription factor GATA-3, 
which binds to loci encoding T Helper 2 (Th2) cytokines (Yamane & Paul, 2012). In 
addition to this, stimulation via the TCR generates production of interleukin 2 (IL-2) 
in both CD4 and CD8 T cells, which causes Stat5 proteins to be phosphorylated. The 
phosphorylated Stat5 protein dimerizes and translocates to the nucleus where it is 
bound to DNA and promotes transcription of genes that promote proliferation and 
differentiation into Helper (CD4+) or cytotoxic (CD8+) T cells. 
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The block in thymic development in Caph2nes/nes mice is first apparent by reduced 
numbers of rapidly proliferating cells that have undergone β-selection (i.e. DP cells – 
Figure 1.12, Table 1.1). The block occurs after the expression of TCRβ protein, 
indicating that faulty VDJ recombination is unlikely to be the principle cause. This is 
further supported by the finding that pre-rearranged T cell receptor transgenes fail to 
rescue block in T cell development (Gosling et al., 2007). This does not rule out the 
possibility that condensin plays a role in VDJ recombination, as has been shown for 
cohesin (Seitan et al., 2011). Rather, the data suggests that the process is not majorly 
affected by the single amino acid change in Caph2 present in the nessy mouse. 
 
1.4.2 B cell development 
 
B cell development occurs in the fetal liver before birth, and continues in the bone 
marrow afterwards. The bone marrow, therefore, contains B cells at various stages of 
development. Cells committed to the B cell lineage can be identified by the expression 
of B220, a cell surface lineage marker. The earliest cells lack the surface marker CD19, 
which is expressed at all later stages of B cell development. The earliest stages of B 
cell development are characterised by the accumulation of CD24, followed by BP-1 
upregulation, and finally loss of CD43 expression. These individual stages were 
determined using flow cytometry, and named Fraction A (B220+ CD43+ CD24- BP-
1), Fraction B (B220+ CD43+ CD24+ BP-1-), and Fraction C (B220+ CD43+ CD24+ 
BP-1+) (Hardy, Carmack, Shinton, Kemp, & Hayakawa, 1991). The gating strategy 
used to determine each of the Hardy stages of B cell development by flow cytometry 
is shown in Figure 1.13 (Hardy et al., 1991).  
  




































































There are many parallels in the development of T and B cells: for example, both 
undergo successive rounds of VDJ recombination, followed by stages of rapid 
proliferation. In the B cells, D-J rearrangement of the Heavy (H) chain genes begins 
at the Fraction B stage and V-DJ rearrangement is completed in cells of Fraction C. If 
rearrangement is successful, the H chain forms part of a pre-B cell receptor, which 
drives massive proliferation in response to signalling. This stage is known as Fraction 
C, and is loosely equivalent to the rapidly proliferating β-selected T cells (DP blast 
cells). In the absence of Ig rearrangement, cells cannot progress to later stages of 
development: for example, SCID mice are unable to rejoin DNA effectively during 
rearrangement of the H chain, and are therefore blocked at Fraction C in development 
(Reichman-Fried, Hardy, & Bosma, 1990). Similarly, inhibition of double strand break 
formation during Ig rearrangement in RAG-2-deficient mice results in a similar block 
in development (Mombaerts et al., 1992; Shinkai et al., 1992). 
 
After the burst of proliferation, the cells downregulate CD43 and exit the cell cycle. 
The subsequent stages of development are classified based on IgM and B220 
expression: Fraction D (B220+ CD43- IgM-), Fraction E (B220+ CD43- IgM+) and 
(B220++ CD43- IgM+) (Hardy et al., 1991). The expression of markers used to 
determine individual stages of B cell development are presented in Figure 1.14.  
 
Rearrangement of the Light (L) chain genes begins during Fraction E, and is completed 
by Fraction F. The relationship between stage of development and VDJ recombination 
is presented in Table 1.2. Like the T cells, B cells that fail to produce functional H or 
L chains undergo apoptosis. Cells that succeed go on to undergo positive and negative 
selection, which ensures that the cells recognise antigens derived from pathogens, but 
do not recognise self-pathogens. Mistakes in this process can lead to autoimmunity 
(Hardy & Hayakawa, 2001). 
  















































1.4.3 Erythroid development 
 
Erythroid cells are responsible for oxygen transport and are produced in massive 
numbers. Therefore, like lymphocyte development, erythropoiesis requires extensive 
cellular proliferation. During fetal development, erythropoiesis occurs in the liver and 
spleen. During the final stages of gestation, the primary site of production is transferred 
to the bone marrow.  
 
The major regulator of the production of erythroid cells is the cytokine erythropoietin 
(EPO). The committed erythroid progenitor cells experience a proliferative burst in 
response to erythropoietin stimulation, during which time they condense their nuclei 
and ultimately undergo enucleation to become immature erythrocytes (reticulocyte) 
(Ji, Murata-Hori, & Lodish, 2011). The process of enucleation is not well understood. 
The main model of enucleation is asymmetric cytokinesis and is based on the 
hypothesis that nuclear extrusion occurs as a consequence of a particular type of cell 
division. According to this model, the process of enucleation produces a small cell 
with almost no cytoplasm called the pyrenocyte (this is the expelled nucleus) and an 
anucleate reticulocyte that will form the mature erythrocyte (Giger & Kalfa, 2015). 
This model is supported by several pieces of evidence, including the presence of a 
structure resembling a cleavage furrow (Koury, Koury, & Bondurant, 1989; Repasky 
& Eckert, 1981; Skutelsky & Danon, 1970). In addition, the process of enucleation is 
dependent on actin: a protein which forms microfilaments which are essential for 
successful cytokinesis. The depolymerizing agent cytochalasin D inhibits enucleation 
in vitro. (Koury et al., 1989; Repasky & Eckert, 1981), further supporting the 
hypothesis that cell division is the mechanism by which enucleation takes place. 
 
Stages of erythroid development can be determined through the expression of cell 
surface markers, specifically CD71 and Ter119 (Figure 1.15). Five sequential stages 
of erythroid differentiation: R1, R2, R3, R4 and R5, can be isolated from the 
population using the main cell surface markers (Zhang, Socolovsky, Gross, & Lodish, 
2003). 
 

























1.5 Thesis Aims 
 
The core aim of this thesis is to understand why a mutation to a ubiquitously expressed 
protein which functions in a fundamental cellular process would result in such a cell-
type specific block in development. To achieve this, I investigated the possibility that 
condensin II is involved in interphase processes, and that this function is affected most 
severely by the mutation to condensin II. I also investigated the possibility that the 
mutation impacts the best-known role of condensin II in mitosis. In addition, I studied 
the aspects of T cell development that may make this lineage particularly vulnerable 
to condensin II deficiency. Finally, I carried out a preliminary investigation into the 
biochemical properties of the condensin complexes.  
 
  






















CHAPTER 2: MATERIALS AND METHODS 
 
2.1 Stock solutions, reagents and buffers 
 
Water used in solutions is deisonised, and solutions were stored at room temperature 
unless otherwise stated.  
 
Table 2.1  Commonly used buffers   
Acetate 
buffer 

























50% deionised formamide (v/v), 10% dextran sulphate (v/v), 1% 






50mM Tris HCl pH 7.5, 150mM NaCl, 1mM EDTA 
  
GTE buffer 50mM glucose, 25mM Tris-HCl pH8, 10mM EDTA, stored at 4oC. 
Approximately 10mg lysozyme/mL was added prior to use   
Hypotonic 0.5% sodium citrate, 0.25% potassium chloride, prepared in deionised 































NuPage LDS Sample Buffer (4x) (Life Technologies cat#1606369) 
NuPage Reducing agent (10x) (Life Technologies cat#1413173) 
  














50mM Tris HCl pH 7.5, 150mM NaCl, 1mM EDTA, 1% DNAse, 1% 





Made as a 10x solution, which was aliquoted and stored at -20oC. 
0.5M Tris pH7.5, 0.1M MgSO4, 1mM DTT, 0.5mg/mL BSA fraction 
V (Sigma)   
NP-40 Lysis 
buffer 
50mM Tris HCl pH8, 150mM KCl, 1.5mM MgCl2 0.1M DTT, 
0.2mM EDTA, 1% NP-40. Aliquoted and stored at -20oC. Protease 




160mM NaCl, 3mM KCl, 8mM Na2HPO4, 1mM KH2PO4 from 
tablets (Oxoid, Thermoscientific, cat#BR0014) 
  
RIPA buffer 1% NP-40 (v/v), 0.5% sodium deoxycholate (v/v), 0.1% SDS in 1x 
PBS. Protease inhibitor Cocktail added immediately prior to use. 





Per litre for 20x solution: NaCl 175.3g, Na3C6H5O7 88.2g 
  
Tris-Acetate 40mM Tris base, 20mM acetic acid, 1mM EDTA. Prepared as 50x 


























TE buffer* 10mM Tris-HCl pH7.6, 1mM EDTA   
Tris Buffered 
Saline (TBS) 











25mM Tris base, 200mM glycine, 20% methanol (v/v), 0.02% SDS 
(v/v). Made fresh prior to use. 
 
*Prepared by Technical Services at MRC HGU IGMM. 
 
  























Centrifugation steps were performed at room temperature unless otherwise stated. 
 
2.2.1 Cell culture 
All cells were incubated under the same growth conditions at 5% CO2 levels. 
2.2.1.1 MEFs: 
Cells were maintained in DMEM medium + L-Glutamine (Invitrogen cat#41965-039) 
supplemented with 15% FCS, 1% Penicillin Streptomycin, 1% β-mercaptoethanol 
(50µM/0.00035%), 1% Non-Essential Amino Acids and 1% sodium pyruvate 
(NaPyr). Cells were passaged at approximately 80% confluence.  
 
2.2.1.2 OP9 in vitro Proliferation and Differentiation System: 
Cells were maintained in αMEM medium (+nucleosides) (Invitrogen cat#22571020) 




The OP9/DL1 cells (OP9 cells expressing the notch ligand DL1) were passaged every 
3 days seeding 2x105 cells into a fresh T75 flask. The cells were passaged by 
incubating the cells at 37oC in 3mL TrypLE Express (1x) (Life Technologies) for 3 to 
5 minutes. The TrypLE Express was neutralised by adding 15mL media and 
transferring to a 50mL Falcon Tube to be centrifuged and re-suspended in fresh 
medium. 
 
Seeding OP9/DL1 cells for Primary T cell culture 
OP9/DL1 cells were seeded 24 hours before the thymocytes were added to the culture. 
The OP9/DL1 cells were dissociated, neutralised (as above) and counted on a 
haemocytometer.  The cells were seeded at a concentration of 20x103 cells per mL of 
media. 3mL of media was added to each well of a 6-well plate. 
 
Primary T cell cultures 
Primary T cells were cultured on OP9/DL1 monolayers (de Pooter and Zúñiga-






















Pflücker, 2007). Primary T cells were MACS purified (according to manufacturer’s 
instructions) to deplete CD4 positive cells using CD4 (L3T4) MicroBeads (Miltenyi 
Biotec cat#130-049-201). The cells were counted using a haemocytometer. 250x103 
Caph2+/+ cells were seeded per well of a 6-well plate, and 250x103 Caph2nes/nes cells 
were seeded per well of a separate 6-well plate. IL-7 was added to each well at a 
concentration of 1ng/mL. The cells were cultured for 4 days before being treated and 
analysed. 
 
The T cells were removed by mechanical dissociation (gentle agitation of the media 
using a p1000 pipette), without removing the adherent monolayer of OP9 DL1 cells. 
The media was allowed to pass through a 40μm nylon mesh cell culture strainer 
(Corning B.V Life Sciences cat#352340). This prevents any OP9 DL1 cells that have 
been removed with the T cells to pass into the sample. 
 
  






















2.2.2 Nucleic Acid methods 
 
2.2.2.1 Spectrophotometric quantification of nucleic acids 
The concentration of nucleic acids was determined by measuring the optical density at 
260nM using a NanoDrop 1000 UV-Vis Spectrophotometer (Thermo 
FisherScientific). 1μL of each sample was used for each measurement. The purity of 
the nucleic acid sample was determined by the absorbance at 230nM, 260nM and 
280nM. The 260/280 ratio of a sample free of protein contamination should be 1.8-2.2 
and 230/260 ratio  1.7 indicates a sample free of carbohydrates and lipids. 
 
2.2.2.2 Agarose gel electrophoresis 
Nucleic acid samples were analysed in 2% agarose gels. Gels were prepared by 
dissolving agarose (Hi-Pure Low EEO agarose, Biogene) in TAE buffer by boiling 
and adding ethidium bromide to a final concentration of 0.5μg/mL. The samples were 
mixed with 5x DNA loading buffer resulting in a final 1x concentration, loaded on to 
the gel and subjected to a voltage of 80-150 volts to resolve the nucleic acid fragments 
by size. The nucleic acids were visualized using a UV transilluminator (BioDoc-It 
System, UVP). For reference, markers containing DNA fragments of known sizes 
were included (New England Biolabs). 
 
2.2.2.3 Preparation of RNA and cDNA for Expression Analysis 
 
RNA extraction 
Total RNA was isolated from cells using Trizol reagent (Ambion) according to 
manufacturer instructions. For purposes of practicality, a minimum of 100μL of Trizol 
was added directly to the cells at a concentration of 0.75mL of Trizol per 0.25mL of 
sample (5–10x106 cells), before lysing the cells by pipetting up and down several 
times. The sample was incubated in the Trizol for 10 minutes at room temperature, 
allowing the nucleoprotein complex to dissociate. 200μL chloroform was added to the 
sample per 1mL Trizol used, and then shaken vigorously. The sample was transferred 
to a Phase-Lock tube (5 Prime) and incubated at room temperature for 2 – 3 minutes, 
before being centrifuged at 12,000g for 15 minutes at 4oC. The aqueous phase was 






















removed, transferred to a new tube, and incubated for 10 minutes at room temperature 
with 5-10μg Glycoblue (Ambien) and 500μL isopropanol per 1mL of Trizol used 
previously. The sample was centrifuged at 12,000g for 10 minutes at 4oC, the 
supernatant was removed, and the pellet washed in 1mL 75% ethanol per 1mL Trizol 
used.  The sample was centrifuged as described previously, the supernatant was 
removed and the pellet allowed to air-dry before being resuspended in 20-50μL (based 
on the size of the RNA pellet) of RNase-free water.  
 
RNA was DNAse treated to remove trace amounts of contaminating DNA using a 
DNA-free kit (Ambion), according to manufacturer’s instructions. Briefly, this 
involved adding 10x DNase1 Buffer at 0.1x total volume of sample and 1μL rDNase1 
to the RNA, mixing gently, and incubating at 37oC for 20-30 minutes. The resuspended 
DNase Inactivation Reagent was added at 0.1x total volume of sample, and mixed well 
by inversion. This was incubated for 2 minutes at room temperature, mixing 
occasionally, and centrifuged at 10,000g for 1.5 minutes. The RNA was transferred to 
a fresh tube and stored at -80oC or used to synthesise first strand cDNA. Concentration 
of RNA was determined using spectrophotometry with a Nanodrop ND-1000 
(Nanodrop Technologies) or a Nanodrop 8000 (Thermoscientific) according to 
manufacturer instructions (A260 of 1 equals 40μg/mL concentration of RNA). 
 
2.2.2.4 cDNA Preparation 
cDNA was prepared using a First Strand cDNA Synthesis Kit (Promega). 500ng of 
RNA was placed in a sterile RNase-free tube. The primer was added at a concentration 
of 0.5μg per microgram of the mRNA sample. RNase-free water was added to the 
sample to give a final volume of 13μL (or less). The tube was heated to 70oC in a heat 
block for 5 minutes to melt the secondary structure within the template, and was then 
immediately cooled on ice to prevent reformation of the secondary structure. The 
sample was centrifuged briefly in order to collect the solution at the bottom of the tube, 
before the following components were added to the annealed primer/template: 
M-MLV 5X Reaction buffer    5μL (Promega) 
dATP 10mM      1.25μL (Invitrogen) 
dCTP 10mM      1.25μL (Invitrogen) 
dGTP 10mM      1.25μL (Invitrogen) 






















dTTP 10mM      1.25μL (Invitrogen) 
Recombinant RNasin Ribonuclease Inhibitor 25 units (40 units per microliter) 
M-MLV Reverse Transcriptase   200 units (200 units per 
microliter) 
Nuclease-free water to final volume   25μL 
 
The sample was mixed gently by flicking the tube, and incubated for 60 minutes at 
37oC, and stored at 4oC. 
 
2.2.2.5 Expression Analysis 
 
Real-time-PCR: 
cDNA generated using First Strand kit (above) was amplified by PCR using primers 
for the gene of interest, Caph2 (Table 2.2) with Gotaq 2x green taq polymerase 
(Promega) according to manufacturer instruction. Actin primers were used as a loading 
control. 
 
PCR reaction was incubated at 95oC for two minutes, followed by 30 cycles of 
amplification (95oC for 30 seconds, 56oC for 35 seconds, 72oC for 45 seconds), and 
products were checked for size by electrophoresis (see Section 2.2.2.2). 
 
Quantitative-PCR: 
Quantitative measurements of gene expression were obtained using qPCR on cDNA. 
In brief, PCR was used to amplify specific cDNA sequences and the amount of PCR 
product at each stage of PCR cycle was measured using the double stranded DNA 
(dsDNA) binding dye SYBR Green as a reporter. 
 
The reaction consisted of 50ng template cDNA, 1x Brilliant II Sybr Green qPCR 
Master Mix (Life Technologies), 0.2μM of each oligonucleotide primer (Table 2.2) in 
a 20μL volume. The themo-cycling reactions were performed in 96 well PCR plates 
(Roche) with optically clear plate seals (Roche) using a LightCycler 480 (Roche). 
 






















The LightCycler continuously detected the fluorescence of each well in the plate in 
real time, producing a cycle threshold (CT) value for each well. This indicates the cycle 
number at which the amount of fluorescence detected reaches a fixed threshold. The 
CT values for each target gene were normalised to the housekeeping gene, Actin. 
Primer efficiency had been previously calculated and found to be 100%. The relative 








Forward Sequence Reverse Sequence 


































2.2.3 Protein handling and preparation 
 
2.2.3.1 Whole cell protein preparations 
A single cell suspension was obtained from the thymus, or bone marrow (as described 
previously). CD4+ T cells, Ter119+ erythroid cells and B220+ B cells were MACS 
purified according to manufacturer’s instructions (MACS Miltenyi Biotec). Cells were 
washed in PBS and pelleted at 400g. Cell pellet volume (in μL) was estimated by eye. 
The cell pellet was re-suspended in 5x its volume of NP-40 lysis buffer and incubated 
on ice for 30 minutes with intermittent vortexing. Lysed cells were centrifuged at 
15,000g for 10 minutes at 4oC, and supernatant collected and stored in the short term 
at -20oC. 
 
2.2.3.2 Protein quantification 
To determine the concentration of proteins in cell extracts or purified recombinant 
protein the Bradford assay was performed with the Bio-Rad Protein Assay kit. 
Initially, a standard curve was drawn using a BSA concentration range of 0.1, 0.2, 0.4, 
0.6, 0.8 and 1.0mg/mL. To measure unknown concentrations, 10μL of each solution 
was added to 200μL 1x Bradfords dye reagent and A595 was measured after 5 minutes. 
The absorbance reading was compared to the BSA standard curve to calculate protein 
concentration. 
 
2.2.3.3 SDS-PAGE Resolution of Proteins 
Protein samples were separated according to their molecular weight by SDS-PAGE 
using the NuPage Novex (Invitrogen) gel system. 4-12% Bis-Tris gels (Invitrogen 
cat#15030984) were used to separate proteins.  
 
Protein samples were denatured by heating at 70oC for 10 minutes in 1x protein sample 
loading buffer (Table 2.1) and loaded onto the gel. 
 
Gels were run in a Novex minicell X-Cell Sure Lock (Invitrogen) electrophoresis tank 
in 1x MOPS running buffer for Bis-Tris gels (Invitrogen) at a constant voltage of 130V 
for approximately 90 minutes, until the desired separation was achieved. A prestained 
protein size ladder of standard molecular weights was loaded alongside all gels 






















(PageRuler Plus 10-250kDa, Thermoscientific cat#26619). 
 
2.2.3.4 Western blotting 
Stacking gel was removed from SDS-PAGE gel, and samples were transferred to 
polyvinylidene difluoride (PVDF) membrane. PVDF membrane was soaked in 
methanol and then transferred to western transfer buffer for 2 minutes before being 
used in transfer on a Genie Blotter (Idea Scientific). Gel and membrane were 
sandwiched between two sheets of 3mm filter paper soaked in western transfer buffer, 
and transfer proceeded for 90 minutes. 
 
Alternatively, the samples were transferred via iBlot 7-minute transfer (Life 
Technologies) using iBlot 2 NC Regular Stacks (Life Technologies cat#IB23001) 
according to manufacturer’s instructions. 
 
After transfer, the membrane was blocked to prevent non-specific protein binding. To 
block, the membrane was incubated with either 5% milk-powder (Premier Foods) or 
3% BSA (Roche) in TBS with 0.2% Tween 20 for 1 hour at room temperature or 
overnight at 4oC with constant agitation. Primary antibodies were added to the 
blocking solution at the appropriate dilution (Table 2.5) and then the appropriate HRP 
labelled secondary antibody (Table 2.5) diluted in appropriate blocking solution, was 
added to the membrane for 1 hour.  
 
To detect horse radish peroxidase (HRP) immobilised onto membrane, ECL detection 
kit (Amersham Biosciences) was used according to manufacturer’s instructions. For a 
20cm2 nitrocellulose membrane, 2mL of ECL solution (1:1 mixture of solutions A and 
B) was added to the protein side of the nitrocellulose membrane and incubated for 30 
seconds at room temperature. The membrane was blotted to remove any excess liquid, 
and signal was detected using the Image Quant.  
 
  






















2.2.4 Fluorescence In-Situ Hybridization (3D FISH) 
 
2.2.4.1 Preparation of FISH probes 
 
Genomic Clones used for FISH 
The UCSC browser was used to identify genomic clones flanking regions of interest 
for FISH experiments. Fosmids were obtained from the BACPAC Resources Centre 
at the Children’s Hospital Oakland Research Institute (http://bacpac.chori.org/). All 
fosmid clones were provided as bacterial stab cultures in agar. A full list of all fosmids 
used in this thesis is provided in Table 2.3. 
 
2.2.4.2 Bacterial culture and stocks 
Fosmids were streaked out onto LB-agar plates containing chloramphenicol (25μg/ml- 
made up in Ethanol) and incubated overnight at 37oC. Single colonies were picked 
using a sterile pipette tip and transferred to a universal tube (Sarstedt Ltd cat# 
60.9922.241) containing 5mL L-Broth supplemented with chloramphenicol 
(25μg/mL) (Sigma cat#C1200000-1EA). These were grown overnight in a 37oC 
incubator with agitation. Bacterial stocks were made of all fosmid clones taking a 1:1 
mixture of the overnight culture of L-Broth: 80% Glycerol. This mixture was stored at 
-80oC. 
































































































































































































































































































































































2.2.4.3 Fosmid minipreps 
L-Broth cultures were pelleted by centrifugation at 16,000g for 30 seconds and 
resuspended in 200μL GTE buffer (50mM glucose, 25mM Tris pH8, 10mM EDTA) 
containing freshly added lysozyme (Sigma cat#L-6876) for 5 minutes at room 
temperature. Subsequently, 400μL of ice-cold lysis buffer (0.2M NaOH, 1% SDS) was 
added and mixed by inversion before being incubated on ice for 5 minutes. Following 
this, 300μL of acetate buffer (5M potassium acetate, 11.5% glacial acetic acid) was 
added to precipitate out cell debris, and the sample was mixed by inversion before 
being incubated for 5 minutes on ice. At this stage white flocculent precipitate formed 
in the tube.  
 
The precipitate was pelleted by centrifugation at 16,000g for 5 minutes at 4oC, the 
supernatant was transferred to a fresh tube, and combined with an equal volume of 
phenol: chloroform (Sigma cat#P2069-100ML). The samples were mixed by inversion 
and centrifuged at 16,000g for 5 minutes at 4oC (as described above). The aqueous top 
layer was removed to a fresh tube and was combined with an equal volume of 
chloroform (Fisher cat#BP1145-1). The samples were mixed and centrifuged (as 
above) and again, the aqueous top layer was removed to a fresh tube. An equal volume 
of isopropanol (Sigma cat#24137-2.5L-R) was added, the sample was mixed by 
inversion, and incubated at -20oC for a minimum of one hour. The samples were 
centrifuged for 15 minutes at 16,000g at 4oC, causing the DNA to form a pellet, which 
was washed in 70% ethanol and air-dried. The pellet was then re-suspended in 20-
30μL (depending on the pellet size) of TE (technical services). 20μg of RnaseA (Roche 
cat#10109169001) was added to the re-suspended DNA and incubated for 5 minutes 
at 37oC. All fosmid DNA preparations were stored at -20oC. 
 
2.2.4.4 Labelling of probes by nick translation 
DNA probes for FISH were labelled by nick translation to incorporate either biotin-
16-dUTP (cat#11095070910) or digoxigenin-11-dUTP (cat#11093088910) (both 
Roche). This was achieved by adding 500ng–1μg of DNA to 2μL of nick translation 
salts (0.5M Tris-HCl pH7.5, 0.1M MgSO4, 1mM DT, 500μg/mL BSA) with 2.5μL of 
each of 0.5mM dATP, dCTP and dGTP. Then either 2.5μL of 1mM biotin-16-dUTP 
was added to the mixture for biotin labelling or 1μL 0.5mM dTTP and 1.5μL 
digoxigenin-11-dUTP to label with dig. DNaseI (Roche cat#04716728001) was 






















diluted 1:20 for a final concentration of (500U/mL) and added to the mixture with 1μL 
of 5U DNA polymerase1 (Invitrogen cat# 18010). The reaction was made up to 20μL 
with deionised water, and was incubated at 16oC for 90 minutes. The nick translation 
was stopped by the addition of 2μL 20% SDS and 3μL of EDTA. Quick Spin sephadex 
Columns (Roche cat#11273965001) were used according to manufacturer instructions 
to remove any unincorporated nucleotides and enzymes. 
 
2.2.4.5 Quantitation of labelled FISH probes 
Labelling was detected using Streptavidin alkaline phosphatase or anti-DIG alkaline 
phosphatase on nitrocellulose filters. These filters were prepared by soaking in 
20xSSC for 10 minutes, and then drying at room temperature. Probes were spotted 
onto the nitrocellulose filters at dilutions of 1:500; 1:1000; 1:5000 and 1:10000 and 
allowed to dry at room temperature. Standards were also spotted onto the filter at 
concentrations of 20, 10, 2 and 1pg. Following this, the DNA was exposed to UV 
irradiation (150mJ) in a UVC500 Crosslinker (Hoefer) in order to facilitate cross-
linking of the DNA to the filter. The filter was immersed in 0.1M Tris-HCl pH 7.5, 
0.15M NaCl for 5 minutes at room temperature followed an incubation in the buffer 
described above, with the addition of 3% BSA (w/v) for 60 minutes at 60oC. 
 
Following this, the membrane was incubated for 15 minutes with gentle agitation at 
room temperature in 10mL of 0.1M Tris pH7.5 and 0.15M NaCl with 1% streptavidin-
alkaline phosphatase (Roche cat#11093266910) and 1% anti-DIG alkaline 
phosphatase (Roche cat#11093274910). The filter was washed twice in 0.1M Tris 
pH7.5 and 0.15M NaCl for 15 minutes per wash. Following this, the filter was sealed 
in a polythene bag containing 5mL of 0.1M Tris pH9.5 and two drops of each of the 
solutions in the alkaline phosphatase substrate kit VI (Vector laboratories). The filter 
was removed from the polythene bag when a blue reaction product formed by 5-
bromo-4-chloro-3-idolyl phosphate and nitroblue tetrazoilum. This allowed the 
biotin/DIG to be detected, and the concentration of the fosmid probes estimated by 
comparison to known standards. 
 
2.2.4.6 Preparation of cells for 3D FISH 
T cells were obtained from the thymus, and B cells were obtained from bone marrow 






















from the tibia and femur. Cells were prepared for flow cytometry cell sorting (as 
described in Section 2.2.7) with the appropriate cell surface antibodies. Cells were 
collected in tubes containing 0.5mL FCS.  
 
2.2.4.7 Preparation of slides for 3D FISH 
Cells were re-suspended in PBS at a concentration of 1x106 cells per mL of PBS. To 
preserve three-dimensional nuclear structure, cells were seeded onto Polyprep slides 
(Sigma cat# P0425-72EA) within a circle drawn with hydrophobic pen. 
Approximately 1x105 cells (100μL) were added to each of the slides. The slides were 
placed in a humidified chamber and incubated at 37oC for 20 minutes. Following this, 
the cells were fixed in 4% PFA in PBS for 10 minutes in a 37oC waterbath before being 
washed three times in PBS and then permeabilised in 0.5% Triton X (Sigma 
cat#T9284-500ML) for 10 minutes. The cells were washed in PBS a further three times 
and the slides were left to dry at room temperature, before being stored at -80oC. Slides 
were rinsed in 2xSSC before use. 
 
2.2.4.8 Hybridisation of labelled FISH probes 
The slides were incubated in 2x SSC, 100μg/mL RNaseA (Roche cat#10109169001) 
at 37oC for 1 hour. The slides were then washed in 2xSSC before being dehydrated 
through a series of two-minute ethanol washes (70%, 90% and 100%) before being air 
dried. The slides were then heated in a 70oC oven for five minutes and denatured for 
30 minutes at 80oC in 70% formamide/2x SSC pH7.5 before being transferred to ice-
cold 70% EtOH for two minutes, before further dehydration in 90% and 100% ethanol 
at room temperature, for two minutes each. 
 
To prepare for hybridisation, one of the fosmid pairs was labelled with biotin-16-dUTP 
and the other fosmid was labelled with digoxigenin-11-dUTP by nick translation (see 
above). Approximately 70-100ng of fosmid was used per slide, together with 18µg 
mouse Cot1 (Invitrogen cat#18440-016) DNA and 5μg of salmon sperm DNA (Sigma 
cat#31149-10G-F). Twice the volume of ethanol was added, and the probes were spun 
under high heat, resulting in a white pellet of DNA. This was resuspended in 15μL 
hybridisation mix (50% deionised formamide, 10% dextran sulphate and 1% Tween 
200 in 2x SSC). Probes were denatured at 70oC for five minutes and then transferred 






















to a 37oC waterbath to allow re-annealing before being pipetted onto a pre-warmed 
coverslip and picked up by a slide. The coverslips were sealed using TipTop rubber 
solution (BRAND cat#) and the slides were incubated in a covered tray for 48 hours 
in a 37oC waterbath. 
 
2.2.4.9 Washing and detection of FISH probes 
Following the 48-hour incubation, the rubber sealing solution was removed from the 
edges of the coverslips and the slides were washed four times in 2x SSC at 45oC for 
three minutes per wash. The slides were transferred to 0.1x SSC at 60oC and were 
washed four times for three minutes each. Slides were then transferred to 4xSSC/0.1% 
Tween at room temperature before being incubated for 5 minutes with blocking buffer 
(4x SSC, 5% Marvel) under a 22x40mm coverslip. Biotinylated probes were detected 
using Texas Red (TR)-conjugated avidin (1mg/mL stock diluted 1:500 in blocking 
buffer), followed by biotinylated antiavidin (BAA) (0.5mg/μL diluted 1:100) and a 
final layer of TR-conjugated avidin (1mg/mL diluted 1:500). Digoxigenin-labeled 
probes were detected with sequential layers of Fluorsecein isothiocyanate (FITC)-
conjugated antidigoxigenin (200μg/mL diluted 1:20) and FITC-conjugated anti–sheep 
(1.5mg/mL diluted 1:100). All antibodies were obtained from Vector Laboratories 
with the exception of FITC-conjugated anti-digoxigenin, which was obtained from 
Roche.  
 
Each antibody incubation was carried out in a humidity chamber at 37oC for 30-60 
minutes, and was followed by 3x 2 minutes washes in 4xSSC/0.1% Tween at 37oC 
before the addition of the next layer of antibody. 
 
After the last antibody incubation, slides were washed as described above, and were 
incubated in 4xSSC/0.1% Tween with 50ng/mL DAPI (Sigma cat#D9542) for 2 
minutes before mounting in Vectashield (Vector). Coverslips were then sealed onto 
the slides using super glue (the brand used was Super Solution F). 
 
  






















2.2.4.10 Image Capture 
 
3 colour imaging with single emission filters 
The imaging system comprises a Photometrics Coolsnap HQ2 CCD camera 
(Photometrics Ltd, Tucson, AZ), Zeiss Axioskop II MOT fluorescence microscope 
with Plan-neofluar or Plan apochromat objectives, a Lumen 200W metal halide light 
source (Prior Scientific Instruments, Cambridge, UK) and Chroma #89014ET single 
excitation and emission filters (Chroma Technology Corp., Rockingham, VT) with the 
excitation and emission filters installed in Prior motorised filter wheels. A 
piezoelectrically driven objective mount (PIFOC model P-721, Physik Instrumente 
GmbH & Co, Karlsruhe) was used to control movement in the z dimension. Hardware 
control, image capture and analysis were performed using Volocity (Perkinelmer Inc, 
Waltham, MA). 
 
Deconvolution of 3D data: 
FITC and Texas Red signals were deconvolved using a calculated PSF with the Fast 
Restoration, nearest neighbour algorithm of Volocity (Perkinelmer Inc, Waltham 
MA). DAPI signals were deconvolved using a calculated PSF with the constrained 
iterative algorithm of Volocity (Perkinelmer Inc, Waltham, MA). 
 























Image analysis was carried out using the Quantitation module of Volocity 
(Perkinelmer Inc, Waltham, MA). 
 
2.2.4.11 Scripts for Image Analysis 
All scripts for image analysis of 3D FISH images were written for Volocity by Shelagh 
Boyle (Research Assistant, Bickmore Lab) using packages set up for Volocity by 
Matthew Pearson (Microscopy and Imaging Department). 
 
Inter-probe distances were calculated by taking the centroid of each probe in the pair 
and calculating the pixel with the highest intensity. The distance was then calculated 
between the highest intensity pixels within the centroid of each probe pair. All inter-
probe distances from 3D FISH were converted from pixels to microns by 
multiplication by 0.134μm. 
 
The inter-probe distances (d) were squared. The difference between the distributions 
of squared inter-probe distances between datasets was assessed statistically using the 
Wilcox test with a cut-off of p < 0.05. 
 
To determine the radial positioning of probe pairs a nuclear erosion script was used in 
IPLab for analysis of FISH images. The 3D images were collapsed and the script 
eroded the nuclei into five concentric shells of equal area. It was then possible to count 
the distribution of probe hybridisation signals across the erosion shells in 50-60 nuclei. 
The number of hybridisation signals in each shell in the dataset were calculated as a 
percentage of the total number of signals and plotted as a histogram. Significance of 
changes in radial positioning of probes between wildtype and mutant was assessed 
using the Mann-Whitney test with a cut off of p < 0.05. 
 
 
























































































2.2.5 Preparation of metaphase spreads 
 
The cells were treated with hypotonic solution (0.5% sodium citrate, 0.25% potassium 
chloride in deionised water) and incubated at 37oC for 10 minutes. The sample was 
then centrifuged at 12000 rpm for 5 minutes before being fixed in 10mL of 3:1 
methanol: acetic acid. The fix was added drop-wise, whilst vortexing the sample. The 
samples were incubated at room temperature for 30 minutes, before being centrifuged 
(as above), re-suspended in 10mL fix, and stored at -20oC overnight. Following this, 
the cell suspension was dropped onto Poly-Prep (Sigma) slides (cleaned in 95% EtOH 
and 1% conc. HCl) to make metaphase spreads.  Slides were stained in 50mL PBS 
with with 50ng/mL DAPI (Sigma cat#D9542) for 2 minutes before mounting in 
Vectashield (Vector). Coverslips were then sealed onto the slides using Super Solution 
F.  
 
The spreads were imaged using a confocal microscope. The imaging system comprises 
a Photometrics Coolsnap HQ2 CCD camera (Photometrics Ltd, Tucson, AZ), Zeiss 
Axioskop II MOT fluorescence microscope with Plan-neofluar or Plan apochromat 
objectives, a Lumen 200W metal halide light source (Prior Scientific Instruments, 
Cambridge, UK) and Chroma #89014ET single excitation and emission filters 
(Chroma Technology Corp., Rockingham, VT) with the excitation and emission filters 
installed in Prior motorised filter wheels. A piezoelectrically driven objective mount 
(PIFOC model P-721, Physik Instrumente GmbH & Co, Karlsruhe) was used to 
control movement in the z dimension. Hardware control, image capture and analysis 
were performed using Volocity (Perkinelmer Inc, Waltham, MA). 
 
2.2.5.1 Preparation of metaphase spreads for Super-Resolution image capture 
 
Super-resolution images were acquired using structured illumination microscopy. 
Cells were treated with hypotonic solution and fixed in 3:1 methanol: acetic acid, as 






















above. The cell suspension was dropped on to high precision cover-glass (Marienfelt, 
Germany) and mounted in Prolong Gold (Life Technologies). 3D SIM images were 
acquired on a N-SIM (Nikon Instruments, UK) using a 100x 1.49NA lens and 
refractive index matched immersion oil (Nikon Instruments). SIM images were 
reconstructed using NiS Elements software (Nikon Instruments) from a z stack 
comprising of no less than 1um of optical sections. In all SIM image reconstructions, 
the Wiener and Apodization filter parameters were kept constant. 
 
 
2.2.6 Sucrose gradients 
 
2.2.6.1 Preparation of 5% - 20% Sucrose gradients 
The relevant quantity of sucrose was dissolved in Gradient buffer (50mM Tris HCl 
pH7.5, 150mM NaCl, 1mM EDTA). Seton tubes (Beckman Coulter cat#344059) were 
placed in a marker block, and a line was drawn around the tubes to indicate 6mL. The 
rubber stoppers were sprayed with 70% EtOH to ensure that they were free of dust, 
and allowed to dry. A 7-gauge needle was attached to a 20mL syringe, and rinsed with 
deionised H2O. Following this, the needle was air-dried by vigorously pumping air 
through the needle with a fresh syringe.  
 
Using a fresh syringe, the Seton tube was filled (Beckman Coulter cat#344059) up to 
the 6mL mark with 5% sucrose solution, without allowing the needle to touch the sides 
of the tube. The needle was rinsed and dried (as above). Following this, a further 6mL 
of 20% sucrose solution was added to the Seton tube, by placing the needle at the 
bottom of the tube, and raising the needle in time with the meniscus. The needle was 
then removed quickly, to avoid disturbing the layers. The rubber cap was slowly 
lowered onto the tube, whilst avoiding air bubbles forming under the rubber cap. A 
linear gradient of 5% - 20% sucrose was obtained using a gradient maker. Following 
this, the gradients were incubated at 4oC for a minimum of one hour. During this time, 
the Seton tubes were covered with foil to prevent contamination. 
 
2.2.6.2 Sample Preparation 
A single cell suspension was prepared from three wildtype thymuses (~3x108 cells) by 






















passing the thymus through a cell culture strainer, as described previously. The cells 
were washed twice in ice-cold PBS, re-suspended in 200μL Lysis buffer (Gradient 
buffer, supplemented with protease inhibitor (Roche cat#04693159001), 1% DNAse 
(Promega cat#0000128463), 1% RNAse (Roche cat#10109169001) and 1% Triton X 
(Sigma cat#053K00262V)). The sample was incubated at 4oC for 30 minutes, before 
being pelleted by centrifugation. 
 
2.2.6.3 Loading of cell lysate 
100μL was removed from the top of the sucrose gradient. Following this, 200μL of 
cell lysate sample was added to the top of the gradient. The gradient was weighed in 
order to ensure that the centrifuge was appropriately balanced. Gradients were placed 
in pre-cooled cradles and loaded onto an SW41 TI rotor. The rotor was lowered into 
the centrifuge (Beckman Coulter Optima L-90K Ultracentrifuge), and the sample was 
centrifuged for 15 hours at 32.4k RPM, 4oC.  
 
2.2.6.4 Protein Precipitation 
Following centrifugation, 24 fractions were removed manually and placed in pre-
cooled eppendorfs. One volume of 100% TCA stock was added to four volumes of 
protein sample. The samples were vortexed and incubated at 4oC for 10 minutes. 
Samples were pelleted by centrifugation at 14,000 rpm for 20 minutes at 4oC. The 
supernatant was then removed leaving the protein pellet intact, before the pellet was 
washed in 200μL of ice-cold acetone. The samples were centrifuged (as above), and 
the pellets were dried at room temperature for 5 – 10 minutes. Samples were re-
suspended in loading buffer, according to manufacturer’s instructions. 






















2.2.7 Flow Cytometry  
 
2.2.7.1 The fundamental concept of flow cytometry 
Flow cytometry is the measurement of certain properties of individual cells, which are 
usually fluorescently labelled. These properties include the relative size and 
granularity of the cell, as well as the relative fluorescence intensity. The flow 
cytometer is designed to focus the cell suspension into a single cell stream (called the 
sheath fluid) so that only single cells pass through the light beam in the flow chamber 
at any given time. This is achieved by ensuring the flow rate (the speed at which cells 
pass through the laser beam) is low, i.e. no greater than 400 events per second. More 
than one cell passing through the laser beam at any given time can result in loss of 
data, as well as consequences for the analysis of the acquired data. 
 
Components of the flow cytometer 
The flow cytometer consists of three main parts: fluidics (i.e. the Flow Chamber), 
optics and electronics. The fluidics system (the Flow Chamber) is designed to transport 
a single cell stream to the light beam (usually a laser). The cells are focussed into the 
centre of the sheath fluid, called the sample core. The degree to which the cells are 
focussed at the centre of the sheath fluid has an impact on the flow rate: decreasing the 
width of the sample core results in fewer cells entering the stream at any one time, 
making it less likely that more than one cell will enter simultaneously. This also makes 
it more likely that all the cells will pass through the centre of the light beam, resulting 
in more uniform emission of light. 
 
Once the cells have passed through the laser beam, they emit light at certain angles 
(depending on the size and granularity of the cell), and the fluorescent particles emit 
fluorescent light of specific wavelengths. This scattered and fluorescent light is 
directed towards the relevant detectors via a series of filters and mirrors called the 
optical system.  
 
The detected light must then be converted into electronic pulses, which the software is 
able to process. The data is stored and analysed to obtain information about the cell 
populations. 























2.2.7.2 Generation of Forward- and Side- Scatter 
 
Forward Scatter (FSC) 
When the cell passes into the laser beam, the cell becomes an obstacle to the path of 
light. Due to the wave-like nature of light, however, the light is able to diffract (bend) 
around the edges of the obstacle. This bending is due to Huygen's principle, which 
states that all points along a wave front act as if they were point sources. The light that 
is diffracted around the edges of the cell is called forward scatter and is detected by a 
photodiode located a small increment away from the axis of the incident laser light, in 
the forward direction.  
 
Usually, this diffraction of light is not noticeable: when we observe light encountering 
an object, we generally see the formation of a shadow, rather than an interference 
pattern caused by diffraction. This is because a diffraction pattern is only noticeable if 
the incident light is a narrow monochromatic beam (such as a laser beam) and the 
object is approximately the same size, or smaller, than the wavelength of the light. 
Since the wavelength of light is small (~x10-7 m) compared to, for example, the 
wavelength of sound, diffraction of light will only be noticeable around very small 
objects, such as cells. The level of diffraction provides information (independent of 
fluorescence intensity) about the size of the cell: larger cells will diffract light by a 
smaller angle than smaller cells. 
 
Side Scatter (SSC) 
Side Scatter of light is generated as a result of reflection of light by a barrier (such as 
a cell membrane) and refraction of light due to a change in refractive index at various 
interfaces within the cell. Reflection and refraction both result in a change in direction 
of the light beam. When light is reflected by a barrier, the angle of incidence (the angle 
at which the light hits the barrier) is equal to the angle of reflection. Since the cell 
passes through the centre of the laser beam, a large proportion of light will encounter 
the cell membrane at an angle of 90 degrees, causing the reflected light to bounce back 
towards the light source. However, due to the curvature of the cell, some light rays 
will hit the barrier at an angle of approximately 45 degrees, and be reflected in a 






















direction approximately 90 degrees to the laser beam.  
 
The speed of a wave is dependent on the medium through which the wave is travelling. 
Refraction of light occurs when the light wave moves from one medium to another 
with a different refractive index (or density). This causes the speed of the light wave 
to change. For example, when light moves from a low-density medium to a medium 
of higher density, the light wave will slow down, and the direction of propagation of 
the wave will be bent towards the perpendicular of the boundary between the two 
media. 
 
When a laser beam is incident on a cell, the light travels into a higher density medium 
(within the cell) and is refracted towards the normal (the perpendicular) of the 
boundary. When the light beam emerges from the cell, it is refracted away from the 
normal. Given that cells are approximately spherical in shape, a large proportion of the 
refracted light will emerge at an angle of approximately 90 degrees to the laser beam, 
along with the reflected light. 
 
The same is true at any interface with a difference in density within the cell, for 
example when the light beam encounters the nucleus, or mitochondria. At each 
interface, some light will be reflected, and some refracted, to be collected by 
photodiodes situated at approximately 90 degrees to the light source. Therefore side 
scatter provides information about the cell granularity and the internal composition of 
the cell. 
 
Forward scatter can be plotted against side scatter, in order to gate out cell debris (e.g. 
dead cells) from the data to be analysed, as shown in Figure 2.1a. The dead cells and 
debris will not share the same forward/side scatter parameters as live cells (i.e. they 
might be smaller and more granular). 
  














































A fluorescent particle absorbs light at a specific wavelength. This light energy (in the 
form of a photon) can be absorbed by an electron in the outer orbit of the fluorescent 
particle, which raises the electron to a higher energy level. This absorption can only 
occur when the photon is of exactly the right energy according to the Planck-Einstein 
relation: E = hf (where E is energy of the photon, which is equal to the difference in 
energy levels of the electron; h is Planck's constant and f is the frequency of the 
photon). The electrons of different fluorescent particles will be excited by different 
wavelengths of incident light: these wavelengths are characteristic for that particle. 
The range of wavelengths that can excite a fluorescent particle is known as its 
absorption spectrum. 
 
Once the electron has been raised to a higher energy level, the electron may lose some 
of the energy gained from the photon through collisions or other interactions. The 
electron will then return to its original energy level, releasing a photon with lower 
energy and a longer wavelength than the original photon. The range of wavelengths 
that are emitted by a fluorescent particle is called its emission spectrum. A particle can 
be labelled by more than one fluorochrome, provided that the emission wavelengths 
are far enough apart that they can be distinguished from one another. The amount of 
signal detected from the fluorescent particles indicates the fraction of fluorescent 
particles within the sample.  
 
2.2.7.4 Compensation 
When multiple fluorescent antibodies are expressed on a single cell, the fluorescence 
expression signal from one antibody may “spill” into the expression signal of another. 
If this is not compensated, the data may not be interpretable. All flow cytometry data 
presented in this thesis has been compensated. 
 
2.2.7.5 Doublet Discrimination  
For many flow cytometry experiments, including ploidy experiments, it is essential to 
be able to exclude doublets (two cells passing through the laser beam together) from 
the analysis. This is because when analysing the DNA content of cells, two diploid 
cells that are attached to each other could be misinterpreted as a cell with 4N ploidy. 






















Doublets can be excluded based on properties of the cell or doublet, such as forward 
and side scatter. 
 
2.2.7.6 Pulse Processing 
As an object passes through the laser beam, a signal is generated. This signal is 
recorded, and can be analysed to obtain information about the object. The width of the 
signal provides information about the length of time the object took to pass through 
the beam. The height (or peak) of the signal directly correlates with the maximum 
fluorescence of the cell. The signal can be integrated to find the area, which directly 
correlates with the total fluorescence of the cell. 
 
If the forward (or side) scatter area signal is plotted against the forward (or side) scatter 
height signal then single cells will lie along the diagonal x=y. This is because a single 
cell with 4N DNA content will be twice as bright as a single cell with 2N DNA content, 
since it has twice as much DNA. Therefore, the forward-scatter area signal will be 
double that of a 2N cell. Since the 4N cell does not double its membrane or cytoplasmic 
size, the maximum fluorescence (forward-scatter height) signal will also be twice that 
of a 2N cell. Therefore, these single cells will lie along the diagonal of the area versus 
height plot. When we compare a doublet (two 2N cells that are stuck together) with a 
single cell with 4N DNA content, the doublet will show the same level of total 
fluorescence (the area value), however the maximum fluorescence (signal height) will 
be half that of the single 4N cell. Therefore, the doublet will not lie along the diagonal 
of forward versus side scatter, and can be gated out from the population to be analysed. 
Clumps of cells (more than two cells stuck together) will also be excluded in this way. 
Unless otherwise stated, forward scatter-area versus forward scatter-height doublet 
exclusion was used in every flow cytometry experiment performed. A figure of a 
typical forward-scatter area (FSC-A) versus forward-scatter height (FSC-H) doublet 
exclusion step is shown below (Figure 2.1b).  
 
Alternatively, the signal width data can be used in a similar way, since a doublet will 
take twice as long to pass through the beam than a single cell with either 2N or 4N 
DNA content. For this technique, forward-scatter width is plotted against forward-
scatter area. It is possible to use both techniques (FSC-A vs FSC-H followed by FSC-
W vs FSC-A, or vice versa) to ensure that no doublets are included in the analysis. 























2.2.8 Cell Sorting 
 
2.2.8.1 Simultaneous Staining of Cell Surface Proteins 
This protocol was carried out to sort specific populations of differentiated cells for 
FISH experiments. To obtain CD4- CD8- DN, CD4+ CD8+ DP CD71+ T cells, a single-
cell suspension was made from a mouse thymus by passing the thymus through a cell 
culture strainer with 40μm nylon mesh (Corning B.V Life Sciences cat#352340).  
 
To obtain Fraction C B cell populations, the bone marrow from a tibia and femur was 
flushed out of the bone, and (as above) passed through a 40μm nylon mesh. The cells 
were counted using a haemocytometer and approximately 2x107 cells were 
resuspended in PBS at a concentration of approximately 1x108 cells/mL. Cell surface 
antibodies were added at the relevant concentrations (see Table 2.5). The cells were 
incubated in the dark with cell surface antibodies for 10 minutes at 4oC, before being 
washed in 5mL of PBS. Following this, the samples were centrifuged for 5 minutes at 
1300K, the supernatant was aspirated and the pellets were resuspended in 500μL PBS. 
Cell sorting of fluorescent cells was performed on a BD FACS AriaII SORP (Beckton 
Dickinson) by Elizabeth Freyer (FACS technician, MRC HGU). Cells were collected 
in FACS-tubes containing 0.5mL of FCS (diluted by the PBS cell suspension). The 





2.2.9.1 Simultaneous Staining of Cell Surface Proteins for DNA content analysis 
This protocol was carried out to acquire data for the proportion of hyperdiploid cells 
and total cell numbers at various stages of haematopoietic differentiation.  
 
To analyse the T cell population, a single-cell suspension was made from a mouse 
thymus by passing the thymus through a cell culture strainer with 40μm nylon mesh 
(Corning B.V Life Sciences cat#352340). To obtain both B cell and Erythroid 






















populations, the bone marrow from a tibia and femur was flushed out of the bone, and 
(as above) passed through a 40um nylon mesh.  
 
The cells were counted using the Moxi Z mini automated cell counter OS 4.0 (Orflo), 
which provides accurate cell numbers. Approximately 5 to 10 million cells of each cell 
type were transferred to a fresh tube and re-suspended in 100μL PBS. Cell surface 
antibodies were added at the relevant concentrations (see Table 2.5).  
 
The cells were incubated in the dark with cell surface antibodies for 10 minutes at 4oC, 
before being washed in 2mL of PBS. Following this, the samples were centrifuged for 
5 minutes at 1300K, the supernatant was aspirated and the pellets were re-suspended 
in 100μL Cytofix/Cytoperm Fixation and Permeabilization Solution (BD cat#51-
2090KZ) and incubated in the dark for a further 15 minutes at 4oC. Each sample was 
washed in 2mL of 1x Perm/Wash buffer (BD cat#51-2091KZ), centrifuged (as 
described above) and re-suspended in 300μL 70% ice-cold ethanol drop-wise, while 
vortexing. The samples were incubated in the dark at 4oC for a minimum of 10 
minutes, and were then washed in 2mL of diluted Perm/Wash (BD cat# 51-2091KZ) 
before being centrifuged (as described above). The supernatant was aspirated, and 
unless otherwise stated, the pellet was re-suspended in 200μL 1X DAPI (Sigma 
cat#081M4005V) staining solution (diluted 1:100 in diluted Perm/Wash (BD)). The 
cells were left at 4oC in the dark for a maximum of 24 hours before being analysed. 
 
In addition to the labelled cells, an aliquot of unlabelled cells were DAPI stained, 
providing a negative control. Single-stains were prepared using OneComp eBeads 
according to manufacturer’s instructions (cat#01-1111-42). 
 
The cells were analysed on either the BD FACS AriaII SORP (Beckton Dickinson) or 
the BD LSR Fortessa X-20 SORP. Once the cell exits the laser beam, it is sent to the 
waste collector. 
 
The data was analysed using FlowJo Version 10. The gating strategies used to 
determine each of the stages of interest of T cells, B cells and erythroid cells are shown 
in Figures 2.2, and 2.3. The same gating strategies were used to determine individual 






















stages of T, B and erythroid development for every experiment. The gating strategies 
used to determine the haematopoietic progenitor populations are indicated in Figure 
2.4. Progenitor cell DNA content was analysed using propidium iodide (PI). 
 
2.2.9.2 In vivo BrdU incorporation studies 
BrdU incorporation studies were undertaken in animals 2 hours following IP injection 
of 1-2 mg of BrdU, and detection was carried out using the FITC BrdU Flow kit (BD 
cat# 51-2354AK) according to manufacturer’s instructions.  
 
A single cell suspension was prepared from the thymus. The cells were counted using 
a haemocytometer and 1x107 cells were transferred to a Falcon tube labelled T cells. 
A single cell suspension was also prepared from the bone marrow and 1x107 cells were 
transferred to a new tube labelled B cells, and another 1x107 cells were transferred to 
a tube labelled erythroid cells. All samples were re-suspended in 100μL PBS and 
fluorescent cell surface antibodies were added at the relevant concentrations (see Table 
2.5).  
 
The cells were incubated in the dark with cell surface antibodies for 10 minutes at 4oC, 
before being washed in 1 mL of PBS. Following this, the samples were centrifuged for 
5 minutes at 1300K, the supernatant was aspirated and the pellets were re-suspended 
in 100μL Cytofix/Cytoperm Fixation and Permeabilization Solution (BD cat# 51-
2090KZ) and incubated in the dark for a further 15 minutes at 4oC.  
 
Each sample was then washed in 1mL of 1x Perm/Wash buffer (BD cat# 51-2091KZ), 
centrifuged (as described above) and re-suspended in 100μL of BD Cytoperm 
Permeabilization Buffer Plus (BD cat#559619). The cells were then incubated at on 
ice in the dark for 10 minutes before being washed in 1mL of 1xBD Perm/Wash 
Buffer, centrifuged (as above) and re-suspended in 100μL Cytofix/Cytoperm Buffer 
(BD cat# 51-2090KZ).  



























































































Following this, the cells were incubated in the dark for 5 minutes at room temperature, 
washed in 1mL of 1x Perm/Wash Buffer, centrifuged (as above) and re-suspended in 
100μL of DNase (BD cat#559619) diluted to a concentration of 300μg/mL in PBS. 
The cells were incubated for an hour at 37oC. 
 
Next, the cells were washed in 1 mL of 1X BD Perm/Wash Buffer (BD cat# 51-
2091KZ) per sample, centrifuged (as above) and re-suspended in 50μL of BD 
Perm/Wash Buffer (BD cat# 51-2091KZ) containing fluorescent anti-BrdU-APC (BD 
cat# 552598) at the relevant concentration. The samples were incubated for 20 minutes 
at room temperature, washed and centrifuged (as above) and re-suspended in 0.5mL 
Perm/Wash buffer. 
 
In addition to the fluorescently-labelled cells, an aliquot of unlabelled BrdU-treated 
cells were DAPI stained, providing a negative control. Single-stains were prepared 
using OneComp eBeads according to manufacturer’s instructions (cat# 01-1111-42). 
 
Cell analysis was performed on a BD FACS AriaII SORP (Beckton Dickinson). 
 
2.2.9.3 DNA content analysis of MEFs 
Mouse Embryonic fibroblasts were prepared from Caph2+/+ and Caph2nes/nes E14.5 
embryos on the C57 Black 6 outbred strain (as described in Section X). Cells were 
trypsonised to dissociate, neutralised with media, and pelleted by centrifugation. Pellet 
was washed in PBS. The cells were fixed and re-suspended in DAPI as above. Cells 
were analysed on the BD LSR Fortessa X-20 SORP. 
 
2.2.9.4 DNA content analysis of Primary T cells cultured ex vivo 
Primary T cells were obtained from Caph2+/+ or Caph2nes/nes thymuses. A single cell 
suspension was obtained by passing the cells through a 40μm nylon mesh (Corning 
B.V Life Sciences cat#352340), and purified using CD4 (L3T4) MicroBeads (Miltenyi 
Biotec cat#130-049-201) according to manufacturer’s instructions. CD4 negative cells 
were counted and seeded onto an OP9/DL1 monolayer at a concentration of 20x103 
cells per mL. The cells were kept in culture for 4 days and were then disassociated 
from the OP9/DL1 monolayer by gently pipetting the media up and down using a 
p1000 pipette. The media was then passed through a 40μm nylon mesh (Corning B.V 






















Life Sciences cat#352340) to remove any OP9/DL1 cells that had been disassociated 
along with the cultured T cells. The cells were washed in PBS, incubated with anti-
CD4-PECy7 (eBiosciences cat#25-0042) anti-CD8-PE (eBiosciences cat#12-0081-
81) fluorescent antibodies, fixed in 100μL Cytofix/Cytoperm Fixation and 
Permeabilization Solution (BD cat# 51-2090KZ) and re-suspended in 200μL 1X DAPI 
(Sigma cat# 081M4005V) staining solution (diluted 1:100 in diluted Perm/Wash 
(BD)) as described above. The cells were kept at 4oC in the dark before being analysed 
on either the BD FACS AriaII SORP (Beckton Dickinson) or the BD LSR Fortessa X-
20 SORP. 
 
2.2.9.5 Ex vivo BrdU incorporation studies 
Primary T cells were cultured on OP9/DL1 monolayers. After 4 days, the cells were 
treated with Bromodeoxyuridine (BrdU) from the FITC BrdU Flow kit (BD cat# 
559619) at a concentration of 10μM (i.e. 10μL of 1mM BrdU per mL of culture 
medium) at 0 hour, 1 hour, 2 hour 3 hour and 4 hour time points. Nocodazole was 
added at the same time points as BrdU, at a concentration 300ng per mL of culture 
medium. The cultured T cells were dissociated from the OP9/DL1 monolayer as 
described above, passed through a 40um nylon mesh (Corning B.V Life Sciences 
cat#352340) to remove any OP9/DL1 cells that had been disassociated along with the 
cultured T cells and washed in PBS. The cells were re-suspended in 100μL PBS and 
CD4 PECy7 (eBiosciences cat#25-0042) CD8 PE (eBiosciences cat#12-0081-81) 
fluorescent antibodies were added at the relevant concentration (see Table 2.5). 
 
The cells were incubated with the antibodies for 10 minutes at 4oC in the dark before 
being washed in 1mL of PBS. The samples were centrifuged at 1300K for 5 minutes, 
the supernatant was aspirated and the pellets were re-suspended in 100μL 
Cytofix/Cytoperm Fixation and Permeabilization Solution (BD cat# 51-2090KZ) and 
incubated in the dark for a further 15 minutes at 4oC.  
 
The cells were then washed in 1 mL of 1x Perm/Wash buffer (BD cat# 51-2091KZ), 
centrifuged (as described above) and re-suspended in 100μL of BD Cytoperm 
Permeabilization Buffer Plus. After being incubated at on ice in the dark for 10 minutes 
the cells were washed in 1mL of 1xBD Perm/Wash Buffer, centrifuged (as above) and 
re-suspended in 100μL Cytofix/Cytoperm Buffer.  























The cells were kept in the dark for a further 5 minutes at room temperature, washed in 
1mL of 1x Perm/Wash Buffer (BD cat# 51-2091KZ), centrifuged (as above) and re-
suspended in 100μL of DNase diluted to a concentration of 300μg/mL in PBS. The 
cells were incubated for an hour at 37oC. 
 
Following this, the cells were washed in 1mL of 1X BD Perm/Wash Buffer (BD cat# 
51-2090KZ) per sample, centrifuged (as above) and re-suspended in 50μL of BD 
Perm/Wash Buffer (BD cat# 51-2090KZ) containing fluorescent anti-BrdU-FITC (BD 
cat# 552598) and anti-PH3S10-APC (New England Biolabs cat#9716s) at the relevant 
concentrations (see Table 2.5). The samples were incubated for 20 minutes at room 
temperature, washed and centrifuged (as above) and resuspended in 0.5mL 
Perm/Wash buffer (BD cat# 51-2090KZ). 
 
For this experiment, the 0 hour time point provided the no-stain control. Single-stains 
were prepared using OneComp eBeads according to manufacturer’s instructions (cat# 
01-1111-42). 
 


























Table 2.5 Antibodies 
    
Experiment Antigen Conjugate Dilution Company Catalogue 
Number       
Cell Sorting 
     
T cell CD4 FITC 1 in 200 BioLegend 100509  
CD8 PE 1 in 200 eBioscience 12-0081-82  
CD71 APC 1 in 100 eBioscience 17-0711-82       
B cell B220 PECy7 1 in 200 eBioscience 25-0452-81  
CD43 PE 1 in 200 eBioscience 12-0431-82  
CD24 APC780 1 in 200 eBioscience 47-0242-80       
In vivo DNA 
content  
     
T cell DP CD4 FITC 1 in 200 BioLegend 100509  
CD8 PE 1 in 200 eBioscience 12-0081-82  
CD71 APC 1 in 100 eBioscience 17-0711-82       
T cell DN CD4 FITC 1 in 200 BioLegend 100509  
CD8 FITC 1 in 200 eBioscience 11-0081-81  
TCRγδ FITC 1 in 100 eBioscience 11-5711-81  
CD25 APC780 1 in 100 eBioscience 47-0251-80  
CD44 PE 1 in 100 eBioscience 12-0441-81  
CD90 PECy7 1 in 200 eBioscience 25-0902-81       
B cell B220 PECy7 1 in 200 eBioscience 25-0452-81  
CD43 PE 1 in 200 eBioscience 12-0431-82  
CD24 APC780 1 in 200 eBioscience 47-0242-80       
Erythro Ter119 PE 1 in 200 eBioscience 12-5921-81  
CD71 APC 1 in 100 eBioscience 17-0711-82  
Streptavidin  FITC 1 in 100 eBioscience 11-4317-87  
CD3e Biotin 1 in 25 eBioscience 13-0031-75  
B220 Biotin 1 in 25 eBioscience 13-0452-75  
Ly-6G (Gr-
1) 
Biotin 1 in 25 eBioscience 13-5931-75 






















      
In vivo BrdU   
     
T cell DP CD4 e450 1 in 200 eBioscience 48-0042-80  
CD8 PE 1 in 200 eBioscience 12-0081-82  
CD71 PECy7 1 in 100 
  
 
BrdU  FITC 1 in 100 BD 
Biosciences 
51-9000019AK 
      
T cell DN CD4 FITC 1 in 200 BioLegend 100509  
CD8 FITC 1 in 200 eBioscience 11-0081-81  
TCRγδ FITC 1 in 100 eBioscience 11-5711-81  
CD25 APC780 1 in 100 eBioscience 47-0251-80  
CD44 PE 1 in 100 eBioscience 12-0441-81  
CD90 PECy7 1 in 200 eBioscience 25-0902-81  
BrdU  FITC 1 in 100 BD 
Biosciences 
51-2354AK 
      
B cell B220 PECy7 1 in 200 eBioscience 25-0452-81  
CD43 PE 1 in 200 eBioscience 12-0431-82  
CD24 APC780 1 in 200 eBioscience 47-0242-80  
BrdU  FITC 1 in 100 BD 
Biosciences 
51-2354AK 
      
Erythro Ter119 PE 1 in 200 eBioscience 12-5921-81  
CD71 APC 1 in 100 eBioscience 17-0711-82  
Streptavidin  FITC 1 in 100 eBioscience 11-4317-87  
CD3e Biotin 1 in 25 eBioscience 13-0031-75  
B220 Biotin 1 in 25 eBioscience 13-0452-75  
Ly-6G (Gr-
1) 
Biotin 1 in 25 eBioscience 13-5931-75 
 
BrdU  FITC 1 in 100 BD 
Biosciences 
51-2354AK 
      
Ex vivo BrdU  
     
T cell DP CD4 e450 1 in 200 eBioscience 48-0042-80  
CD8 PE 1 in 200 eBioscience 12-0081-82  
BrdU  FITC 1 in 100 BD 51-2354AK 


































      
B cell IGM PerCPCy5.5 1 in 100 eBioscience 46-5790-80  








      
Ex vivo DNA 
content  
     
T cell  CD4 PECy7 1 in 200 eBioscience 25-0042  
CD8 PE 1 in 200 eBioscience 12-0081-82       
Westerns  









1 in 2000 Bethyl labs A300-603A  
CAP-H2 
 
1 in 2000 Bethyl labs A302-276A  
PCNA 
 
1 in 3000 Santa Cruz sc56  









1 in 2000 Bethyl labs A300-603A  
CAP-H2 
 
1 in 2000 Bethyl labs A302-276A  
α rabbit IgG  HRP 1 in 10000 Sigma A0545 






















CHAPTER 3: ABNORMALITIES IN CHROMOSOME STRUCTURE IN 
CAPH2 MUTANT CELLS 
 




The role of condensins both in the process of condensation and in the removal of 
catenations between sister-chromatids in preparation for mitosis is well-established 
(Baxter & Aragón, 2012; Hagstrom, Holmes, Cozzarelli, & Meyer, 2002; Hirano & 
Mitchison, 1993, 1994; Hudson, Vagnarelli, Gassmann & Earnshaw, 2003; Ono et al., 
2004). Mistakes in mitosis can lead to aneuploidy, chromosomal instability, and 
cancer, but mutations in genes encoding individual condensin subunits are not found 
in a large proportion of cancers. 
 
3.1.1.1 Aneuploidy Defined 
 
The term “aneuploidy” is often used to describe cells with an incorrect number of 
chromosomes. Strictly, however, the term should be reserved for cells with an 
abnormal number of chromosomes that is not an integer multiple of the haploid 
chromosomal complement. This definition therefore includes cells that have lost or 
gained whole chromosomes. Partial aneuploidies arise when sub-chromosomal 
regions are multiplied or deleted. In contrast, cells containing an integer multiple of 
chromosomes are referred to as “polyploid”. Polyploid cells contain a balanced 
number of chromosomes, and are therefore less deleterious to the cell in comparison 
to an unbalanced chromosome complement (Guo, Davis, & Birchler, 1996; Papp, Pál, 
& Hurst, 2003). If the daughter cell, for example, loses part of a chromosome encoding 
a tumour suppressor gene, or gains a copy of an oncogene, this may result in 
inappropriate and extensive cellular division (Torres, Williams, & Amon, 2008). 
 
Specifically, cells that undergo failed cytokinesis and therefore contain a 4n DNA 
complement (the haploid complement multiplied by four) are referred to as 






















“tetraploid”. In the absence of cell cycle arrest, tetraploid cells have a strong tendency 
to assemble multipolar spindles due to the presence of supernumerary centrosomes, 
which then have an increased tendency to generate aneuploid cells via the 
missegregation of individual chromosomes (Figure 3.1) (Ganem, Storchova, & 
Pellman, 2007; Pfau & Amon, 2012). 
 
Often, the assays used in this thesis are unable to distinguish between whole genome 
duplications (polyploidy) and either whole chromosome or partial aneuploidy. 
Therefore, throughout this thesis I have referred to cells with more than 4N DNA 
content as being “hyperdiploid”, since these cells may be either polyploid or 
aneuploid. 
 
Cells with 4N DNA content may arise as a consequence of failed cytokinesis, in which 
case they are termed “tetraploid” (as discussed above). Alternatively, a cell with 4N 
DNA content may represent a diploid cell in G2. Strictly, these cells should not be 
labelled tetraploid. However, the assay I have used most frequently in this thesis (flow 
cytometry) is unable to distinguish between these two possibilities. Therefore, I refer 
to cells with 4N DNA content as being “tetraploid”, regardless of their stage in the cell 
cycle. 
 
3.1.1.2 Condensins and tumourigenesis 
  
Cancers tend to exhibit mutational heterogeneity, where a small number of 
“gatekeeper” genes, often direct regulators of the cell cycle, are frequently mutated. 
However, there are very many infrequently mutated genes, often with “caretaker” 
functions in the cell (Vogelstein et al., 2013). Condensin and cohesins belong to this 
second group of ‘caretakers’. Interestingly, recent pan-cancer analysis revealed that 
the genes encoding subunits of condensin I, condensin II and cohesin are mutated in a 
small number of cancers. When the subunits were analysed separately, only the SMC4 
mutation was found to be significant. However, when the condensin II complex 
subunits were analysed as a unit, it was discovered that this complex was significantly 
mutated in lung adenocarcinoma (LUAD) (Leiserson et al., 2015). These mutations 
were missense. In addition, somatic point mutations in SMC2 and SMC4 have been 
observed in gastric and colorectal cancers (Je, Yoo, & Lee, 2014) and human 






















pyothorax-associated lymphomas (Ham et al., 2007), reaffirming the importance of 
condensins in maintaining chromosomal stability.  
 
Although previous studies concluded that the Caph2nes/nes phenotype most likely arises 
due to interphase abnormalities (Gosling et al., 2007; Rawlings et al., 2011), I first 
decided to investigate the consequences of condensin II depletion on its well-
established role in mitosis. In this section of Chapter 3, I describe the experiments 
carried out to determine whether the mutant cells exhibit abnormalities consistent with 
aberrant mitosis, as well as experiments that set out to investigate the morphology of 
mutant metaphase chromosomes in comparison to wildtype. 
 
  
























3.1.2.1 Overview of the Caph2nes/nes developmental phenotype in T cells  
Previous investigations into the Caph2nes/nes mutation revealed that the mutant 
thymuses are considerably smaller than wildtype, with a hypocellular cortex and an 
increased proportion of CD4- CD8- DN stage cells relative to CD4+ CD8+ DP (Gosling 
et al., 2007). A 5-fold reduction in cell numbers at the DN4 stage and ~ 100-fold 
reduction at the DP stage was reported in mutant relative to wildtype. These results are 
consistent with a developmental block in T cell differentiation, specifically at the DN 
to DP transition (Figure 1.12). B cell differentiation was also analysed in the 
Caph2nes/nes mice, but despite undergoing similar processes during development, only 
T cells were found to be affected by the mutation to Caph2 (Gosling et al., 2007).  
 
My results are broadly consistent with this previously published data: flow cytometry 
experiments reveal an increase in the proportion of mutant DN3 cells relative to 
wildtype (67.8% versus 35.9%) and approximately 2.5-fold reduction in the proportion 
of Caph2nes/nes DN4 cells (Figures 3.2b and 3.2c). Additionally, a considerable 
reduction in the proportion of DP cells is apparent in mutant animals (Figures 3.2d and 
3.2e). Finally, quantification of absolute cell numbers at various stages of T cell 
differentiation revealed a reduction in cell numbers in mutant animals, which peaks at 
approximately 85-fold at the DP 71- resting stage (Figure 3.2f).Recently, PanCancer 
network analysis identified condensin subunit mutations in tumour genomes 
(Leiserson et al., 2015). This led other lab members to carry out aging studies on the 
condensin mutant mice to investigate the relationship between condensin deficiency 
and tumourigenesis, which revealed that the Caph2nes/nes mice develop thymic 
lymphomas with high penetrance. Half of the mutant cohort had become moribund 
within 15 months (A. Wood, unpublished data, Figure 3.3a), with thymic lymphoma 
identified in all individuals. The thymic lymphomas originate from CD4+CD8+DP 
cells, i.e. the stage known to be vulnerable to the Caph2nes/nes mutation (Wood, 
unpublished data, Figure 3.3b). I therefore set out to characterise the cellular events 
that lead to both the developmental block and the tumour phenotype in Caph2nes/nes 
mutant mice. 
 




































































3.1.2.2 Investigating ploidy at the DP blast stage of T cell development using flow 
cytometry 
 
To look for evidence of mitotic errors in Caph2nes/nes mice, I used flow cytometry to 
measure DNA content at the various stages of thymic T cell differentiation shown in 
Figure 3.2a. Cells were labelled with the DNA dye DAPI, in combination with 
fluorescently-conjugated antibodies to cell surface markers of T cell differentiation 
(Table 2.5). Interestingly, all later stages of Caph2nes/nes thymic T cell development 
show increases in the proportion of cells with 4N, or greater than 4N (hyperdiploid) 
DNA content. However, in this Chapter, I will focus on one specific developmental 
stage: CD4+ CD8+ double positive (DP) blast. This is the stage of development during 
which T cells proliferate rapidly following successful VDJ rearrangement of the TCR 
β-locus. This is also the stage at which the frequency of hyperdiploid cells is highest 
in the Caph2nes/nes mutant relative to Caph2+/+, and from which lymphoma cells 
originate in aging Caph2nes/nes mice. A more detailed analysis of the dynamic changes 
in ploidy during differentiation is provided in Chapter 4. 
 
Once dead cells and other debris had been excluded from the population using 
forward- and side-scatter properties (see Materials and Methods Section 2.2.7.2), the 
developmental stage of interest was selected using the gating strategies shown (Figure 
3.4). Briefly, CD4 was plotted against CD8 and the population of cells positive for 
both cell-surface markers was selected. A histogram of CD71 - a cell surface marker 
for blasting DP cells (Brekelmans, van Soest, Leenen, & van Ewijk, 1994; Seitan et 
al., 2011) was plotted and the CD71 positive cells were selected. DNA-content profiles 
of these DP blast cells are shown (Figures 3.4e and 3.4f). 
 
At this specific stage of development, there is an altered ploidy profile with a particular 
increase in the frequency of 4N and greater than 4N (hyperdiploid) DNA content in 
the Caph2nes/nes mutant. This may indicate that errors occur during mitosis at the DP 
blast stage of Caph2nes/nes development, resulting in increased levels of both tetraploid 
and hyperdiploid cells.  
 
  













































To confirm that the hyperdiploid cell populations are indeed individual cells rather 
than aggregates, a sample population was analysed using Image Stream: a technique 
that combines flow cytometry with imaging capabilities. Each cell is imaged as it 
passes through the laser beam, confirming whether the registered event is indeed a 
single cell, or aggregated cells. The results of this experiment provided visual 
confirmation that the vast majority of the hyperdiploid events detected by conventional 
flow cytometry are indeed single cells (Figure 3.5), thereby validating the use of the 
greater than 4N gate to identify individual cells with abnormal ploidy. This flow 
cytometry analysis was carried out by David Jameson of Newcastle University. 
 
3.1.2.3 Investigating ploidy at the DP blast stage of T cell development using FISH 
 
Even when subjected to stringent doublet exclusion, flow cytometry can be hampered 
by the inclusion of cell aggregates within a population. Given the potentially 
interesting implications of increased levels of aneuploidy in Caph2nes/nes T cell 
development, it was important to verify this finding using an independent method that 
would not be subject to the same limitations. To do this, I carried out 3D 3-colour 
Fluorescence in situ Hybridisation (FISH) on DP blast Caph2+/+ and Caph2nes/nes cells.  
 
FISH is a well-established cytogenetic technique that allows copy number 
enumeration of specific chromosomal sequences based on the number of hybridisation 
signals per nucleus. However, the technique is vulnerable to false-positive signals, 
which could be mistaken for elevated copy number. I therefore used pairs of fosmid 
probes that hybridise within 200kb of each other, and only counted foci at which both 
probe signals were clearly present in close proximity (Figure 3.6). 
 
The CD4+ CD8+ DP population of cells was FACS-sorted (Materials and Methods: 
Cell sorting) using fluorescently conjugated antibodies to cell surface markers (Table 
2.5) and seeded onto polyprep/polylysine slides (as described in Materials and 
Methods: Preparation of Slides for FISH). Pairs of fosmids were selected to target two 
different loci: the CD8 locus - which is highly transcribed at this stage of thymic 
development, and HoxA, which is inactive (Table 2.3). Both loci are located on 
chromosome 6 which allowed me to assess the copy number of chromosome 6, using 
two independent loci.  















































For each locus one probe was labelled with biotin-16-dUTP (biotin) and the other with 
digoxigenin-11-dUTP (DIG). Representative FISH images are shown for the CD8 
locus (Figure 3.6a) and HoxA locus (Figure 3.6b).  
 
The number of paired fosmid hybridisation signals were counted per nucleus, and the 
proportion of nuclei with one pair, two pairs, three, four and more than four pairs was 
calculated, and expressed as a percentage of the total number of nuclei imaged, and 
plotted as a histogram (Figure 3.6c). The results showed an increased frequency of 
Caph2nes/nes mutant DP blast cells with more than two copies of each locus. Although 
four copies was the next most frequent copy number after two (~22% in Caph2nes/nes 
versus ~4% in wildtype), three spots were also observed at frequencies that were 
elevated over wildtype (~8% versus ~1%). Differences in the number of fosmid pairs 
between wildtype and mutant were found to be significant at p < 0.05 using a Fisher 
test. 
 
Very consistent results were obtained for both the CD8 and HoxA loci, and the 
difference in the number of fosmid pairs was also found to be statistically significant 
for HoxA at p < 0.05. The similarity in the results for both loci implies that whole 
chromosome aneuploidy occurs in Caph2nes/nes DP blast T cells (at least of 
chromosome 6). These data support the finding of increased frequencies of 
hyperdiploid DP blast cells in Caph2nes/nes observed using flow cytometry. 
  













































3.1.2.4 Investigating ploidy during T cell development using an ex vivo T cell culture 
system 
 
Finally, in order to confirm the elevated frequency of hyperdiploid mutant cells 
relative to wildtype using a third independent technique, I prepared metaphase spreads 
from T cells cultured briefly ex vivo using the OP9 DL1 in vitro T cell culture system 
(de Pooter and Zúñiga-Pflücker, 2007). T differentiation can be recapitulated ex vivo 
by culturing primary T cell precursors on a monolayer of OP9/DL1 cells: a stromal 
cell line that is induced to ectopically express the notch ligand Delta-like 1 (DL1). The 
use of an ex vivo culture system as a tool to study the abnormal ploidy phenotype in 
Caph2nes/nes was validated by DNA content analysis of CD4+ CD8+ DP T cells cultured 
on the OP9 DL1 monolayer, which revealed an increased proportion of hyperdiploid 
cells in mutant relative to wildtype (Figures 3.7a and 3.7b). However, the proportion 
of hyperdiploid mutant cells was lower than in vivo (Figures 3.4e and 3.4f). 
To prepare metaphase spreads, I plated a monolayer of OP9 DL1 cells onto the wells 






















of a 6-well plate. MACS purified CD4- wildtype and Caph2nes/nes cells were added to 
separate wells onto the monolayer. T cells were cultured in the presence of IL-7 on the 
monolayer for four days (Materials and Methods: Section 2.2.9.5) resulting in a 
population of approximately 40%-50% CD4+ CD8+ wildtype DP cells and 15-20% 
mutant DP cells. The cells were treated with colcemid for two hours, before they were 
removed (Figure 3.8a), treated with hypotonic solution (0.5% sodium citrate, 0.25% 
potassium chloride in deionised water) and fixed with 3:1 methanol: acetic acid 
(Materials and Methods: Section 2.2.5). 
 
After fixation, metaphase spreads were prepared by dropping the cell suspension onto 
slides. The sample was dehydrated before being rehydrated in PBS containing DAPI 
and the mitotic chromosomes imaged by confocal microscopy. Representative images 
are shown (Figure 3.8b). The number of centromeres in each of the spreads was 
counted and the proportion of hyperdiploid cells for both the Caph2+/+ and Caph2nes/nes 
populations was determined, and plotted as a histogram (Figure 3.8c).  
 
Optimisation of the conditions to provide fully spatially distinct chromosomes proved 
to be challenging for this cell type. I therefore chose to count the number of 
centromeres rather than the number of chromosomes, since the centromeres were 
easily discernible, whereas the chromosomes were not always easily distinguished 
from one another. This may be due to the amount of time spent in colcemid treatment, 
which is known to affect the morphology of chromosomes, but could also reflect 
intrinsic properties of the nuclear matrix and nuclear membrane in primary T cells that 
inhibit spreading. 
 
To account for the potentially high margin of error using this approach, for example 
due to chromosomes lying on top of each other, or from individual chromosomes being 
spread beyond the field of view, I adopted a liberal definition of “~diploidy” for this 
analysis: 38 – 40 chromosomes. There are several reasons why diploid metaphase 
spreads may appear to have lost two centromeres: for example, if two centromeres lie 
on top of each other, it may be difficult to distinguish one from the other.  
  













































Of the 93 wildtype spreads imaged, no hyperdiploidy was observed. In contrast, I 
observed 12 hyperdiploid mutant spreads within the 98 that were imaged. A Fisher 
exact test was performed on the data giving a statistic value of 0.000172. Therefore, 
the differences in the levels of hyperdiploidy between wildtype and mutant were found 
to be significant at p < 0.05. These data therefore show that the increased levels of 
hyperdiploidy in the Caph2nes/nes mutant, observed using two independent techniques, 
is also detected in primary cells following short-term culture.  
 
The hyperdiploid mutant chromosomes were, in the majority of cases, intermediate 
between 2N and 4N, indicating that whole chromosome aneuploidy is present in the 
Caph2nes/nes mutant. However, flow cytometry revealed an increase in the proportion 
of cells with 4N as well as > 4N DNA content at the DP 71+ blast stage (Figures 3.4e 
and 3.4f). Therefore, as defined by Amon et al. (Pfau & Amon, 2012), the Caph2nes/nes 
mutant displays whole genome duplications in addition to whole chromosome 
aneuploidy.  
 
3.1.2.5 BrdU chase assay to determine whether mutant 4N cells arise due to mitotic 
slip or G2 arrest 
 
The population of 4N mutant cells may represent tetraploid cells that have undergone 
G1 arrest following unsuccessful mitosis, or diploid cells that have arrested after 
failing to enter mitosis. To distinguish between these two possibilities, I devised a 
BrdU “chase” assay that allowed S phase cells to be followed into mitosis over a time 
course. BrdU is a thymidine analogue, and is incorporated into genomic DNA during 
S phase DNA synthesis. For these experiments I cultured MACS purified CD4- 
wildtype and Caph2nes/nes T cells on the OP9 DL1 system (Section 3.1.2.4). Once 
approximately 40%-50% of the wildtype and 15%-20% of mutant cells had progressed 
to the DP stage, the cells were simultaneously treated with the microtubule inhibitor 
nocodazole and the nucleotide analogue BrdU over a four hour time course (Materials 
and Methods: Section 2.2.9.5). The BrdU analogue was used to label S phase cells, 
while nocodazole arrests cells in prometaphase. The T cells were then removed from 
the monolayer and incubated with fluorescently conjugated anti- CD4 and CD8 
antibodies as well as antibodies to BrdU and phosphorylated serine 10 on histone 3 
(PH3S10: which labels cells from mitotic prophase). The cells that expressed both 






















CD4 and CD8 (the DP population) were analysed by flow cytometry.  
 
PH3S10 was plotted against BrdU for each time point (Figure 3.9c), to determine the 
percentage of DP cells that had progressed to M phase from S phase (i.e. the proportion 
of PH3S10+ BrdU+ double-positive cells as a fraction of total cells positive for BrdU). 
Having progressed to M phase, the cells accumulate in prometaphase, due to the 
nocodazole treatment. The relevant time points in this experiment in relation to the 
cell cycle are indicated in Figure 3.9b. The rate of progression of the wildtype and 
mutant cells from S phase into M phase is shown as a line graph (Figure 3.9d). 
 
The rate of progression from S to M phase is very similar between wildtype and mutant 
as judged by BrdU incorporation and PH3S10 (Figure 3.9d). This indicates that, at the 
relevant stage of T cell differentiation, the Caph2nes/nes cells are not impeded in their 
progression into mitosis i.e. there is an absence of a cell cycle block in G2. Therefore, 
it is likely that the increased frequency of 4N and > 4N cells is not a consequence of 
arrest at G2 stage. Finally, the data suggests that the tetraploid cells that arise in the 
Caph2nes/nes mutants are not a consequence of mitotic skip, since cells undergoing 
mitotic skip would not progress to, and accumulate in mitosis at all. 
 













































3.1.2.6 Metaphase chromosome abnormalities in Caph2nes/nes mutant fetal liver 
erythroblasts (E12.5) 
 
In the previous sections I confirmed the presence of increased levels of hyperdiploidy 
in the Caph2nes/nes mutant at the DP blast stage of T cell development using two 
independent techniques. In addition, I found increased levels of aneuploid Caph2nes/nes 
T cell metaphase spreads compared to wildtype. Therefore, I have confirmed using 
three independent techniques that there is an increase in the frequency of hyperdiploid 
Caph2nes/nes T cells in comparison to wildtype. 
 
To investigate possible causes of the abnormal ploidy, I next studied the consequences 
of the Caph2nes/nes mutation on metaphase chromosome structure and explored the 
possibility that the increased frequency of hyperdiploid cells could be a consequence 
of aberrant mitosis. To do this, I imaged metaphase chromosomes directly, in order to 
look for any differences in structure resulting from Caph2nes/nes mutation. I initially 
chose to use E14.5 fetal liver cells since this is a relatively synchronised population of 
cells, eliminating the need for MACS purification or flow cytometry sorting. DNA 
content quantification using flow cytometry confirmed that, like T cells, the 
Caph2nes/nes erythroid cells also show an increase in the proportion of cells with 
hyperdiploid DNA content in comparison to wildtype. These experiments are 
described in Chapter 4 (Figure 4.6c). The erythroid cell lineage was therefore deemed 
a suitable choice to determine whether the increased proportion of cells with abnormal 
ploidy is reflected in an increased incidence of abnormal mitotic chromosome 
morphology. 
 
Metaphase cells were treated with colcemid for 30 minutes, fixed with methanol-acetic 
acid (Materials and Methods: Section 2.2.5), DAPI-stained and imaged by confocal 
microscopy. Whereas wildtype chromosomes had long, thin chromosome arms with 
sister chromatids closely associated along their arms, in contrast many of the 
Caph2nes/nes chromosomes appeared to be much more bloated or “puffier”, indicating 
a disruption of chromosome architecture. In some instances, the Caph2nes/nes chromatid 
arms appeared to be more splayed than in wildtype (Figures 3.10a and 3.10b). A higher 
mitotic index in mutant relative to wildtype might account for these differences, since 
the mitotic mutant cells would be exposed to colcemid for longer. However, the mitotic 






















index of the wildtype and mutant cells were estimated by eye, and substantially fewer 
mitotics were observed in the Caph2nes/nes spreads relative to wildtype. 






















In addition, the Caph2nes/nes chromosome arms appeared to have a “wavy” structure. 
This phenotype has previously been reported in condensin II-deficient cells (Ono et 
al., 2013). However, the low resolution of the confocal images made it difficult to 
draw any firm conclusions. 
 
Traditional confocal microscopes are limited in the image resolution that can be 
obtained. As light passes through an aperture (for example, as the light passes through 
the objective aperture in a confocal microscope), the light is spread out due to 
diffraction. Therefore, a sharp point on the object being imaged will become blurred, 
in a process called the point spread function (PSF). The fine detail within this “spread” 
of light cannot be resolved. Therefore, the resolution of a conventional confocal 
microscope is diffraction limited. 
 
In order to obtain higher resolution images of the metaphase chromosomes, I used 
Structured Illumination Microscopy (SIM). This process involves illuminating the 
sample with patterned light, causing the light diffracted by the fine detail in the sample 
and the grating pattern to interfere with one other. The resulting Moire fringe patterns 
are of much lower frequency than the original diffraction pattern produced by the 
sample. This allows more information to be collected from the sample that was 
previously outside the observable region: confocal imaging typically provides a 
resolution of approximately 200-210nm, whereas SIM allows a resolution of 
approximately 140nm.  
 
The fetal liver erythroid cells were prepared as before (Section 3.1.2.4), but were 
dropped directly onto coverslips, rather than onto slides in order to reduce the distance 
between the sample and the light source, thereby minimising diffraction of light, and 
loss of information.  
 
The SIM images revealed profound differences in the morphology of the metaphase 
chromatid arms (Figure 3.11). The wavy (zig-zag) shape of the chromatid arms was 
striking in the condensin mutant chromosomes, and this morphology was apparent in 
every Caph2nes/nes metaphase spread that was imaged (98 spreads in total). None of the 
93 wildtype chromosome spreads that were observed revealed this morphology. 













































3.1.2.7 Metaphase chromosome abnormalities in Caph2nes/nes mutant T cells  
 
For the previous experiments fetal liver erythroblasts were used to make metaphase 
spreads. This was largely due to convenience, since there was no need to sort the cells 
to obtain a population of cells that were relatively homogeneous with respect to 
differentiation status. However, since the nessy phenotype appears to be most 
profound in thymic T cells, I next analysed the morphology of metaphase T cells. 
 
Having cultured MACS purified CD4- T cells on OP9 DL1 monolayers for four days 
(as described above), the T cells were removed from the monolayer following two-
hour colcemid treatment. The cells were prepared as before (Materials and Methods: 
Section 2.2.5). Differences in the metaphase chromosome morphologies were 
observed between wildtype and mutant spreads (Figure 3.12b). A higher proportion of 
the Caph2nes/nes chromosomes appeared shorter and “puffier”, with less well-defined 
structure compared to wildtype. In addition, a higher proportion of chromatid arms 
appeared “splayed” in mutant compared to wildtype T cells. Due to the “puffy” nature 
of the chromosomes, however, this was difficult to quantify (the chromosomes were 
not always easily distinguished from one another, as discussed in Section 3.1.2.4). A 
higher proportion of splayed chromosomes may indicate that the centromeres of the 
Caph2nes/nes cells are less rigid than in wildtype (Rieder & Cole, 1999), although more 
work is needed to confirm this. Finally, several of the mutant chromosome spreads 
appeared to have a wavy (zig-zag) morphology, similar to that observed in the mutant 
fetal liver spreads (indicated by arrows), although a higher resolution, such as that 
provided by SIM would be required to attempt to quantify this. The puffy, zig-zag 
morphology was not observed in any of the wildtype spreads that were imaged.  
 
The data presented thus far implies that T cells in Caph2nes/nes mice experience 
abnormalities in mitotic chromosome structure, which leads to abnormal mitosis and 
increased levels of hyperdiploidy at specific stages of T cell development. This data 
called for a re-examination of previously published work on the Caph2nes/nes mouse, 
which, based partly on the expectation that mutations affecting mitosis should impact 
all dividing cells, concluded that the observed phenotype is most likely caused by 
abnormal interphase processes (Gosling et al., 2007; Rawlings et al., 2011). 


















































Since condensin carries out an important role in all dividing cells, it is surprising that 
a mutation in one of its subunits causes a tissue-specific developmental phenotype. 
Given the well-documented epigenetic processes crucial for successful T cell 
development, and the role of condensins in regulating gene expression in several 
model organisms, previous studies into the Caph2nes/nes mutation concluded that the T 
cell-specific phenotype is a result of abnormal interphase processes (Rawlings et al., 
2011). I therefore decided to further investigate the possibility that the Caph2nes/nes 
mutation could be affecting non-mitotic functions of condensin, such as its proposed 
role in organizing interphase chromosome structure (see Section 1.2.5). 
 
3.2.1.1 Epigenetic processes during T cell differentiation 
 
T cell differentiation is an extremely well-studied process, for which an increasing 
body of evidence implicates epigenetic processes. For example, certain regulatory, 
growth and transcription factors are necessary at multiple stages of T cell 
differentiation, but in each case this results in drastically different cell fates.  
 
TCR-dependent signalling, for example, takes place during positive selection, and 
determines which cells will survive, and which will undergo apoptosis. In addition to 
this though, TCR signalling also helps to determine which cells will become CD4+ 
single positive, and which will become CD8+ single positive, depending on both the 
strength and duration of the signal (Alberola-Ila & Hernández-Hoyos, 2003; Bosselut, 
2004; Singer, 2002). TCR-dependent signalling is also important during TCRγδ 
development, but again results in very different developmental pathways to cells that 
undergo TCR-dependent signalling in the TCRαβ lineage (Rothenberg & Taghon, 
2005).  
 






















These differences in cell fate are caused by the expression of transcription factors such 
as Notch (Huang, Gallegos, Richards, Lehar, & Bevan, 2003; Schmitt, Ciofani, Petrie, 
& Zúñiga-Pflücker, 2004; Wolfer, Wilson, Nemir, MacDonald, & Radtke, 2002) and 
GATA-3 (Garćia-Ojeda et al., 2013; Hosoya et al., 2009), which are expressed at 
crucial stages of T cell development, such as β-selection and positive selection. It is 
clear, therefore, that epigenetic mechanisms such as transcription-factor-mediated 
regulation of cell fate decisions play an important role during T cell development. 
 
Polycomb group proteins, a well-studied family of proteins known to induce 
epigenetic silencing of genes, have been shown to be vital for successful differentiation 
of haematopoietic lineages. Generally, knock-outs of the polycomb proteins is 
embryonic lethal – reflecting their importance – and so conditional knockouts have 
been used to study their functions. One such study found that knock-out of the 
polycomb gene Bmi-1 resulted in several defects in the haematopoietic lineages, 
including reduced cellularity of the thymus, bone marrow and spleen. A developmental 
block was observed at the CD4- CD8- DN stage of T cell development, and at an 
equivalent stage of B cell development resulting in reduced numbers of mature T and 
B cells (Van Der Lugt et al., 1994). 
 
Mutations to other polycomb group genes have resulted in similar phenotypes: Mel-
18 mutant mice reveal hypoplasia of both the spleen and thymus, with abnormalities 
resulting in developmental blocks at the CD4- CD8- DN stage of T cell development 
(Kimura et al., 2001) as well as at the pro-B cell stage of development (Tetsu et al., 
1998). Reduced cellularity is also apparent in the spleen of Rae28 mutant mice, with 
a developmental block in B cell development (Ohta et al., 2002). Since polycomb 
mutant mice generally display developmental abnormalities after commitment to 
either the B or T cell lineages, it seems likely that the polycomb genes are involved in 
terminal gene silencing to maintain lineage decisions, rather than being involved in 
lineage decisions of cells (Raaphorst, Otte, & Meijer, 2001). 
 
In addition to the role of transcription factors and polycomb group proteins in 
determining cell fate, further research has been carried out into the restructuring of 
chromatin during haematopoietic differentiation to facilitate gene silencing. This 
chromatin remodelling is thought to be transferred to daughter cells, thereby ensuring 






















that cell fate decisions are maintained across multiple rounds of cell division.  
 
The CD4+ CD8+ DP stage of T cell development has been a useful model to study 
genes silencing, since cells that have successfully undergone VDJ recombination 
quickly downregulate the expression of genes that encode the recombination 
machinery. These genes are crucial for successful rearrangement and generation of 
diversity, and therefore a great deal of work has been carried out to better understand 
their roles. One of the genes associated with carrying out VDJ recombination, Dntt, 
has been studied in detail by Su et al. who investigated the process of silencing Dntt 
after successful VDJ recombination (Su, Sridharan, & Smale, 2005). 
 
Using an ex vivo T cell differentiation system, Su et al. found that restriction enzyme 
accessibility to the promoter of Dntt was reduced following stimulation of the cells to 
differentiate. This was interpreted to represent a change in chromatin confirmation, 
which occurred as the Dntt locus was observed to relocate to pericentromeric 
heterochromatin.  Deacetylation of H3-K9 occurred at the Dntt promoter, within the 
same time frame as the changes to chromatin confirmation. Following this, there is 
methylation of H3-K9 and demethylation of H3-K4: these events are all consistent 
with silencing of the Dntt locus. 
 
In this chapter I describe the experiments undertaken to study chromatin compaction 
and decompaction of the mutant relative to wildtype cells. The extent of any 
compaction or decompaction was studied both on a large, whole-genome scale, as well 
as a more localised scale of 100Kb to 5Mb. Further experiments were carried out to 
investigate any other differences in interphase chromatin architecture between 
wildtype and mutant. 
 
  
























3.2.2.1 Investigating interphase chromatin compaction using flow cytometry 
 
Here, the term “compaction” is used to describe an increase in the amount of chromatin 
per unit volume. The term “condensation” is reserved to describe the restructuring of 
chromosomes into dense, individualised structures (e.g. before mitosis). As a first step 
to investigate interphase chromatin compaction in Caph2nes/nes T cells, I used flow 
cytometry to look for differences in cell size relative to wildtype. This was quantified 
using forward scatter: a measure of cell size. Given that the nucleus makes up a large 
majority of the cell volume in lymphocytes, forward scatter can be used as a reasonably 
accurate indicator of nuclear size (Jorgensen et al., 2007).  
 
Before entry into the periphery, T cells become smaller and undergo quiescence. This 
has previously been interpreted as chromatin condensation, which was proposed to 
help prevent premature activation of naïve lymphocytes in the absence of T Cell 
Receptor stimulation (Rawlings et al., 2011). In that study, flow cytometry was used 
to show that Caph2nes/nes CD4+ CD8+ DP thymocytes are increased in size relative to 
wildtype. They used this data to infer abnormal interphase chromatin decompaction in 
Caph2nes/nes cells. 
 
However, in light of the evidence described in Section 3.1.2 that was not previously 
reported, I decided to re-examine the evidence presented by Rawlings et al. I labelled 
wildtype and Caph2nes/nes thymocytes with fluorescently conjugated anti- CD4 and 
CD8, fixed the samples and stained with DAPI (as described in Materials and 
Methods: Section 2.2.9.1). The samples were analysed using a flow cytometer. 
Stringent doublet exclusion was carried out (Materials and Methods: Section 2.2.7.5) 
– this was particularly necessary here, since cell aggregates would display forward 
scatter profiles consistent with very large cells. In order to achieve a direct comparison 
with the Rawlings data set, I gated on the same population (the CD4+ CD8+ DP cells). 
The cells expressing CD4 and CD8 epitopes were selected (quadrant labelled DP 
Figures 3.13a and 3.13b) and their forward scatter profiles analysed (Figure 3.13c). 
My results confirm that CD4+ CD8+ DP Caph2nes/nes thymocytes display a higher 






















forward scatter (FSC) profile compared with Caph2+/+ DP cells. Specifically, the 
Caph2nes/nes forward scatter profile reveals a bimodal distribution, with cells 
corresponding to the larger modal value much more abundant relative to Caph2+/+. 
The lower forward scatter population is similar in size to the bulk of the wildtype 
population. This suggests that if interphase decompaction occurs in Caph2nes/nes, it only 
affects a subset of cells. 
 
However, large differences in ploidy exist between wildtype and Caph2nes/nes 
thymocytes (Figures 3.13d and 3.13e), which are very likely to affect the cell size 
distribution of the DP population independently of genome compaction. This was not 
considered by Rawlings et al. In order to control for differences in DNA content, I 
next gated specifically on CD4+ CD8+ DP cells with either 2N or 4N ploidy based on 
DAPI fluorescence (Figures 3.13d and 3.13e). The forward scatter profiles of the 2N 
and 4N populations were then compared between wildtype and Caph2nes/nes.  
 
For both populations (2N and 4N DNA content), there was no obvious difference in 
the mutant forward scatter profiles relative to wildtype (Figure 3.13f).  This indicates 
that the differences in cell size observed by Rawlings et al. using forward scatter are a 
result of an increase in ploidy in the Caph2nes/nes mutant cells. The absence of cell size 
differences between wildtype and Caph2nes/nes populations that were matched for both 
differentiation status and ploidy suggest that global decompaction of interphase 
chromatin is either subtle or absent. 
 
  













































3.2.2.2 Investigating interphase chromatin compaction using FISH 
 
Although I was unable to find evidence for large scale decompaction of chromatin in 
Caph2nes/nes mutant cells, I next investigated the possibility that condensin deficient 
cells may undergo decompaction of interphase chromatin on a more localised scale.  
 
FISH has been used extensively to study chromatin compaction across a specified 
genomic distance, in multiple cell types (Chambeyron, Da Silva, Lawson, & 
Bickmore, 2005; Gilbert et al., 2004; Morey, Da Silva, Perry, & Bickmore, 2007), and 
to study localized differences in chromosome compaction between wildtype and 
mutant cells (Eskeland et al., 2010; Tark-Dame, Jerabek, Manders, Heermann, & van 
Driel, 2014). I chose to carry out 3D rather than 2D FISH, since it is possible to prepare 
the flow cytometer-sorted T cells in such a way that their 3D structure is preserved 
(described in Materials and Methods: Section 2.2.4.7). Although less time is required 
to image, process and analyse 2D FISH, 3D FISH provides more information since the 
distances between probes in the z-direction are taken into account. 
 
I first measured the distances between the hybridisation signals from two probes, 
situated approximately 100kb apart in the linear genome, in three-dimensional nuclear 
space. I selected two tissue-specific loci to analyse: one – CD8 -that is activated during 
thymic development (Figure 3.14a), and one gene cluster that is inactive during this 
stage of development (HoxA – Figure 3.14c). By choosing fosmid probes that flank 
each of these two loci, I was able to study the impact of Caph2 mutation on chromatin 
compaction across active and inactive loci. 
 
The fosmid probes were chosen using the UCSC genome browser fosmid end pairs 
track (http://genome.ucsc.edu/), and details of these are given in Table 2.3. Labelling 
and detection of the selected fosmids was carried out as described in Materials and 
Methods (Section 2.2.4).  
 
  













































The inter-probe distances, determined by the distance between the centroids of the red 
and green hybridisation signals, were calculated using an in-house script (Materials 
and Methods: Section 2.2.4.11). The units of the distances between fosmid probes 
were converted from pixels to microns and then squared (d2), which has been shown 
to be proportional to genomic distance (Gilbert et al., 2004; van den Engh, Sachs, & 
Trask, 1992). This is due to the fact that interphase chromatin follows a random walk 
giant-loop mathematical model, where chromatin behaves like a flexible polymer 
(Sachs, van den Engh, Trask, Yokota, & Hearst, 1995). Distances squared were used 
to determine the level of chromatin compaction in all comparisons between wildtype 
and Caph2nes/nes. Statistical significance and p-values were assessed using the Wilcox 
test, with a cut-off value of p < 0.05. This non-parametric test was used since it does 
not assume that the data follows a normal distribution. All data (distance between 
probes (d), distance squared (d2), and significance levels (p-values)) are provided in 
Table 2.4.  
 
When analysing 2D FISH, it is customary to normalise to the nuclear area (d2/r2). 
However, for 3D FISH the nuclear volume is very difficult to determine due to 
decreased resolution in the z-direction. In addition, there are substantial differences in 
cell size between wildtype and mutant (shown using forward scatter profiles – Figure 
3.13c). Since the differences in cell size are not due to large-scale decompaction of 
chromatin, but instead due to an increase in ploidy at the CD4+ CD8+ DP stage of 
Caph2nes/nes development, normalising to nuclear volume would therefore skew the 
data, making the mutant loci appear more compact than they really are. Therefore, 
absolute d2 values are presented here and throughout, without normalisation to nuclear 
volume. 
 
3.2.2.2.1 Investigation into chromatin compaction at the 100kb scale 
 
When FISH was performed on the rapidly cycling CD4+ CD8+ DP blast (CD71+) T 
cells, i.e. the stage at which the Caph2nes/nes ploidy abnormalities are most severe, there 
were no significant differences in the mean distance squared between probe pair 
signals flanking either CD8 or HoxA in wildtype compared to Caph2nes/nes (p-values 
are displayed on the boxplots (Figures 3.14b and 3.14d)). This data suggests that, at 
least at the two loci investigated, the condensin mutation does not cause a difference 






















in the compaction of interphase chromatin.  
 
3.2.2.2.2 Further investigation of chromatin compaction across increasing genomic 
distances 
 
In order to extend this analysis across progressively larger genomic distances, I next 
studied compaction using an additional fosmid probe, Igkv, situated 1Mb away from 
CD8 (Figure 3.15a, details of the fosmid are given in Table 2.3). It has previously been 
shown that the random walk model is valid for probes separated by up to 1.5Mb in the 
linear genome, and so chromatin compaction between these loci can be correctly 
inferred using d2 values (van den Engh et al., 1992).  
 
3D FISH was carried out as before, on cells at the same stage of T cell development 
as used previously: DP 71+ blast T cells and representative FISH images are shown in 
Figure 3.15b. The distance between fosmid probes in wildtype and mutant was 
determined, and the results are plotted as boxplots. No significant difference was found 
in the compaction of interphase chromatin between wildtype and mutant at loci 
situated 1Mb apart in the linear genome (Figure 3.15c). 
 
Finally, I chose a probe situated 5Mb away from CD8 (Figure 3.15a, Table 2.3). Since 
the Random-walk model breaks down at approximately 1.5Mb – 2Mb (van den Engh 
et al., 1992), the use of d2 to determine chromatin compaction will be less accurate 
than in previous experiments. However, since it is the differences in compaction 
between wildtype and Caph2nes/nes mutant that are of interest, useful information may 
be obtained from the comparison of the two datasets (wildtype and mutant) despite the 
potential uncertainty in the calculation of absolute compaction. 
 
For probes situated 5Mb apart in the linear genome it was not always possible to be 
sure which probe paired with which. Therefore, nuclei in which it was difficult or 
impossible to reliably match fosmid pairs were excluded from the analysis. The 
frequency of discarded nuclei was very similar in wildtype and mutant, and therefore 
did not bias the results. I again found no significant difference between wildtype and 
Caph2nes/nes in the compaction of interphase chromatin (Figure 3.15c).  













































Therefore, having measured inter-probe distances across sequentially larger distances 
at the CD8 locus, I was unable to find a significant difference in the compaction of 
interphase chromatin at any of the distances studied (Figure 3.15c).  
 
3.2.2.2.3 Chromatin compaction measurements using a control cell type 
 
Finally, in order to ensure that interphase chromatin compaction did not differ between 
wildtype and Caph2nes/nes in cell lines that were not obviously affected by the 
condensin mutation, I performed FISH on the closely related B cell lineage. As a direct 
comparison with DP blast T cells, Fraction C (rapidly proliferating) B cells were 
selected using flow cytometry with antibodies to B220, CD43, BP1 and CD24 (see 
Materials and Methods: Section 2.2.8). The cells were prepared and analysed as 
described previously. When 3D FISH was carried out on this cell type using fosmid 
probes to the CD8 locus, no significant difference in the distance between probe pairs 
between wildtype and the condensin mutant cells was observed (Figure 3.16). 
 
For each FISH experiment, a minimum of 50 wildtype and 50 mutant nuclei were 
analysed. Prior experience using the FISH technique indicates that analysis of 50 
nuclei provides sufficient power to detect differences in compaction. Despite this, the 
possibility that subtle decompaction takes place in the mutant nuclei cannot be ruled 
out. However, these differences are of insufficient magnitude to result in a statistically 






















significant difference.  
3.2.2.3 Further analysis into interphase chromatin organisation of Caph2nes/nes cells 
at the DP 71+ blast stage of T cell development 
 
Having found no evidence for chromatin decompaction in Caph2nes/nes T cells at the 
active and silent loci studied, I went on to investigate whether other aspects of 
interphase chromosome structure might be affected by the condensin II deficiency.  
 
3.2.2.3.1 Radial nuclear organisation 
 
Radial organization of the interphase genome appears to be non-random, and is 
conserved in eukaryotes (Meister & Taddei, 2013). Actively transcribed regions are 
often located towards the centre of the nucleus, and in contrast, gene-poor and late 
replicating regions are often located towards the periphery. I was interested in 
determining whether the nuclear organization of CD4+ CD+ DP T cells changes in 
mutant relative to wildtype. The nuclear position of the CD8 locus and the HoxA locus 
was quantified using FISH images captured previously with fosmid probes located 
100kb apart in the linear genome: Table 2.3.  The nuclear area was divided into five 
concentric shells, each with equal area using a nuclear erosion script used previously 
by the lab (Rafique, Thomas, Sproul, & Bickmore, 2015; Therizols et al., 2014), 
Figure 3.17a, Materials and Methods: Section 2.2.4.11.  
 
Nuclei were eroded in from the periphery (shell 1) to the centre (shell 5) and the 
proportion of signals within each shell counted and the percentage of CD8 and HoxA 
signals in each shell were plotted as histograms. A Mann-Whitney test was performed 
on the data and the difference between the localisation of signals in wildtype and 
mutant was not found to be significant at p < 0.05, for either CD8 (Figure 3.17b) or 
HoxA (Figure 3.17c). This implies that no nuclear re-localisation of chromosome 6 
occurs as a result of the condensin II mutation. A Kolmogorov-Smirnov test was 
performed on the data to test whether the wildtype and nessy datasets are drawn from 
the same distribution. The K-S test statistic was 0.2 for the CD8 locus and 0.4 for the 
HoxA locus, with p-values of 1 and 0.873 respectively, indicating that the wildtype 
and mutant datasets originate from the same distribution. Therefore, it is unlikely that 
differences in the radial organization between wildtype and mutant would become 






















significant if more nuclei were analysed.  






















3.2.2.3.2 Chromocenter clustering 
 
In addition to studying chromatin compaction and nuclear organisation to determine 
whether differences exist in the organisation of interphase chromatin, I was interested 
in the analysis of chromocenters. These structures are composed of blocks of 
pericentric heterochromatin with major satellite repeats from multiple different 
chromosomes, which associate together in sub-nuclear compartments during 
interphase. They can be detected by probes for centromeric regions (Mayer et al., 
2005), or by regions of intense DNA staining (Nishide & Hirano, 2014).  
 
The spatial organization of centromeres has been shown to change during 
differentiation of multiple cell types (Manuelidis, 1985; Solovei, Grandi, Knoth, Volk, 
& Cremer, 2004), including during T cell development (Kim et al., 2004), suggesting 
that the nuclear organization of centromeres may be important for proper gene 
expression. In addition, the distribution patterns of chromocenters during 
haematopoietic differentiation have been analysed in relation to gene expression. 
These studies found that chromocenter localisation is closely related to gene silencing 
(Brown et al., 1997, 2001). Analysis of chromocenters, therefore, is likely to provide 
further insight into any potential differences between wildtype and mutant T cells in 
the organisation of interphase chromatin. 
 
A study into the different roles of condensin I and condensin II found that condensin 
II deficient mouse neuronal stem cells contain significantly decreased numbers of 
chromocenters, whereas no reduction was observed in condensin I conditional knock-
outs (Nishide & Hirano, 2014). The researchers concluded that the reduction in 
chromocenter number is a consequence of hyperclustering, and that condensin II 
specifically (rather than condensin I) is involved in interphase nuclear organisation of 
the neuronal cells to prevent chromocenter hyperclustering. 
 
Given this interesting discovery, I investigated whether nuclear architecture might be 
altered in the condensin II mutated T cells, resulting in a reduced number of 
chromocenters. I therefore counted the number of intense DAPI stained regions of DP 
71+ blast Caph2+/+ and Caph2nes/nes T cells using maximum intensity projections. 
Examples of the types of high intensity DAPI-stained regions counted are shown in 






















Figure 3.18a. The mutant cells showed a larger distribution of chromocenter numbers 
than wildtype, however the mean number of regions was very similar. A Wilcoxon 
rank test was performed on the data and no significant difference was found in the 
numbers of chromocenters present in DP 71+ blast stage nuclei (p < 0.05, Figure 
3.18b). However, as shown previously (Section 3.1.2), there is a higher proportion of 
mutant cells with >4N DNA content versus wildtype, which might affect the 
chromocenter counts. Future work could include repeating this assay on cells matched 
for ploidy, as well as developmental stage.  
 
 
























In this chapter, I have provided several pieces of evidence to suggest that the 
abnormalities observed in the Caph2nes/nes mice arise due to aberrant mitosis and not 
due to altered nuclear organisation of chromatin. Increased levels of hyperdiploidy 
were observed in the mutant cells using several independent techniques.  
 
3.3.1 Evaluation of the strengths and limitations of the techniques used to assess ploidy 
 
The purpose of utilising several independent techniques to assess ploidy is to ensure 
that the weaknesses of an individual approach will not result in inaccurate conclusions. 
Each of the techniques used to assess ploidy are subject to different limitations. In the 
following section I seek to critically assess the validity of different methods used. 
 
3.3.1.1 Flow cytometry as a method to assess ploidy 
 
There are several advantages of using flow cytometry: it is fast and provides 
quantitative information about whole populations on a cell-by-cell basis, i.e. each cell 
is analysed individually. A particular advantage of this technique for my work is the 
ability to simultaneously quantify DNA content and cell surface marker expression, 
allowing the accurate detection of changes in ploidy during cellular differentiation in 
a relatively quick and straightforward manner. However, even when employing 
stringent doublet exclusion techniques, flow cytometry is vulnerable to the inclusion 
of cell aggregates, where multiple cells are analysed as a single event. This results in 
an apparent increased proportion of hyperdiploid cells.  
 
To eliminate the possibility that cell aggregates were being recorded as single events, 
the samples were re-analysed using Image Stream: a technique that combines flow 
cytometry with imaging capabilities. Using this technique, the vast majority of the 
hyperdiploid events detected by conventional flow cytometry were confirmed to be 
single cells (Figure 3.5).  
 






















A drawback of flow cytometry is the inability to distinguish diploid cells in S phase 
from arrested aneuploid cells, as both will contain DNA quantities that are 
intermediate between multiples of the haploid genome complement (Figure 3.19). By 
focusing on >4N cells, I have identified the frequency of a subpopulation of cells 
containing abnormal ploidy. However, this parameter would fail to detect many cells 
containing whole chromosome aneuploidies without whole genome duplication. Also, 
tetraploid cells arrested in G1 would be indistinguishable from diploid cells in G2. 
Therefore, the results obtained using flow cytometry may underestimate the overall 
proportion of cells with abnormal ploidy that arise due to aberrant mitosis. 
 
Finally, in order for a cell to register within the > 4N gate, cells must be actively 
cycling, i.e. a cell with the correct chromosome complement must undergo aberrant 
cytokinesis resulting in a daughter cell that is hyperdiploid. This cell must then 
progress into S phase and duplicate its chromosome complement, in order to be 
identified as having greater than 4N DNA content. This may be particularly important 
in non-transformed cells such as the primary T cells analysed here, because aneuploidy 
often results in cell cycle exit (Davoli & de Lange, 2011).  
 
3.3.1.2 Fluorescence in situ Hybridisation (FISH) as a method to assess ploidy 
 
FISH enables direct visualization of DNA copy number using fluorescent probes, and 
each cell is analysed individually. Unlike flow cytometry, FISH does not require the 
cells to be actively cycling in order to be included in the hyperdiploid population. 
Importantly, unlike flow cytometry, it is possible to detect the copy number of 
individual loci using FISH, since these cells will contain one pair, rather than two pairs 
of locus-specific hybridisation signals. Hyperdiploid cells, in contrast, will contain 
greater than two pairs of spots. 
 
However, the use of fosmid probes to only one locus per chromosome will not provide 
information about whether the abnormal copy number is due to gain or loss of a whole 
chromosome (polyploid), or the partial gain or loss of a chromosome (aneuploid). To 
take this into account, fosmid probes to two loci on chromosome 6 were used. The 
number of fosmid pairs observed was very consistent using both sets of fosmids, 






















indicating that whole-chromosome duplication occurs in the majority of instances.  
 
Whole chromosome duplications and losses sometimes precede the acquisition of an 






















aneuploid karyotype, which is generally considered to be an early event in 
tumourigenesis (Pfau & Amon, 2012).  
 
Like flow cytometry, however, FISH is vulnerable to artefacts including promiscuous 
probes hybridization , or failed hybridization, resulting in either gain or loss of fosmid 
signal and an overestimation or underestimation of copy number, respectively. 
Therefore, single cell copy number analysis would provide the most accurate 
indication of levels of aneuploidy. This technique involves the isolation of single cells 
from the tissue of interest, amplification of genomic DNA via PCR, and sequencing 
of the amplified DNA. The copy number is inferred by comparison with a control 
genome, which is known to contain no copy number aberrations (Knouse, Wu, 
Whittaker, & Amon, 2014).  
 
3.3.1.3 Centromere counts of metaphase spreads as a method to assess ploidy 
 
Although counting of chromosomes and/or centromeric sequences can give 
information relating to karyotype, this approach also probably underestimates the total 
fraction of cells with abnormal ploidy. In order to progress to and be blocked in M 
phase, cells must be actively cycling. Therefore unlike FISH, only the cycling cells 
will be included in the analysis. Just as for flow cytometry analysis, therefore, this 
method may also underestimate the proportion of hyperdiploid cells.  
 
3.3.2 Summary of investigation into mitotic abnormalities 
 
The increase in the proportion of hyperdiploid DP 71+ cells in nessy mutant mice may 
arise due to mitotic slip, where the cells enter mitosis but fail to divide successfully 
(Brito et al., 2008) or alternatively may represent a population of diploid cells that 
have been arrested in G2. Experiments carried out on cultured primary T cells suggest 
that this arrested tetraploid population most likely arises due to mitotic slippage, rather 
than a G2 delay resulting in mitotic skip (Figure 3.9). 
 
In addition, FISH analyses on tetraploid cells revealed a lack of SCC, consistent with 
removal of cohesin during mitosis and arguing against a mitotic skip mechanism 






















(Wood, unpublished data). Furthermore, abnormal anaphase figures were observed 
directly following washout of the proteasome inhibitor MG132. Anaphase bridges 
were the most frequent abnormality (Wood, unpublished data). 
 
Abnormal metaphase morphology of both fetal liver erythrocytes and cultured primary 
T cells was observed. In the future, it would be interesting to attempt to quantify some 
of the metaphase abnormalities observed in the Caph2nes/nes cells. For example, the 
axial length of the mutant chromosomes relative to wildtype might be determined by 
measuring the length of the chromatids, with “puffier” chromosomes appearing to be 
shorter than wildtype. Future experiments might also include immunofluorescence for 
chromosomal axis proteins, including topoisomerase I and condensin.  
 
Additionally, chromatid arms appeared more splayed in several mutant metaphase 
spreads in comparison to wildtype. Previous work carried out by Ribeiro et al. revealed 
that condensin depletion affects the stiffness of centromeric chromatin in DT40 cells 
(Ribeiro et al., 2009). This could allow more bending at the centromere resulting in 
increased distance between chromatid arms and could provide a possible explanation 
of the observed phenotype in Caph2nes/nes mutant spreads.  
 
Quantification of the degree to which the chromatid arms are splayed could be 
determined using FISH with fosmid probes situated along the length of the chromatid 
arm. The distance between fosmid signals located on sister chromatids would be 
measured and compared between wildtype and mutant. If a significant difference is 
found between wildtype and Caph2nes/nes, further work could be carried out to 
determine whether this is a consequence of reduced centromeric stiffness. These 
assays might resemble those carried out by Ribeiro et al., where a cell line bearing a 
conditional knock out of SMC2 was used with a lacO array inserted in the 
pericentromeric region of a micro-chromosome (Ribeiro et al., 2009). 
 
Finally, it would be interesting to image T cell metaphase spreads using SIM and 
attempt to quantify the zig-zag morphology observed in both fetal liver erythrocytes 
and T cell chromosomes.  
 






















In summary, the results of this section indicate that DP cells reveal normal cell cycle 
kinetics (Section 3.1.2.5), but abnormal metaphase structure (Sections 3.1.2.6 and 
3.1.2.7). 
 
3.3.3 Summary of investigation into interphase abnormalities 
 
Although it is very difficult to state categorically that interphase processes are 
completely normal in the Caph2nes/nes mutant T cells, I was unable to find any 
statistically significant difference in chromatin decompaction across any of the 
genomic distances that I analysed. In addition, no evidence for interphase chromosome 
abnormalities was observed, either in terms of a reduction in the average number of 
chromocenters per nucleus, or a repositioning of loci as determined by nuclear erosion 
scripts. Transcriptome comparisons, which were performed by other members of the 
Wood lab, also did not identify abnormal expression of known regulators of T cell 
differentiation such as Notch or TCR signalling (A. Wood, unpublished data). Instead, 
deregulated genes were mostly involved in stress response pathways known to respond 
to aneuploidy and DNA damage, including P53, interferon and proteostasis. 
 
A previous study into the Caph2nes/nes mutation concluded that the phenotype most 
likely arises due to abnormal interphase processes (Rawlings et al., 2011). However, 
this assumption was based on forward scatter data from cells that had not been 
normalised for ploidy. In addition, Rawlings et al. provided evidence for chromatin 
decompaction in the Caph2nes/nes mutant using transmission electron microscopic 
images of wildtype and mutant cells. However, this data was not quantified, and is 
likely due to the different proportion of cycling (CD71+) versus non-cycling (CD71-) 
cells within the DP population in wildtype relative to Caph2nes/nes mutant. Analysis of 
the CD4+ CD8+ DP population reveals that approximately 5% of wildtype cells are at 
the DP 71+ stage (Figure 3.13a), whereas more than four times as many Caph2nes/nes 
cells are DP 71+ (Figure 3.13b). Large-scale changes in nuclear organisation occur as 
cells enter and exit the quiescent state, and so the higher proportion of cycling mutant 
cells may account for the observations described by Rawlings et al. 
 
From the results of this chapter, I conclude that the Caph2nes/nes phenotype most likely 
arises due to abnormalities that occur during mitosis. However, given that the 






















requirements for mitosis are thought to be similar between differentiated cell types, it 
would be expected that many, if not all stages of haematopoietic differentiation would 
be affected by condensin deficiency, since all lineages undergo several rounds of 
division before becoming quiescent.  Therefore, in the next chapter, I describe 
experiments designed to characterise cell cycle parameters across different 


























CHAPTER 4: CELL CYCLE REGULATION DURING 
HAEMATOPOIESIS IN WILDTYPE AND CHROMOSOMALLY 
UNSTABLE (CIN) CAPH2 MUTANT MICE 
 
4.1 Introduction  
 
Haematopoiesis is a well-characterised developmental process in which cells undergo 
multiple rounds of division and several stages of rapid proliferation. Haematopoietic 
precursors are self-renewing and give rise to all haematopoietic lineages. Certain 
stages of haematopoiesis are associated with particularly high levels of proliferation: 
for example CD4+ CD8+ DP blast stage T cells that have successfully undergone TCR 
beta rearrangement proliferate rapidly in response to signalling via the pre-T cell 
receptor (Miosge & Goodnow, 2005; Rothenberg, Moore, & Yui, 2008). B cells also 
undergo a burst in proliferation following successful VDJ recombination at Fraction 
C of development (R. Hardy et al., 1991; R. R. Hardy & Hayakawa, 2001). In the 
periphery, both T and B naïve cells undergo further rapid proliferation when presented 
with their cognate antigen, in an effort to destroy the invading pathogen (Tangye & 
Tarlinton, 2009; Yamane & Paul, 2012). 
 
The data presented in the previous chapter suggests that the Caph2nes/nes mutation 
affects the well-established function of condensin II in the regulation of mitotic 
chromosome structure. Given that condensin II is likely to function in many, if not all 
dividing cells, this raised the question of whether additional stages of development are 
also affected in Caph2nes/nes mice. 
 
In this chapter I describe experiments which set out to investigate the effect of the 
condensin II mutation on multiple stages of haematopoietic differentiation. I used 
BrdU incorporation studies to establish levels of proliferation in wildtype cells and 
flow cytometry to determine the levels of aneuploidy across multiple stages of 
development for both wildtype and mutant. I went on to study the consequences of the 
Caph2nes/nes mutation on cellularity across different haematopoietic lineages. Finally, I 
investigated possible reasons for the apparent T cell specific Caph2nes/nes phenotype. 
 
























4.2.1 Cell cycle regulation during T cell differentiation 
 
The Caph2nes/nes mutation results in a developmental block in T cells, at the CD4- CD8- 
DN to CD4+ CD8+ DP transition. As described in the previous chapter, an increase in 
the proportion of hyperdiploid Caph2nes/nes was observed relative to wildtype, 
specifically at the DP 71+ blast stage of T cell development. Given the possibility that 
these abnormalities may arise due to abnormal chromosome segregation, I decided to 
study the possible cause of the aberrant mitosis at this stage of development. It could 
be that increased frequencies of proliferating cells at the DP 71+ blast stage impose 
additional strain on the mitotic machinery. In order to test this hypothesis, I carried out 
a cell proliferation assay to determine levels of proliferation across individual stages 
of T cell development. 
 
4.2.1.1 Investigation into extent of proliferation during T cell differentiation 
 
Wildtype mice were intra-peritoneally (IP) injected with bromo-deoxyuridine (BrdU) 
and incorporation studies were undertaken two hours following treatment (Materials 
and Methods: Section 2.2.9.2). Frequencies of proliferating cells at individual stages 
of T cell development were determined using fluorescently conjugated antibodies to 
CD4, CD8 and CD71 (Table 2.5), in combination with anti-BrdU. Following cell 
fixation and permeabilisation, the cells were analysed on a flow cytometer. Exclusion 
of debris and cell aggregates was carried out (as described previously) and the gating 
strategies used to differentiate the individual stages of T cell development are shown 
in Figure 2.2. The same gating strategies were used for all T cell experiments. 
 
  













































The proportion of cells positive for BrdU was calculated for each developmental stage 
(Figure 4.1b). The lowest proportion of S phase cells was found at the DP71- resting 
stage of development (as expected) with the DP CD71+ blast cells undergoing the 
highest rates of proliferation. These data may suggest that the DP71+ blast stage of 
development could be particularly predisposed to mitotic defects, due to more rapid 
proliferation at this stage compared to other stages of T cell development. 
Alternatively, it could be that the higher frequency of cycling cells provides a greater 
opportunity for abnormal mitosis to occur.  
 
4.2.1.2 Consequences of the Caph2nes/nes mutation on hyperdiploidy during T cell 
differentiation 
 
Cells that undergo aberrant mitosis produce daughter cells with a hyperdiploid or 
hypodiploid chromosome complement. Once hyperdiploid cells have progressed 
through S phase, they can be distinguished from the population with the correct 
complement using flow cytometry. Therefore, this proportion of hyperdiploid cells at 
each stage of differentiation is an indicator of the frequency of aberrant mitoses. In 
order to determine the stage of T cell differentiation at which the Caph2nes/nes mutation 
caused abnormal mitosis, I investigated the dynamic changes in ploidy during wildtype 
and mutant T cell development using flow cytometry. The individual stages of 
differentiation were determined using fluorescently-conjugated antibodies to CD4, 
CD8 and CD71 (Table 2.5) and the DNA dye DAPI was used to assess ploidy. Cell 
debris and doublets were excluded from the analysis as described previously. 
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In order to compare frequencies of hyperdiploid cells between experiments, gating 
strategies were kept consistent: the hyperdiploid gate was set to the point at which the 
gradient of the histogram changes most dramatically, following the 4N peak. DNA 
content histograms for each of the stages of differentiation are shown in Figure 4.2. 
The hyperdiploid gate is illustrated for each stage. Slightly elevated frequencies of 
hyperdiploid mutant cells relative to wildtype were observed at most stages of thymic 
T cell differentiation. However, there was a large increase in the frequency of cells 
with > 4N DNA content at the DP 71+ blast stage in mutant versus wildtype (8% vs < 
1%, respectively). The highest frequencies of hyperdiploid cells, for both wildtype and 
mutant, occurred at the stage associated with the highest levels of BrdU incorporation, 
which may indicate that the elevated frequency of hyperdiploid mutant cells is a 
consequence of more rapid proliferation at this stage (Figure 4.1c). 
 
4.2.1.3 Consequences of the Caph2nes/nes mutation on absolute cell numbers during T 
cell differentiation 
 
Having discovered that the DP blast stage of Caph2nes/nes development contains an 
elevated frequency of hyperdiploid cells, I investigated whether this affects absolute 
cell numbers. I used the automated cell counter Moxi Z (Orflo cat#MXZ001) to 
accurately determine the number of cells per wildtype and Caph2nes/nes thymus. The 
cells were incubated with cell surface antibodies which allowed individual stages to 
be distinguished from one another (as before: Table 2.5). Exclusion of cell debris and 
doublets was carried out as described previously, and absolute cell numbers were 
calculated from the proportion of cells at each stage (given as percentages) multiplied 
by the initial number of cells, calculated using the cell counter.  
 
Cell numbers were found to be relatively consistent between wildtype and Caph2nes/nes 
mutant at the early stages of development. However, the most dramatic difference in 
cell number between wildtype and mutant occurs at the DP 71- resting stage. At this 
stage there is an approximate 10-fold reduction in Caph2nes/nes mutant cell numbers 
relative to wildtype (upwards of 1x108 wildtype cells per thymus compared with 
roughly 1x107 mutant cells). This reduction in mutant cell numbers occurs 
immediately after the DP 71+ blast stage, where the highest rates of proliferation and 
also the highest levels of mutant hyperdiploid cells were observed (Figure 4.1d). 























4.2.1.4 Investigation into the proportion of cells with 4N DNA content during T cell 
differentiation in wildtype and mutant 
 
Having established that the Caph2nes/nes cells exhibit increased levels of abnormal 
ploidy at a specific stage of T cell development, I investigated whether there is a 
similar increase in the proportion of cells with 4N DNA content in the mutant relative 
to wildtype. An increase in the proportion of mutant cells with 4N DNA content 
relative to wildtype may indicate an increased incidence of failed mitosis due to mitotic 
slip, or an increased incidence of failed entry into mitosis due to G2 arrest/mitotic skip, 
as discussed in Chapter 3: Section 3.1.2.5. In contrast, aneuploid cells (cells that do 
not contain an integer multiple of the haploid complement) cannot arise solely due to 
mitotic slip or skip, but instead must remain cycling before loss or gain of 
chromosomes in a subsequent tetraploid mitosis. The stages of differentiation were 
determined as described previously, and the DNA dye DAPI was used to assess ploidy, 
as before. The results of this experiment are displayed as a histogram (Figure 4.3a). 
 
Interestingly, the DP 71- resting population of mutant cells contained a high frequency 
of cells with 4N DNA content relative to wildtype (approximately 1% in wild-type vs 
32% of mutant cells) (Figures 4.3b and 4.3c). The CD71 transferrin receptor is a 
marker of T cell proliferation (Brekelmans et al., 1994; Seitan et al., 2011) and so this 
result indicates that mutant cells frequently exit the cell cycle with an inappropriate 
DNA content.  
 
In order to investigate this 4N population further, the CD71 marker was plotted against 
forward scatter, and a population of CD71- (non-cycling) mutant cells was identified 
(Figures 4.4a and 4.4b). These cells are abnormally large (as judged by their forward 
scatter profiles). Approximately 37% of the mutant DP population fall within this 
CD71- FSChi gate, compared to just 4% of the wildtype population. The DNA content 
profiles of these populations were analysed, and the majority (74%) of mutant cells 
were found to have 4N, rather than 2N DNA content compared with only 27% of 
wildtype cells (Figures 4.4c and 4.4d).  














































Further analysis of the DP cells revealed a population of BrdU- FSChi cells in mutants 
(Figure 4.5b) that are largely absent from wildtype (Figure 4.5a). This result is 
consistent with the existence of a non-cycling population of large mutant cells, 
observed using CD71 versus forward scatter. 
  






















The population of large non-cycling mutant cells may represent tetraploid cells that 
have undergone G1 arrest following unsuccessful mitosis, or diploid cells that are 
arrested after failing to enter mitosis. Previous experiments (Chapter 3: Section 
3.1.2.5) revealed no difference in the rate of progression from S to M phase between 
wildtype and mutant CD4+ CD8+ DP cells, indicating that the 4N population arises due 
to mitotic slip, rather than G2 arrest or mitotic slip. 
 
Analysis of T cell ploidy data (both 4N, Section 4.2.1.4 and >4N, Section 4.2.1.2) 
indicates that once mutant cells have undergone abnormal cytokinesis (likely due to 
mitotic slip), the cells may exit the cell cycle with 4N DNA content, as revealed by the 
high frequency of tetraploid CD71- resting cells. Alternatively, the cells may continue 
to cycle and re-synthesize their DNA during S phase, as indicated by the high 
frequency of CD71+ blast cells with hyperdiploid (greater than 4N) DNA content. 
 
  






















4.2.2 Cell cycle regulation during Erythrocyte differentiation 
 
Having investigated the rates of BrdU incorporation, the relative frequencies of 
hyperdiploidy in wildtype and mutant and the consequences on cell number across 
multiple stages of T cell development, I next extended this analysis to additional 
haematopoietic cell lineages. Since T cells form part of the lymphoid branch of 
haematopoiesis, I next analysed a cell type belonging to the myeloid lineage: the 
erythrocytes. Analysis was carried out on cells undergoing bone marrow 
erythropoiesis. Erythrocyte differentiation (like T and B lymphopoiesis) involves 
extensive proliferation, and therefore cell cycle abnormalities might be expected in 
Caph2nes/nes. 
 
4.2.2.1 Investigation into extent of proliferation during erythrocyte differentiation 
 
BrdU incorporation studies were carried out as described previously. Individual stages 
of erythrocyte development were determined using fluorescently conjugated 
antibodies to Ter119 and CD71 (Table 2.5). Following cell fixation and 
permeabilisation, the cells were incubated with a fluorescently conjugated antibody to 
BrdU (Table 2.5) and analysed by flow cytometer, as before. The proportion of BrdU 
positive cells was calculated for each developmental stage. Gating strategies used to 
determine the individual stages of erythrocyte development are shown in Figure 2.3a, 
and these gates were used for all erythrocyte experiments.  
 
For erythrocytes, the developmental stage associated with the highest levels of BrdU 
incorporation (and therefore the highest proportion of S phase cells) was found to be 
Stage 3 (Figure 4.6b), which is identified based on high expression of both CD71 and 
Ter119 (Figure 4.6a). In fact, the proportion of cells positive for BrdU is higher during 
Stage 3 of erythrocyte development than at the DP 71+ blast stage of T cell 
development (Figure 4.1b), which may indicate that the Stage 3 erythrocytes undergo 
more extensive proliferation than DP 71+ T cells.  
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4.2.2.2 Consequences of the Caph2nes/nes mutation on hyperdiploidy and cell number 
during erythrocyte differentiation 
 
I next investigated the dynamic changes in ploidy during wildtype and mutant 
erythrocyte development using flow cytometry, in the same way as described for T 
cells. The individual stages of differentiation were determined using fluorescently-
conjugated antibodies to Ter119 and CD71 (Table 2.5) and the DNA dye DAPI was 
used to assess ploidy. DNA content histograms for each of the stages of differentiation 
are shown in Figure 4.7. The hyperdiploid gate is illustrated for each stage. 
 
As observed in the T cells, a spike in the frequency of hyperdiploid Caph2nes/nes 
erythroid cells occurred at the stage (Stage 3) associated with the highest rates of BrdU 
incorporation. However, the frequency of hyperdiploid erythroid cells was lower than 
for T cells: the frequency of hyperdiploid mutant erythroid cells peaked at 
approximately 5% compared to 8% observed at the DP 71+ blast stage of T cells. The 
frequency of hyperdiploid wildtype cells did not vary greatly between stages of 
development: in fact, the levels remained fairly consistently below 1% throughout all 
tested stages of erythropoiesis (Figure 4.6c). From the data presented above, it is clear 
that the rapid increase in the proportion of hyperdiploid Caph2nes/nes T cells coincides 
with dramatic reductions in cell numbers. Since a similar peak in the frequency of 
hyperdiploid mutant cells is observed at a comparable stage of erythrocyte 
development, I was interested in investigating the consequences of the high levels of 
hyperdiploidy on mutant erythroid cell numbers relative to wildtype numbers.  
 
Experiments to determine cell number at each of the stages of erythrocyte development 
were carried out in the same way as described for T cells (see above). Accurate 
determination of the number of cells per tibia and femur was achieved using an 
automated cell counter. Cell surface antibodies to Ter119 and CD71 (Table 2.5) were 
used to determine the stage of development. Surprisingly, although a similar peak in 
the levels of hyperdiploid mutant cells was observed in both the T cell and erythroid 
lineages, no corresponding large-scale reduction in Caph2nes/nes cells was observed 
relative to wildtype at any stage of development (Figure 4.6d).  












































4.2.2.3 Investigation into the proportion of cells with 4N DNA content during erythroid 
differentiation in wildtype and mutant mice 
 
Having discovered a population of large arrested mutant T cells that were 
predominantly tetraploid (Figure 4.4d), I next wanted to establish whether a similar 
population exists within the erythroid lineage. The percentage of 4N wildtype and 
mutant cells for each of the stages of differentiation (determined in the same way as 
described for T cells) was plotted as a histogram (Figure 4.8a). Unlike the T cells, no 
stage of erythroid development revealed a considerably higher proportion of 4N 
mutant cells relative to wildtype.  
 
In order to further compare the data with that obtained from the T cells, CD71 was 
plotted against forward scatter. In contrast to the T cells, where an almost ten-fold 
increase in the proportion of abnormally large CD71- cells was observed in mutant 
compared to wildtype (Figures 4.4a and 4.4b), no sizeable difference was found 
between mutant and wildtype erythroid cells. Approximately 14% of wildtype cells 
were labelled as CD71- FSChi, compared to approximately 18% of mutant cells 
(Figures 4.8b and 4.8c). 
 
Further analysis revealed a < four-fold increase in the proportion of mutant cells that 
are BrdU negative and FSC-hi (Figures 4.8d and 4.8e). This increase is much smaller 
than for T cells, where a > 15-fold increase was observed (Figure 4.5). This implies 
that tetraploid erythroid cells are far less likely to undergo cell cycle arrest in 
comparison to tetraploid T cells. 
 
From this data, it is evident that both stages of haematopoietic development analysed 
thus far are affected by the condensin II deficiency, resulting in increased frequencies 
of cells with abnormal ploidy. However, the consequences of the increased frequency 
of hyperdiploid cells in mutant relative to wildtype vary between the two cell types. 
The reason for this difference may be that the erythrocytes are better able to cope with 
the abnormal ploidy and so do not undergo such dramatic cell number reductions. One 
could speculate that since erythroid cells enucleate upon terminal differentiation 
(Keerthivasan, Wickrema, & Crispino, 2011), the potential for negative consequences 
arising from chromosomal instability (CIN) and abnormal ploidy is less severe. In 






















contrast, T cells must maintain the capacity for massive clonal expansion during an 
adaptive immune response, and may therefore require more stringent safeguards to 
protect against malignant transformation. 
 
4.2.3 Cell cycle regulation during B cell differentiation 
 
Having investigated cell cycle dynamics in two haematopoietic lineages, I next 
extended my analysis to B cells. The B cells, like the T cells, are members of the 
lymphoid lineage. Both cell types undergo VDJ recombination at antigen receptor loci, 
and massive clonal expansion when presented with cognate antigen, and so analysis 
of the consequences of condensin deficiency between these two cell types may provide 
valuable insight into the effect of CIN and condensin II deficiency on cell viability. 
 
B cell progression in the condensin II mutant mouse was analysed in detail by Gosling 
et al. but no difference was found in the percentage of B cells in Caph2nes/nes compared 
to wildtype at any of the stages analysed (Gosling et al., 2007). Given that B cells and 
T cells undergo very similar processes during development, such as recombination 
followed by rapid proliferative bursts, it is surprising that the mutation in condensin II 
seems to result in such a T cell specific phenotype. Therefore, I decided to further 
investigate cell cycle dynamics during B cell development in wildtype and mutant 
cells. 
 
4.2.3.1 Cell proliferation during B cell differentiation 
 
BrdU incorporation studies were undertaken as described previously. The cells were 
incubated with fluorescently conjugated antibody to BrdU, as well as to the cell surface 
markers B220, CD24 and CD43 (Table 2.5). Stages of B cell differentiation were 
identified based on the Hardy B cell classification scheme (R. Hardy et al., 1991). Due 
to insufficient flow cytometer channels, antibodies to BP-1 or IGM were not included. 
Consequently, Fractions B and C are presented as a single stage, as are Fractions D 
and E. The cells were fixed and analysed using flow cytometry (A. Wood, unpublished 
data). The gating strategies used to determine B cell stages in each experiment are 
indicated in Figure 2.3b. 























Rearrangement of the IgH locus occurs in Fraction B and C of B cell development (R. 
R. Hardy & Hayakawa, 2001). Cells that successfully undergo VDJ rearrangement 
then undergo a stage of rapid proliferation. This is supported by the BrdU 
incorporation data, which shows that the stage associated with the highest levels of 
BrdU incorporation occurs during Fraction B/C (Figure 4.9b – A. Wood, unpublished 
data).  
 
4.2.3.2 Consequences of the Caph2nes/nes mutation on hyperdiploidy during B cell 
development 
 
Having established that the most extensive proliferation during B cell development 
occurs within Fraction B/C, as judged by BrdU incorporation, I next investigated the 
dynamic changes in ploidy during wildtype and mutant B cell development using flow 
cytometry. This was achieved in the same way as described for T cells and 
erythrocytes. DNA content histograms for each of the stages of differentiation are 
shown in Figure 4.10. The hyperdiploid gate is illustrated for each stage. 
 
Intriguingly, unlike in either the T cell or erythroid lineages, no significant increase in 
the frequency of hyperdiploid mutant cells relative to wildtype was observed at any 
stage of B cell development. A small increase in hyperdiploidy (~ 1% of cells) was 
observed at Fraction B/C, however this was true for both wildtype and mutant (Figure 
4.9c). 
 
B cells reveal similar frequencies of proliferating cells compared to T cells, as judged 
by BrdU incorporation: approximately 47% of cells are BrdU+ during Fraction B/C of 
B cell development (Figure 4.9b) compared with 50% of DP 71+ blast T cells (Figure 
4.1b). Therefore, the spike in the frequency of hyperdiploid mutant T cells cannot be 
solely due to increased frequencies of proliferating cells at the DP 71+ blast stage. 
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4.2.3.3 Consequences of the Caph2nes/nes mutation on absolute cell numbers during B 
cell differentiation 
 
Finally, I studied whether B cell numbers were affected by the condensin II mutation. 
An automated cell counter was used to accurately determine the number of cells per 
tibia and femur.  The cells were then incubated with cell surface antibodies, analysed 
on the flow cytometer and absolute cell numbers calculated, as before.  
 
No sizeable reductions in cell numbers were observed in mutant relative to wildtype 
at any stage of B cell development analysed. Since B cells do not undergo large-scale 
changes in ploidy as a result of the condensin II mutation (unlike T or erythroid cells), 
it is unsurprising that B cell numbers are unaffected in the mutant (Figure 4.9d).  
 
4.2.4 Cell cycle regulation at the haematopoietic precursor stage of development  
 
Analysis of the three haematopoietic lineages studied thus far reveals that each cell 
type is affected differently by mitotic stress and CIN: the Caph2nes/nes mutation results 
in different outcomes, in terms of levels of aneuploidy and a reduction in cell numbers, 
in each cell type. Each of the haematopoietic cell lineages analysed so far have 
contained cells engaged in the process of differentiation and lineage commitment. For 
the next stage of my analysis, I investigated the consequences of the condensin II 
mutation on abnormal ploidy or cell number in earlier haematopoietic precursors. 
 
In adult mice, the haematopoietic stem cells are located in the bone marrow, where 
they undergo self-renewal (which replenishes the stem cell population) and 
differentiate into multipotent progenitor cells (Giebel & Bruns, 2008; Marciniak-
Czochra, Stiehl, Ho, Jäger, & Wagner, 2009). The balance between self-renewal and 
differentiation must be carefully regulated, since sufficient cells must always be 
available to replenish peripheral blood cells of all lineages, but extensive and 
uncontrolled self-renewal may lead to tumourigenesis. Several mechanisms to 
maintain the appropriate balance between renewal and differentiation have been 
suggested, including asymmetric cell division (Roegiers & Jan, 2004; Yu, Kuo, & Jan, 
2006), in which only one daughter cell inherits the necessary proteins to maintain self-






















renewal. Additionally, stem cells located within certain regions (termed stem cell 
niches) may be provided with an external stimulus which allows the cell to remain as 
stem cells. Cells that are not located in these “niches” are not exposed to these signals, 
and therefore differentiate (Giebel & Bruns, 2008; Lin, 2002). 
 
True stem cells are capable of replicating indefinitely, whereas there is a limit to the 
amount of divisions the precursor cells are capable of (Seaberg & Van Der Kooy, 
2003). The stages of haematopoietic differentiation that I analysed were: the Lin-Sca-
1+c-kit+ (LSK) population, the common myeloid progenitor (CMP) and the common 
lymphoid progenitor (CLP). The LSK population contains the true haematopoietic 
stem cells and other early derivatives (Spangrude et al., 1989). The common lymphoid 
progenitor produces cells that can differentiate into T and B cells, while the common 
myeloid progenitor is a precursor of erythrocytes and other myeloid cell types (Iwasaki 
& Akashi, 2007).  
 
4.2.4.1 Consequences of the Caph2nes/nes mutation on DNA content and absolute cell 
number of haematopoietic precursor cells  
 
Ploidy was determined using the fluorescent DNA stain propidium iodide (PI) 
(Materials and Methods: Section 2.2.9.1). The cells were analysed by flow cytometry, 
and doublets were excluded using both forward-scatter width versus area, and forward 
scatter area versus height. Exclusion of dead cells, debris, doublets and lineage 
committed cells was carried out as before. Finally, c-kit was plotted against Sca-1 to 
differentiate between the LSK, CMP and CLK populations (Figure 2.4). 
 
An increase in the proportion of hyperdiploid mutant cells was observed relative to 
wildtype in both the LSK and CMP populations. However, the increase was small: 
approximately 0.1% of mutant LSK cells were hyperdiploid compared to 0.06% of 
wildtype, and 0.2% of mutant CMP cells compared with 0.1% of wildtype. None of 
the progenitor populations analysed revealed levels of hyperdiploidy above 0.3%, 
which is 28-fold lower than DP blast cells in the T cell lineage (Figure 4.11a). The 
DNA content histograms for the progenitor cells, as well as the T, B and erythroid 
cells are displayed together in Figure 4.12, for ease of comparison. 
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In addition to studying the DNA content of the haematopoietic precursors, I 
investigated whether progenitor cell numbers were affected by the condensin II 
mutation. Given that the Caph2nes/nes progenitor cells did not reveal increased levels of 
hyperdiploidy, it is unsurprising that the mutant precursor cells, like the B cells, do not 
undergo reductions in cell numbers. In fact, a slight increase in the number of mutant 
progenitor cells is observed relative to wildtype (Figure 4.11b). The difference in cell 
numbers, however, is relatively small.  
 
Interestingly, the largest difference occurs at the common myeloid progenitor (CMP) 
stage where there are approximately 2.5 million wildtype cells in comparison to 
approximately 4.5 million mutant cells. Having shown that the Caph2nes/nes erythroid 
cells show increased levels of hyperdiploidy (Figure 4.6c), but no reduction in cell 
number (Figure 4.6d), the increased numbers of mutant cells at the progenitor stage 
might suggest the existence of an autoregulatory feedback loop, to replenish cell 
numbers that are impacted by abnormal chromosome segregation later during 
differentiation at the erythroblast stage. In contrast, the difference between the number 
of wildtype and mutant lymphoid progenitor cells is considerably smaller (~0.4 million 
versus ~0.5 million for wildtype and mutant, respectively) which may suggest the 
absence of effective autoregulatory feedback, resulting in cell number reductions 
following chromosome segregation failure in the T cell lineage (Figure 4.1d). 
 
4.2.5 Consequences of Caph2nes/nes on DNA content of Mouse Embryonic Fibroblasts 
(MEFs)   
The primary cell type most commonly used to characterise cellular defects in mouse 
models of chromosomal instability are MEFs (Liu et al., 2009; Vitre & Cleveland, 
2012; Wijshake et al., 2012). Therefore, in order to complete my investigation into the 
consequence of the Caph2nes/nes mutation on ploidy in different cell types, cultured 
MEFs were obtained from both wildtype and mutant mice. The cells were DAPI 
stained, and their DNA content profiles analysed by flow cytometry. Representative 
DNA content profiles for both Caph2+/+ and Caph2nes/nes are shown in Figures 4.13a 
and 4.13b. The percentage of cells with >4N DNA content was calculated and the 
results plotted as a histogram (Figure 4.13c). A small increase in the proportion of 
hyperdiploid cells was observed in mutant versus wildtype (approximately 5% mutant 
versus 4% wildtype). However, this difference was not substantial. 













































4.2.6 A preliminary investigation into the cause of the differential susceptibility to the 
Caph2nes/nes mutation  
 
Investigations into the consequences of the Caph2nes/nes mutation have revealed that 
different haematopoietic lineages are affected differently by the mutation to condensin 
II. The haematopoietic precursors are not affected in terms of abnormal ploidy or 
reduction in cell numbers, and this is also true for B cells and MEFs. The erythroid 
cells reveal abnormal ploidy, but no reduction in cell numbers. In contrast, the T cells 
display profound defects as a result of the mutation: a high proportion of cells reveal 
abnormal DNA content at a specific stage of development, which coincides with a 
drastic reduction in cell numbers. The next stage of my analysis focusses on 
investigating the reason why different stages of haematopoietic differentiation exhibit 
differential susceptibility to condensin II mutation. 
 
The essential role of eukaryotic condensins in preparing chromosomes for segregation 
must take place between genome duplication during S phase, and chromosome 
segregation during anaphase. Alleviation of increasing mechanical stress during 
replication is thought to occur by fork rotations, resulting in the introduction of sister-
chromatid catenations into circular chromosomes (Champoux & Been, 1980). These 
catenations must be resolved before chromosome segregation can proceed. Due to the 
difficulty in maintaining and visualizing catenations in linear chromosomes, it is not 
known whether fork rotations resulting in sister catenations also occur in higher 
eukaryotes. However, given the evidence for the introduction of precatenations into 
circular chromosomes during replication, it seems likely that similar processes may 
give rise to sister catenations in linear chromosomes. 
 
Thus, although the phenotype of condensin deficient cells is most striking during and 
following mitosis, it is possible that the cell type differences in susceptibility to 
condensin mutation originate from differences during S phase. For example, S phase 
conditions which result in higher frequencies of catenations may impose a greater 
requirement for condensin activity. 
 
Based on the results of the study carried out by Gruber et al. (discussed in Section 
1.2.6.1), I investigated the possibility that the Caph2nes/nes phenotype arises due to 






















different rates of progression between cell types through various stages of the cell 
cycle. Faster progression through S phase into M phase might result in increased 
pressure on cell cycle machinery to resolve catenations between sister chromatids and 
quickly condense chromosomes into discrete structures, in preparation for cell 
division. Cells undergoing rapid progression from S to M phase may therefore be more 
vulnerable to condensin deficiency in comparison to cells that undergo a slower rate 
of progression. The possibility that condensin is required to a greater extent at the DP 
stage of T cell development is supported by transcriptome data assembled from more 
than 150 different immune cell subsets, which reveals that transcripts of the subunits 
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4.2.6.1 Measurement of the rate of progression of Caph2+/+ and Caph2nes/nes T cells 
from S phase to M phase 
 
In order to investigate the rate of progression from S phase to M phase at the DN and 
DP stages of T cell development, I used the BrdU chase assay outlined above in Figure 
3.9. MACS-purified CD4- wildtype and mutant T cells were added to the OP9 DL1 
monolayer. The cells were cultured as described previously, until judged to be 
proliferating rapidly with approximately 40%-50% CD4+ CD8+ DP and 30% CD4- 
CD8- DN wildtype cells, and 15-20% DP 60%-70% DN mutant. I then treated the cells 
with nocodazole and BrdU over a four-hour time course, as described previously, 
before staining with CD4 and CD8 antibodies to determine differentiation state, and 
BrdU and pH3S10 to determine cell cycle progression. The rate of progression of the 
wildtype and mutant cells from S phase into M phase is shown as a line graph for CD4- 
CD8- DN and CD4+ CD8+ DP cells (Figure 4.15d), Results for DP cells shown 
previously in Figure 3.9, Section 3.1.2.5. 
 
As discussed previously, no difference in the rate of progression from S to M phase 
was observed between wildtype and mutant at the DP stage and additionally, no 
difference was observed at the DN stage. Interestingly, however, the data shows that 
the rate at which BrdU+ cells accumulate in a nocodazole block increases upon 
differentiation from the CD4- CD8- DN stage of development to the DP stage. This 
change in the rate of progression is apparent in both wildtype and mutant cells. In total, 
four biological replicates and eight technical replicates were performed and the general 
trend of the data was very consistently replicated. 
 
In contrast, the CD4- CD8- DN stage of development does not reveal such rapid rates 
of progression from S to M phase. As shown previously, the DN cells do not display 
dramatic abnormalities (such as high levels of hyperdiploidy or large-scale reductions 
in cell numbers) as a consequence of the Caph2nes/nes mutation in vivo (Figures 4.1c 
and 4.2). Mutant DN T cells cultured ex vivo also do not display dramatic increases in 
levels of hyperdiploidy in comparison to wildtype (0.55% ± 0.2 DN wildtype cells are 
hyperdiploid versus 0.78% ± 0.1 DN mutant. Figures are based on three biological 
replicates). 
  













































This result may provide a potential explanation for why the DP blast T cells are 
specifically affected by the condensin II deficiency. If the speed at which cells progress 
from S to M phase is particularly fast at this stage of differentiation compared to others, 
this could influence the workload for condensins. For example, rapid replication fork 
progression could lead to more catenations that require removal, and/or a reduced 
window of time for the removal to take place. 
 
If the accelerated rate of progression from S phase to M phase observed as DN 
thymocytes differentiate to the DP stage is linked to the vulnerability of DP cells to 
Caph2 mutation, the rate at which BrdU+ cells accumulate in nocodazole block should 
be more rapid than in other cell types that are able to maintain ploidy in Caph2nes/nes 
mice. I therefore proceeded to analyse the rates of progression of cell types that were 
not obviously affected by the Caph2nes/nes mutation. 
 
4.2.6.2 Measuring the rate of progression of Caph2+/+ B cells and MEFs from S to M 
phase 
 
The rate of progression of IGM- (Fractions A, B, C and D) and IGM+ (Fractions E and 
F) B cells from S phase to M phase was determined in a similar way as described for 
T cells. I MACS purified IGM- B220+ wildtype B cells and added the cells to an OP9 
monolayer. The OP9 cell line supports the differentiation of B cells in the presence of 
IL-7. The cells were cultured in the presence of IL-7 and Flt-3 for four days until they 
were judged to be proliferating rapidly. I then treated the cells with nocodazole and 
BrdU over a four-hour time course, as described for the T cells.  
 
The B cells were removed from the monolayer, treated with fluorescently conjugated 
antibodies to IGM, BrdU and PH3S10, and analysed by flow cytometry. The data was 
analysed in the same way as for T cells. The results indicate that both B cell 
populations (IGM- and IGM+) progress from S to M phase at a slower rate in 
comparison to DP T cells, but more rapidly than T cells at the DN stage (Figure 4.16).  
 
  













































In order to confirm that the difference in the rates of progression between cell types 
was not due to differences in the reagents used, T cell cultures were prepared 
simultaneously with B cell cultures, treated with the same media and reagents, and 
processed as before (Section 4.2.6.1). The results of this experiment were consistent 
with data obtained from previous T cell experiments, indicating that the reagents used 
did not impact the rate of progression of the cells from S to M phase. 
 
To determine the relative rates of progression from S to M phase between cell types 
the data is normalised to the proportion of cells in S phase at each time point. This is 
to ensure that differing frequencies of proliferating cells do not affect the results: for 
example, a higher proportion of S phase cells in one lineage compared to another 
would result in an increased proportion of cells progressing from S to M phase if the 
data were not normalised.  
 
The proportion of BrdU+ cells were calculated for all cell type at each of the time 
points measured (Figure 4.17). In fact, DP T cells do not reveal higher frequencies of 
proliferating cells compared to many of the other cell lineages, as judged by BrdU 
incorporation. The results indicate that the extent of proliferation is highest in the IGM- 
B cells, i.e. the IGM- B cells are comprised of the highest proportion of S phase cells. 
This confirms that the rapid progression of DP T cells from S to M phase is not a 
consequence of an increased proportion of DP T cells in S phase, but more likely 
reflects a genuine increase in the speed at which DP T cells progress through S phase 
and G2 and into mitosis.  This indicates that BrdU incorporation alone is a poor 
indicator of the rate of progression through the cell cycle: only the DP 71+ cells show 
high levels of BrdU incorporation (Figure 4.1b), however the DP 71+ cells make up a 
very small proportion of the total DP stage (Figure 4.1d). The majority of DP cells do 
not reveal high levels of S phase cells. 
 
Having established that DP T cells progress more quickly from S to M phase relative 
to DN T cells and IGM- and IGM+ B cells, I next investigated the rate of progression 
of MEFs. Data described previously revealed that the Caph2nes/nes MEFs do not exhibit 
drastically higher levels of aneuploidy in comparison to wildtype MEFs (Figures 4.13a 
and 4.13b). Therefore, a slower rate of progression into M phase from S phase in 
comparison to DP T cells would provide further evidence that, of all the cell types 






















analysed, the DP T cells are unique both in the proportion of cells with abnormal 
ploidy, and in their rate of progression through certain stages of the cell cycle. 
 
Wildtype CD1 MEFs were cultured until judged to be proliferating rapidly. The cells 
were then treated with BrdU and nocodazole in the same way as described for T and 
B cells. The MEFs were trypsinized to dissociate, neutralised with media, before being 
fixed and incubated with fluorescently conjugated antibodies to BrdU and PH3S10, as 
described for T and B cells. The cells were analysed on the flow cytometer. 
 
The results revealed that very few cells progressed to S phase from M phase: by the 
four hour time point approximately 4% of MEFs had reached M phase from S phase 
(Figure 4.16). This result indicates that the MEFs progress very slowly from S to M 
phase in comparison to the CD4+ CD8+ DP T cells. The experiment was repeated for 
two biological replicates, each with two technical replicates, and the general trend of 
the data was very consistent between replicates. 
























The results described in this Chapter reveal that the consequences of the Caph2nes/nes 
mutation vary between cell types. The Caph2nes/nes T cells show increased levels of 
hyperdiploidy at the DP blast stage of differentiation, as well as an increase in the 
proportion of tetraploid arrested cells at the DP resting stage. Experiments carried out 
on cultured primary T cells described in Chapter 3 suggest that this arrested tetraploid 
population most likely arises due to mitotic slippage, rather than a G2 delay resulting 
in mitotic skip (Figure 3.9). 
 
Erythroid cells from nessy mice do not undergo drastic reductions in cell number 
(Figure 4.6d) despite an increase in the levels of hyperdiploid mutant cells (Figure 
4.6c). In addition, in contrast to the T cells, there is no increase in the fraction of large, 
BrdU-, mutant erythroid cells (Figure 4.8). These data indicates that although erythroid 
cells also undergo abnormal chromosome segregation, unlike in T cells, this does not 
result in reduced cell numbers or obvious cell cycle arrest. Analysis of the myeloid 
progenitor population reveals higher numbers of mutant cells relative to wildtype 
(Figure 4.11b). This may suggest the existence of an autoregulatory feedback loop 
during erythroid development, which could explain the apparent lack of mutant cell 
number reductions in the erythroid lineage at later stages. There is other evidence to 
suggest that erythroid cells are subject to signalling networks that act to maintain 
homeostasis. For example, erythropoietin is produced in response to hypoxia, thereby 
stimulating increased erythropoiesis. In addition, computer modelling has identified a 
negative autoregulatory network motif, mediated by the death receptor FAS, and its 
ligand. This mechanism is activated when Ter119+ erythroid cell numbers reach a 
sufficient number, and acts to reduce proliferation at the preceding Ter119-CD71+ 
stage, thereby maintaining homeostasis (Socolovsky et al., 2007). Interestingly, no 
substantial increase in the number of mutant lymphoid progenitor cells was observed 
relative to wildtype (Figure 4.11b). 
 
As discussed previously, the consequences of abnormal ploidy may be less deleterious 
in erythroid cells relative to lymphocytes, since they undergo enucleation during 
development. It will be of interest to characterise the stress response signalling 
pathways that are activated in different primary haematopoietic cells containing 






















abnormal ploidy following mitotic errors. In other work carried out in the Wood lab, 
it has been shown that mutation of P53 partially rescues the block in T cell 
differentiation in Caph2nes/nes mice, and also drastically accelerates the T cell 
lymphoma phenotype, while having no detectable effect in the erythroid lineage. It is 
notable that P53 mutant mice, which are wildtype for Caph2, also develop T cell 
lymphomas originating from the DP blast stage, more rapidly than any other tumour 
type (Donehower, Harvey, & Slagle, 1992; Jacks et al., 1994). These tumours are 
highly aneuploid, providing independent evidence that the DP blast stage is vulnerable 
to cell cycle-related stress.  
 
Finally, no difference in the levels of hyperdiploid cells was observed between 
wildtype and mutant for either the B cells or the cultured MEFs. Therefore, it is 
possible that the widespread use of MEFs to characterise cellular phenotypes in mouse 
models of CIN may miss important information if other cell types are not also 
analysed. As well as revealing no increase in the levels of hyperdiploidy, Caph2nes/nes 
B cells also exhibited no reduction in cell numbers. This result is particularly 
surprising, given the similarly high frequency of proliferating cells at specific stages 
of B cell and T cell differentiation (as judged by BrdU incorporation: Figures 4.1b and 
4.9b). Therefore, the reason for the T cell specific phenotype cannot simply be that 
more stress is put on the replication machinery in T cells due to an increased frequency 
of cycling cells.  
 
Transcriptome data from more than 150 different types of immune cell stages 
described previously (Section 4.2.6) implies that the cellular requirements for 
condensin complexes are particularly acute at this stage of haematopoietic 
development, resulting in more extreme consequences for the DP 71+ blast cells when 
CAP-H2 is depleted. This led me to investigate the possibility that certain cell types, 
such as DP T cells, undergo rapid rates of progression at specific cell cycle stages, in 
comparison to other cell types. 
 
BrdU experiments described in this Chapter were used to assess the extent of 
proliferation at various stages of differentiation. However, these experiments provide 
a momentary “snapshot” of the proportion of cells in S phase at any given time, rather 
than information about the rate of progression of cells through different stages of the 






















cell cycle. In fact, time course experiments on cultured primary cells revealed that DP 
T cells undergo more rapid progression from S to M phase in comparison to B cells, 
DN stage T cells and MEFs. That is, the DP T cells undergo faster progression from S 
to M phase in comparison with cells that do not show altered ploidy profiles as a 
consequence of the Caph2nes/nes mutation (Figure 4.16). 
 
Proteinaceous links and DNA intertwines are formed between sister chromatids during 
DNA replication (Michaelis, Ciosk, & Nasmyth, 1997; Sundin & Varshavsky, 1980) 
and must be resolved before cell division in order for correct chromosomes segregation 
to take place. Work carried out by Liang et al. suggests that some inter-chromatid links 
persist until late prophase, when removal of these links results in a conformational 
change in chromosome structure (Liang et al., 2015). However, most topological links 
between strands are removed during replication by topoisomerase II, as shown in S. 
cerevisiae (Charbin et al., 2014) and Xenopus (Lucas, Germe, Chevrier-Miller, & 
Hyrien, 2001). 
 
Increased rates of progression from S to M phase could result in faster replication fork 
progression, increased frequencies of fork collisions and an increased pressure on the 
replication machinery to quickly relax the accumulation of positive supercoils and 
sister chromatid catenations that arise due to the progression of the replication fork. 
Faster progression may therefore result in an increased incidence of sister chromatid 
catenations. In addition to this, the time taken to resolve the catenations is reduced due 
to faster progression into mitosis. Together, this might result in the persistence of a 
higher frequency of unresolved catenations between sister chromatids, at the point of 
entry into M phase.  
 
Therefore, the cell cycle stage at which T cells progress most rapidly in comparison to 
other cell types occurs between replication and cell division, when condensins are 
required to resolve sister catenations and restructure chromosomes (Jonathan Baxter 
& Aragón, 2012). This data may therefore begin to explain why the DP T cells, 
specifically, suffer severe consequences in cell division as a consequence of condensin 
II deficiency. However, this data does not indicate whether the increased rate of 
progression is due to a shorter S phase, or more rapid progression through G2. More 
rapid S phase progression may indicate that the abnormal cell division likely arises 






















due to increased formation of sister-chromatid catenations. In contrast, more rapid G2 
would favour the hypothesis that abnormal chromosome segregation arises due to 
insufficient time to resolve catenations.  
 
To distinguish between these two possibilities, experiments could be carried out to 
infer whether DP cells progress more rapidly than other cell types from G2 to M. This 
would be determined by calculating the percentage of BrdU- PH3S10+ cells at one-
hour time points up to, and including, 4 hours. This represents the proportion of cells 
that have progressed to M phase from G2. Because S phase is thought to take at least 
4 hours in post-embryonic mammalian cells (Cooper & Hausman, 2007), BrdU-
PH3S10+ cells must have been in G2, or early M phase at the start of the experiment. 
The data would then be normalised to the percentage of G2/M cells at time point zero, 
to control for different frequencies of cells that start in G2 at time point zero between 
cell types. The proportion of G2 cells would be calculated by labelling the cells with 
relevant cell surface antibodies as well as antibodies to PH3S10 and finally, the cells 
would be DAPI-stained. Slower DP T cell progression from G2 to M in comparison to 
other cell types would indicate that these cells progress more rapidly through S phase, 
rather than through G2 to M. 
 
Perhaps a more direct method of assessing rate of progression through S phase would 
be to carry out a double labelling experiment – injecting a mouse first with a thymidine 
analogue (e.g. BrdU) followed by a second analogue (e.g. EdU) ninety minutes later. 
The mouse would be culled after a further thirty minutes. A single cell suspension of 
the T and B cells would be obtained, and labelled with cell surface antibodies to 
determine the stage of development, as well as antibodies to each of the thymidine 
analogues. Assuming that the proportion of cells leaving S phase remains constant 
(and equally, the proportion entering S phase is constant), then the total length of the 
cell cycle can be calculated by dividing the time period between the first and second 
injections by the fraction of cells leaving S phase (which can be determined by the 
proportion of cells that are BrdU+ and EdU-). Secondly, assuming that the proportion 
of cells in S phase is constant at any given time, then the length of S phase can be 
calculated by multiplying the total length of the cell cycle by the fraction of cells in S 
phase (i.e. cells that are BrdU+ EdU+). These concepts are illustrated in Figure 4.18. 
 













































Work carried out by Rudner et al. in B. subtilis, revealed that inactivation of the SMC 
condensin subunit results in an inability to separate origins of replication during 
mitosis. In addition, topoisomerase IV inactivation (known to be involved in sister 
chromatid decatenations) results in an inability to separate sister chromatid arms. 
Surprisingly, however, topoisomerase IV inactivation had no effect on the separation 
of origins of replication (Wang et al., 2014). This may suggest that, in bacteria at least, 
the inability of chromatids to separate their origins of replication is not caused by 
persistent DNA intertwining. Alternatively, fast replication may result in the 
production of large swathes of DNA in close proximity to its sister DNA. This could 
increase the likelihood of stable bridges forming between sisters by nucleoid-
associated proteins. The role of the condensin II complex may be to rapidly condense 
newly synthesised DNA away from its sister DNA, thereby limiting the potential for 
the formation of linkages between the sisters (Gruber et al., 2014). This mechanism 
might not be relevant in higher eukaryotes, where replication and condensation do not 
occur concomitantly, however, some work on HeLa cells indicates that condensin 
mediated chromosome individualisation may begin as early as S phase (Ono et al., 
2013). If this is the case, it is possible that individualisation of sister chromatids during 
S phase could inhibit the formation of inter-chromatid linkages by contracting sister 
chromatids away from one another. 
 
However, investigations into the process of decatenation of circular chromosomes in 
budding yeast found that depletion of condensin subunits did not result in an increase 
in the accumulation of catenanes, but instead resulted in slower resolution, with 
approximately 15% of catenations persisting through mitosis into G1 (Charbin et al., 
2014). This may reflect differences between prokaryotes and eukaryotes since it 
conflicts with the hypothesis that condensin is involved in the prevention of link 
formation between sister chromatids, rather than their resolution in B. subtilis. 
Importantly, however, these experiments indicate that condensin promotes catenane 
removal in eukaryotes, rather than inhibiting the introduction of linkages.  
 
Given that the majority of sister chromatid catenations are resolved quickly by 
topoisomerase II (Charbin et al., 2014; Lucas et al., 2001; Wang, 2002), the discovery 
that a subset of the catenanes persist late into the cell cycle and can only be resolved 
in the presence of condensin led to the hypothesis that DNA replication may result in 






















two different types of catenations. Easily resolved catenations are separated quickly 
by topoisomerase II alone, whereas more complex topological linkages between sister 
chromosomes require condensin activity (Charbin et al., 2014). If this is the case, it 
could be that certain properties of the DNA sequence at the origin of replication in B. 
subtilis results in complex, or “knotty” sister catenations during replication, which 
cannot be fully resolved in the absence of condensin. Interestingly, SMC is recruited 
to parS sequences that cluster near the origin of replication (Minnen, Attaiech, Thon, 
Gruber, & Veening, 2011; N. L. Sullivan, Marquis, & Rudner, 2009), which may 
indicate that condensin is particularly necessary at the origin, perhaps to resolve 
topologically complex catenations.  
 
Similarly, fast S phase progression could result in a higher incidence of this type of 
catenations, which would explain the increased requirement of condensin at the DP 
stage of T cell development, when S phase progression is most rapid. This hypothesis, 
however, is very difficult to test, given the lack of tools available to detect catenations 
on linear chromosomes. 
 
Reduced replication fork velocity rescues the condensin deficient phenotype in B. 
subtilis (Gruber et al., 2014), implying that some aspect of fast fork progression results 
in an increased necessity for condensin activity in B. subtilis. Further work must be 
carried out to investigate whether the observed rapid rate of progression from S to M 
phase in T cells results in an increased replication fork velocity relative to other 
lineages. Alternatively, it could be that the CD4+ CD8+ DP T cells licence more origins 
of replication during S phase. More replication forks covering the same distance would 
not need to travel as quickly, resulting in fewer opportunities for the formation of sister 
chromatid bridges.  Experiments designed to artificially reduce the rate of replication 
fork progression (such as treatment with hydroxurea, HU) would indicate whether 
slower replication fork progression at the DP stage of T cell development would result 
in fewer Caph2nes/nes cells with abnormal DNA content. Additionally, replication fork 
velocity and number of fired origins could be determined using DNA combing 
(Herrick & Bensimon, 1999; Michalet et al., 1997). This involves pulse-labelling cells 
with two different thymidine analogues sequentially (e.g. IdU followed by CIdU), 
which would be incorporated into newly replicated DNA. The long DNA strands are 
stretched out onto a glass slide after cell lysis and each of the thymidine analogues 






















detected with fluorescently conjugated antibodies. DNA replication tracts are 
identified by the presence of adjacent thymidine signals under fluorescence 
microscopy. The number of fired origins is inferred from the proportion of IdU signals 
(i.e. the newly synthesised DNA adjacent to the origin). The rate of progression of the 
fork would be calculated by dividing the length of the first signal (IdU) by the period 
of time between pulses (IdU treatment followed by CIdU). The concepts of fibre 































CHAPTER 5: PRELIMINARY INVESTIGATION INTO THE 
BIOCHEMICAL PROPERTIES OF THE CONDENSIN COMPLEXES 
 
5.1 Introduction  
 
The condensins belong to a family of SMC proteins, which also includes cohesin and 
SMC5/6. Eukaryotes possess condensin I and condensin II, which share the same 
heterodimer of SMC proteins, a kleisin subunit, and different accessory subunits 
(Nasmyth & Haering, 2005). The structure and function of condensin I is well 
conserved from yeast to humans, although some organisms lack condensin II. 
Prokaryotes also possess condensin-like complexes, which are involved in the 
organisation of chromosome structure.  
 
The dramatic process of restructuring interphase chromatin into mitotic chromosome 
structures is a poorly understood process, due to the difficulty in removing 
chromosomes whilst maintaining the structure and interactions that are present in vivo.  
Topoisomerase II could be removed from the chromatin by washing with weak salt 
solutions, whereas the remaining two proteins could not (Hirano & Mitchison, 1993). 
Immunodepletion of SMC4 was shown to prevent chromosome condensation and the 
formation of mitotic chromosomes, confirming its importance in mitotic chromosome 
assembly (Hirano & Mitchison, 1994). 
 
Affinity purification experiments using an antibody to SMC4 confirmed the presence 
of additional proteins that associate with the SMC2 and SMC4 proteins. These proteins 
are now known to be the condensin I non-SMC proteins CAP-G, CAP-D2 and CAP-
H (also known as kleisin gamma). The affinity-purified sample was run on a sucrose 
gradient and assayed via immunoblot with antibodies to SMC2, SMC4 and the 
associated subunits. The researchers found that the SMC proteins and non-SMC 
subunits form a complex with a sedimentation coefficient of 13S, whereas the SMC 
proteins, without additional subunits, form a complex that sediments at 8S (Hirano, 
Kobayashi, & Hirano, 1997). Further experiments have confirmed that the condensin 
II complex (SMC2, SMC4, CAP-G2, CAP-D3 and kleisin beta/CAP-H2) 
approximately co-sediments with condensin I at 13S (Figure 5.1a) (Ono et al., 2003). 























Cohesin and condensin are both known to form tripartite ring-like structures: the SMC 
proteins form anti-parallel coiled coils (Melby, Ciampaglio, Briscoe, & Erickson, 
1998), connected to each other by a dimerization domain which forms a V-structure 
(Figure 1.5). The carboxy and amino termini of the kleisin protein bridge the opposing 
SMC head domains, which closes the ring. Cross-linking experiments have shown that 
the N-terminal of the kleisin protein in cohesin (Scc1/Rad21) binds to the coiled coil 
of SMC3, while the C-terminal of the kleisin interacts with SMC1 head domain  
(Gligoris et al., 2014). It has been suggested that this ring structure allows the cohesin 
complex to entrap sister DNA strands (Gligoris et al., 2014; Gruber et al., 2003) by 
the formation of both intra- and inter-chromosomal topological links. Given the 
structural similarity between condensin and cohesin, condensin could act to restructure 
chromatin in a similar way: by topologically encircling the DNA strand and 
introducing intra-chromosomal links by binding to another segment within the same 
strand, (as shown in Figure 5.1b, left), or by encircling both segments (Figure 5.1b, 
right) (Cuylen et al., 2011). Alternatively, condensin may compact chromatin by 
introducing right-handed supercoils, as discussed previously (Chapter 1 Section 1.2.4, 
Chapter 4 Section 4.3). 
 
In this chapter, I set out to further characterise the biochemical properties of the 
condensin complexes in order to better understand their roles in reorganising 
chromatin structure and promoting accurate cell division. Specifically, I was interested 
in comparing the biochemical features of condensins between the primary 
haematopoietic cell types analysed in Chapter 4, in order to determine whether 
condensin complexes have any unique properties in T cells, compared to other 
haematopoietic lineages. 
  















































5.2.1 Expression of Caph2 mRNA 
 
First, I measured Caph2 mRNA abundance in three hematopoietic lineages (T, B and 
erythroid) by quantitative PCR on cDNA generated from MACS-purified B220+ B 
cells, Ter119+ erythroid cells and CD4+ T cells, as described in Materials and Methods: 
Section 2.2.2.5. Actin primers were used as a reference to determine ΔCt values and 
transcript levels were normalized to CD4+ T cell expression. The results indicate that 
the relative abundance of the Caph2 mRNA is reasonably consistent between cell 
types (there is a less than 1.6-fold difference between cell types), with slightly 
increased expression in the erythroid cells, although more replicates would be required 
to determine whether this difference is significant (Figure 5.2).  
 
5.2.2 Caph2 mRNA splice variants between cell types 























Six possible isoforms of CAP-H2 have been reported, arising due to three methods of 
alternative splicing in the mouse Caph2 gene: a long or a short 3’-UTR, a NAGNAG 
variation at the 5’ end of exon 16, and alternative exon 1 isoforms. Three splice 
variants of the first exon of the condensin II subunit Caph2 were identified using 
expressed sequence tag (EST) data: a long form of exon 1 (the exon is not truncated), 
an intermediate form (the last 17 base pairs are lost) and a short form (lacking the last 
93 base pairs). These exon 1 variants were potentially of relevance to the Caph2nes/nes 
phenotype, because the single nucleotide substitution causes distinct missense 
mutations in the long and intermediate isoforms, but lies within an intron of the short 
isoform.   
 
The Caph2 reading frame is conserved in both the long and short isoforms, but a 
truncated protein would result from the intermediate isoform if the same start codon is 
used. Alternatively, the intermediate isoform could give rise to a protein with a 
different amino acid sequence from exon 1, but identical to exon 2 onwards if an 
alternative downstream start codon was used (Figure 5.3a).  
 
Since EST data represents transcribed mRNA, it seemed likely that these splice 
variants were real, and produced transcripts. This was confirmed by RT-PCR on RNA 
from different mouse tissues. Given the developmental defect evident in Caph2nes/nes 
thymocytes, the researchers (Theodoratos, Wilson, Gosling, & Fahrer, 2012) 
investigated the possibility that the exon 1 splice variants may be differentially 
expressed across different stages of T cell differentiation (DN, DP, CD4 SP and CD8 
SP). Although differences were observed in the expression levels between cell types, 
the pattern of expression of each isoform remained consistent. 
 
To test whether each of these transcripts can give rise to Caph2 protein, cDNA from 
each splice variant was cloned into a GFP fusion protein vector. Each splice variant 
produced GFP fusion protein, demonstrating that all three variants can produce stable 
protein (Theodoratos et al., 2012). 
 
Previous studies into the Caph2nes/nes mutation revealed that the introduction of 






















wildtype Caph2 expressing the long isoform of exon 1, was sufficient to rescue the 
Caph2nes/nes phenotype (Gosling et al., 2007). Moreover, the portion of Caph2 ORF 
that is unique to the long isoform is highly conserved between species, which is not 
the case for the intermediate isoform. This may suggest that the long isoform is 
predominant in T cells. This is supported by the EST data, which shows that the most 
abundant transcript is the long form.  
 
Since the Caph2nes/nes mutation (a single nucleotide change within exon 1) is absent 
from the short isoform (Figure 5.3a) and does not result in the same amino acid change 
in the intermediate isoform (due to the alternative start codon), I investigated the 
possibility that different isoforms are preferentially expressed in different cell types. 
If, for example, the short or the intermediate isoforms are preferentially expressed in 
cell types that are apparently unaffected by the Caph2nes/nes mutation, such as B cells, 
then this would suggest a possible explanation for the apparent T cell specificity.  
 
I carried out non-quantitative PCR experiments to directly compare the relative 
abundance of the long, intermediate and short isoforms between cDNA generated from 
MACS-purified B220+ B cells, Ter119+ Erythroid cells and CD4+ T cells, as well as 
mouse ES cells (Materials and Methods: Section 2.2.2.5). Information about the 
primers used is provided in Table 2.2. Comparisons were made by densitometry 
analysis using Quantity One 4.6.9 software (Bio Rad Ltd). The results revealed no 
substantial difference in the relative expression of the long isoform compared to the 
intermediate isoform between cell types (Figures 5.3b and 5.3c). The short isoform 
was not detected in any of the cell types. This result is consistent with the EST data 
described by Theodoratos et al, which estimates from the number of ESTs representing 
each splice variant that the short isoform is the least abundant (Theodoratos et al., 
2012).  
 
The data presented here suggests that the cause of the apparent resistance of certain 
cell types (such as B cells) to the Caph2nes/nes mutation is not a consequence of 
differential expression of splice isoforms of Caph2. 
 













































5.2.3 Expression of condensin subunits at the protein level 
 
The relative abundance of condensin subunit proteins was analysed across three 
haematopoietic lineages. Cells obtained from the thymus and bone marrow were 
MACS-purified to obtain populations of B220+ B cells, Ter119+ Erythroid cells and 
CD4+ T cells. The concentration of total protein in each sample was evaluated using 
the Bradford protein assay (Materials and Methods: Section 2.2.3.2). A total of 20µg 
of protein per sample was assayed via Western blot, and antibodies specific to SMC4, 
CAP-H2 and CAP-H (Table 2.5) were used to determine the relative levels of protein 
across the different cell types (Figure 5.4). 
 
The relative abundance of SMC4 appeared to be fairly consistent across the three 
different cell types. However, although CAP-H2 and CAP-H were detected in CD4+ 
T cells, they were not detected in either the B220+ B cell or the Ter119+ erythroid 
populations. It seems unlikely that the kleisin subunits are completely absent from the 
B- or erythroid cells, but rather that the protein levels of these condensin subunits are 
much lower in those cell populations in comparison to T cells. 
 
These results appear to reveal stoichiometric imbalances in the expression of 
condensin subunits between cell types. SMC4 appears to be uniformly expressed, 
whereas the levels of the condensin subunits vary. Given that it was possible to detect 
the Caph2 transcript in all three cell types analysed with an apparent increase in 
erythroid cells (Figure 5.2), difference in transcript abundance between cell types is 
not sufficient to explain the differences in the levels of CAP-H2 protein that are 
detected. Although it is difficult to compare the techniques of western blot and PCR, 
it could be that some post-transcriptional modification occurs in these cell types. This 
possibility is discussed in greater detail in Section 5.3. An alternative explanation 
could be that each of the cell types analysed are comprised of different frequencies of 
cells that are proliferating rapidly – condensin “accessory” subunits might be expected 
to be most abundant in proliferating cells (discussed in more detail in Section 5.3). 
 
One further possible explanation of this apparent imbalance is that the non-SMC 






















condensin subunits form a non-canonical complex with proteins other than the SMC2 
SMC4 heterodimer, specifically in T cells.  






















5.2.4 Sedimentation profiles of condensin subunits 
 
Sucrose gradient experiments using HeLa cell extracts suggest that the condensin 
subunits (CAP-D2, CAP-D3, CAP-G, CAP-G2, CAP-H and CAP-H2) do not exist on 
their own, without forming a complex with the SMC2 SMC4 heterodimer proteins; 
i.e. the subunits are not present in any of the light fractions where SMC2 or SMC4 are 
absent (T Hirano et al., 1997; Keiji Kimura & Hirano, 1997; Ono et al., 2003). If this 
is also found to be the case in T cells, it would suggest that the increase in the levels 
of subunits relative to SMC4 in T cells (Figure 5.4) may be due to the CAP-H and 
CAP-H2 proteins forming stable complexes with other proteins, rather than there being 
an increase in the presence of kleisins as individual proteins. To test this hypothesis, I 
performed sucrose gradient experiments on whole thymus extracts to determine 
whether the CAP-H and CAP-H2 subunits could be detected in any fractions where 
SMC4 was absent. 
 
A single cell suspension was made from a wildtype thymus, which is comprised 
primarily of CD4+ CD8+ CD71- thymocytes (approximately 80% of the wildtype 
thymus is comprised of CD4+ CD8+ DP thymocytes, of which 85-90% are CD71-/non 
cycling). The cells were lysed and the lysate was added to a linear gradient of 5% - 
20% sucrose. The samples were centrifuged overnight to separate proteins based on 
the molecular weight of the macromolecular complexes in which they reside 
(Materials and Methods: Section 2.2.6). The fractions were manually removed, and 
assayed via Western blot.  
 
SMC4 is detected in almost every fraction, from approximately Fraction 6, onwards 
(Figure 5.5). The intensity of the signal is strongest from approximately Fraction 10 to 
Fraction 16. SMC4 has previously been shown to sediment in this way in HeLa cell 
extracts: it is absent from the very lightest fractions but is present in all remaining 
fractions, although the intensity of the signal diminishes following the 13S peak, 
Figure 5.1a (Ono et al., 2003).  
 
CAP-H co-sediments with SMC4 (fractions 10 to 14) and is not present in any of the 
other fractions where SMC4 is absent (Figure 5.5, top). This is in agreement with the 
previously published data showing the fractionation patterns of CAP-H in HeLa cells 






















(Kimura & Hirano, 1997; Ono et al., 2003). These data suggest that CAP-H does not 
form a complex of different molecular weight to the complex it forms with SMC4. 
 
CAP-H2 also co-sediments with SMC4 (Figure 5.5, bottom). However, unlike CAP-
H, CAP-H2 is detected in the heaviest molecular weight fractions. In fact, the intensity 
of the CAP-H2 signal remains strong, even after the intensity of the SMC4 signal 
diminishes. Unfortunately, no information is provided about the number of fractions 
taken by Hirano et al. in their sucrose density sedimentation experiments with 
antibodies specific to condensin II subunits, Figure 5.1a (Ono et al., 2003). Therefore, 
no direct comparison can be made between the two experiments to determine whether 
the sedimentation profile seen in T cells is atypical. Experiments are ongoing to obtain 
sedimentation profiles for CAP-H2 in other primary cell types.  
 
Although the sucrose gradient experiments described above do not provide conclusive 
proof that CAP-H2 forms a complex with a protein other than SMC4, it leaves open 
the possibility that this may be the case. Further experiments, including mass 
spectrometry following immunoprecipitation for Caph2, must be carried out to further 
investigate this result. If, indeed, it is the case that CAP-H2 forms a novel complex 
with non-SMC proteins specifically in T cells, it may be this second complex that is 
affected by the Caph2nes/nes mutation. For example, if the region of Caph2 containing 
the I15 residue was more important for interactions with non-canonical condensin 
subunits than for canonical subunits, then the non-canonical interaction would be more 
severely affected. This would provide an explanation for the observed T cell 
specificity. However, the fact that the cellular phenotype in Caph2nes/nes T cells is 
consistent with perturbation to the canonical condensin II complex argues against this 



















































From the results described in this Chapter, several experimental avenues present 
themselves. There appear to be stoichiometric imbalances in the expression of 
condensin subunits as shown by western blot (Figure 5.4). Further analysis into the 
expression of condensin I subunits revealed further imbalances at the sub-cellular level 
(Taylor, unpublished data). CAP-H, a subunit of condensin I (which has been shown 
to gain access to the chromosomes only after breakdown of the nuclear membrane 
during prometaphase (Hirano, 2012; Ono et al., 2003) was detected in the nucleus of 
T cells and mES cells, specifically. In contrast, SMC4 was uniformly detected in the 
cytoplasm and nucleus across all cell types tested. Taken together, this data may 
suggest that condensin subunits form different complexes in different tissues.    
 
The sedimentation profile of CAP-H2 does not exclude the possibility that it forms a 
complex with non-SMC proteins. The next step in this analysis is to perform 
immunoprecipitation (IP) experiments followed by mass spectrometry to determine 
whether CAP-H2 associates with proteins other than those in the canonical condensin 
II complex. 
 
Further work must be carried out to determine whether the CAP-H2 sedimentation 
pattern is unique to T cells, by performing sucrose gradient experiments on bone 
marrow, HeLa cell and MEF extracts. If this non-canonical complex is found to be 
specific to T cells, then this could potentially explain the Caph2nes/nes cell type specific 
phenotype: i.e. if the CAP-H2 mutation specifically disrupts the function of the non-
canonical complex.  However, this seems unlikely since the results from the previous 
chapters suggest that the Caph2nes/nes mutation affects the well-known function of 
condensin in mitosis.  
 
From the sedimentation pattern of CAP-H, it is unlikely that this subunit forms a 
complex with any proteins other than SMC2 and SMC4, since CAP-H co-sediments 
with SMC4, and is only detected in a small number of fractions. It could be that neither 
CAP-H nor CAP-H2 form complexes with proteins other than the SMC heterodimer. 
If this is the case, then the increase in the levels of CAP-H and CAP-H2 detected in T 






















cells compared to other cell lineages must have another explanation.  
 
A survey of transcriptome data (Immgen) reveals that the expression of condensin I 
and condensin II subunit transcripts is highest at the DP CD71+ blast stage of T cell 
development, in comparison with over 150 other immune cell subsets (Figure 4.14). 
The increase in the expression levels of Caph and Caph2 (and other condensin 
subunits) at the DP 71+ blast stage is evident when the data is viewed as a heatmap 
(Figure 5.6). This supports the hypothesis that condensin is required to a greater extent 
at the DP 71+ blast stage of development, perhaps due to more rapid progression 
through S phase resulting in an increase in the number of catenations introduced 
between sister DNA strands (as discussed in Chapter 4, Section 4.3), although further 
work must be carried out to determine whether the increase in the abundance of 
condensin subunits at the DP71+ stage is also true at the protein level. Interestingly, 
the Fraction C stage of B cell development also exhibits high levels of condensin 
subunit transcripts, although to a lesser extent than DP 71+ blast T cells (Figures 4.14 
and 5.6). 
 
However, the increased levels of CAP-H and CAP-H2 proteins in CD4+ thymocytes 
versus other cell types cannot simply be due to an increased requirement for 
condensins at the DP stage of T cell development, since if this were the case, higher 
levels of SMC4 would be detected in T cells in addition to the increase in expression 
of CAP-H and CAP-H2 (Figure 5.4). It is known that the levels of the cohesin kleisin 
Scc1 vary throughout the cell cycle (Uhlmann & Nasmyth, 1998) and a study into the 
structure of cohesin found that the kleisin subunit Scc1 is rate limiting for the 
formation of the cohesin complex (Mishra et al., 2010). Given the structural similarity 
of condensin and cohesin, it may be that CAP-H2 is the limiting factor in condensin II 
formation. Indeed, some evidence exists for CAP-H2 acting as the rate limiting subunit 
for holocomplex formation in Drosophila (Hartl, Smith, et al., 2008). Additionally, 
CAP-D2 is rate limiting to condensin I formation in Xenopus oocytes (Watrin, 
Cubizolles, Osborne, Le Guellec, & Legagneux, 2003). 
 
The hypothesis that CAP-H2 is rate limiting to mammalian condensin II holocomplex 
formation is supported by transcriptome data, which shows that despite exhibiting the 
highest expression levels of condensin subunit transcripts at the DP 71+ blast stage, 






















Caph2 transcripts are the least expressed of all the condensin subunits (Figure 5.6). If 
CAP-H2 is indeed the limiting factor, then stages of development that undergo very 
rapid progression from S to M phase (such as at the DP stage of T cell development), 
may require higher levels of CAP-H2, so that condensin II holocomplex formation can 
take place more readily.  
 
The expression data reveals that Caph and Caph2 transcript levels in Fraction C B 
cells are slightly lower, but in the same range as DP 71+ blast T cells (Figure 5.6). This 
agrees with experiments described in this Chapter, which reveal similar transcript 
levels of Caph2 in B220+ B cells and CD4+ T cells as determined by qPCR. The 
expression of Caph2 in erythroid cells is slightly higher compared to the other two cell 
types, although more replicates are required to determine whether the difference is 
significant (Figure 5.2). In contrast, CAP-H and CAP-H2 protein levels are not 
detected in B cells or erythroid cells (Figure 5.4). This may imply that the kleisin 
subunits of both condensin complexes are regulated at the level of translation.   
 
Using ribosome profiling, Stumpf et al. provided evidence for the widespread 
translational control of hundreds of mRNAs during the cell cycle (Stumpf, Moreno, 
Olshen, Taylor, & Ruggero, 2013). Ribosome profiling (Ribo-seq) uses deep 
sequencing of mRNA fragments in a process that is similar to RNA-seq. Unlike RNA-
seq, however, this technique sequences only the ribosome-protected mRNA 
fragments.  This provides information about the location of transcription start sites, as 
well as the rate of progression of the ribosome. In their study, Stumpf et al. reported 
cell cycle-dependent regulation of mRNAs involved in wide-ranging processes 
including metabolism, nuclear transport and DNA repair. Interestingly, ribosome 
occupancy of condensin and cohesin subunits is high during S and G2, and diminishes 
during mitosis. This result therefore confirms that cell cycle-dependent control of 
condensin does take place at the translational level (Stumpf et al., 2013). 
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Upstream open reading frames (u-ORFs) have been shown to regulate the expression 
of genes at the downstream ORF by triggering mRNA decay or by regulating 
translation (Barbosa, Peixeiro, & Romão, 2013; Morris & Geballe, 2000). A highly 
conserved u-ORF has been located in the CAP-H2 mRNA (Theodoratos et al., 2012). 
In humans, it was predicted that CAP-H2 translation initiates from two start codons, 
resulting in the production of two different sized proteins. Both proteins were depleted 
by shRNA against CAP-H2 transcripts. By knocking out the uORF start codon, 
Yokoyami et al. proceeded to show that translational regulation from the two start 
codons was regulated by the u-ORF. It was hypothesised that the u-ORF may be 
involved in the regulation of expression of the two translational variants in a cell-cycle 
dependant manner (Yokoyama, Zhu, Zhang, & Noma, 2015).  
 
However, the second AUG start site is absent in mice, and so only one of the 
translational variants exists. Despite this, the u-ORF itself is conserved in mice, which 
raises the question: what is its purpose? One hypothesis could be that the u-ORF is 
involved in cell cycle regulation of CAP-H2 expression. Additionally, it could be that 
the u-ORF is involved in the cell-type dependent repression of CAP-H2 translation, 
resulting in a reduction of CAP-H2 protein in B cells and erythroid cells, relative to T 
cells. Further work must be carried out to test these hypotheses. This might include 
ribosome profiling to determine whether the uORF sequence exhibits a higher 
ribosome occupancy in some cell types in comparison to others. In addition, it would 
be interesting to knock out the uORF in a mouse, and analyse whether CP-H2 
transcription is upregulated in some cell times rather than others.  
 
  






















CHAPTER 6: DISCUSSION 
 
The requirement for condensin in efficient chromosome segregation is a general 
property of almost all characterised organisms, as indicated by the presence of 
anaphase bridges, which are common in condensin depleted cells (Vagnarelli et al., 
2006). However, it has been suggested that the cellular requirements for condensin 
activity differ between species, as well as between cell types (Hirano, 2012). The first 
studies of condensin were performed in Xenopus oocyte extract, where condensin I 
appears to be essential for the condensation of sperm chromatin (Hirano & Mitchison, 
1994). However, in subsequent studies using cellular systems such as chicken DT40 
cells (Vagnarelli et al., 2006) or C. elegans (Hagstrom et al., 2002), chromosome 
condensation can still occur when condensin function is perturbed. In mice, condensin 
I and II were both shown to be essential for neuronal stem cell divisions (Hirano, 
2012), while condensin II but not condensin I is essential for murine meiosis I and the 
first embryonic mitosis (Houlard et al., 2015). 
 
Arguably the most striking example of tissue-specific condensin function in the 
literature is the mouse model Caph2nes/nes (Gosling et al., 2007), which, as discussed, 
reveals cellular abnormalities primarily in the T cell lineage. Before the work 
presented in this thesis, it was not known whether the T cell developmental block 
occurred due to abnormal mitosis, or one of the other cellular functions that have been 
attributed to condensins.  
 
I have described experiments carried out during my PhD, which provide strong 
evidence to suggest that these cellular abnormalities arise due to errors in segregation. 
I went on to investigate the possibility that the T cell specific abnormalities arise due 
to abnormal interphase processes within the T cell lineage, but I did not find any strong 
evidence for this. While it is possible that condensin II is involved in epigenetic 
processes during interphase in T cells specifically (Rawlings et al., 2011), my analysis 
does not support the hypothesis that it is this function of condensin II that is perturbed 
in Caph2nes/nes. 
 
I proceeded to study the different stages of hematopoietic differentiation in a 






















systematic manner, and, based on ploidy profiling, was able to pinpoint the precise 
stage of differentiation that was most vulnerable to condensin II deficiency: the DP 
blast T cells. This discovery led me to investigate what property of this particular 
developmental stage could cause increased vulnerability to condensin II deficiency. 
 
6.1 Evidence to suggest that the Caph2nes/nes phenotype arises due to errors in mitosis 
 
The T cell phenotypes arising from Caph2nes/nes mutation I have described in this thesis 
include abnormal chromosome structure and increased ploidy in the T cell lineage, 
which are likely to be the cause and consequence of abnormal mitosis, respectively. 
Further characterisation of these defects was carried out using T cells cultured on 
OP9/DL1 monolayers. In unsynchronised cultures, Caph2nes/nes cells showed a 
significant decrease in the fraction of anaphase cells in which sister chromatids were 
resolved, suggesting that mitosis is specifically impaired during this stage (Wood, 
unpublished data). To enrich for anaphase cells, T cell cultures were treated with the 
proteasome inhibitor MG132 to arrest cells in metaphase, before being released into 
anaphase by wash out of MG132. Analysis of mitotic figures following MG132 
washout revealed an elevated incidence of anaphase bridges and occasionally other 
defects associated with aberrant mitosis, including lagging chromosomes, multipolar 
spindles and micronuclei (Wood, unpublished data). Together, these data provide 
strong evidence that the developmental block during T cell differentiation in 
Caph2nes/nes mice arises from defects in the well-known role of condensin II in 
restructuring chromosomes between DNA replication and chromosome segregation.  
 
  






















6.2 Interphase processes seem unperturbed by the mutation to Caph2 
 
However, the question of cell-type specificity remains: why would condensin II 
deficiency impact the DP T cells so drastically in comparison with other lineages? As 
discussed in Section 3.2, condensins have been implicated in interphase processes, and 
specifically gene regulation (Bauer et al., 2012; Haeusler et al., 2008; Kruesi et al., 
2013), but the evidence for cell cycle independent functions of condensin in mammals 
is relatively sparse (Li et al., 2015). Unlike regulators of mitotic chromosome 
structure, regulators of gene expression are well known to impact individual cell types 
differently. One possible explanation for the Caph2nes/nes cell-type specificity is that 
the phenotype arises due to a separation of function mutation in the kleisin β subunit, 
which would affect its hypothesised role in T cell-specific gene regulation, rather than 
its established role in mitosis (Gosling et al., 2007). A similar separation of function 
mutation was described for the cohesin/condensin kleisin subunit ScpA in Bacillus 
subtilis (Dervyn et al., 2004). Mutations were isolated in ScpA which only subtly 
affected the ability of the complex to condense or segregate chromosomes, but strongly 
affected epigenetic processes including DNA damage repair and transcriptional 
control. 
 
In addition to its role in chromosome cohesion, cohesin is known to function in the 
regulation of gene expression (Dorsett, 2007; Gause, Schaaf, & Dorsett, 2008; Rollins, 
Korom, Aulner, Martens, & Dorsett, 2004). Heterozygous mutations in cohesin 
subunits (SMC1 and SMC3) and regulatory proteins (NIPBL) have been identified in 
patients with Cornelia de Lange–like Syndrome (CdLS) (Gil-Rodríguez et al., 2015). 
This was initially surprising since sister chromatid cohesion is a fundamental process 
which, like chromosome condensation and decatenation, is important in all dividing 
cells. However, it’s now believed that the developmental abnormalities arise due to 
the secondary role of cohesin in the regulation of gene expression during development 
(Liu et al., 2009; Revenkova et al., 2009).  
 
One of the symptoms associated with Cornelia de Lange syndrome is microcephaly 
(reduction in head size). Interestingly, condensin II has been shown to interact directly 
with MCPH1: one of the causative genes responsible for this condition (Wood, Liang, 
Li, & Chen, 2008). In addition, combined MCPH1 and NCAPG2 (condensin II 






















subunit) deletions were discovered in a patient with severe microcephaly (Perche et 
al., 2013). Given that condensins have been implicated in interphase processes in 
invertebrates, it is tempting to speculate that condensin II may also play a role in 
mammalian gene regulation, like the structurally similar complex cohesin.  
 
However, Caph2nes/nes mice have no overt dysmorphology similar to CdLS and I was 
unable to find any significant difference in interphase chromatin compaction between 
wildtype and Caph2nes/nes using 3D FISH (Figure 3.15) or any differences in 
compaction in ploidy-matched cells using flow cytometry (Figure 3.13). Further 
investigation revealed no obvious interphase abnormalities in Caph2nes/nes mutant T 
cells (Figures 3.17 and 3.18). Transcriptome studies in DP T cell subsets from wildtype 
and Caph2nes/nes animals uncovered relatively subtle differences in transcript levels 
(Wood, unpublished). Gene ontology analysis revealed that the most significantly 
deregulated genes were part of signalling pathways that are known to respond to 
aneuploidy, such as P53 and protein homeostasis (Sheltzer, Torres, Dunham, & Amon, 
2012; Thompson & Compton, 2010; Wood, unpublished data). Together the data 
implies that the I15N mutation in Caph2nes/nes does not primarily impact the proposed 
role of condensin II in interphase processes.  
 
Although I was unable to find any statistically significant differences in interphase 
chromatin compaction between wildtype and mutant, that is not to say that chromatin 
is not at all decompacted in Caph2nes/nes. Perhaps the differences are subtle, and require 
analysis of an increased number of nuclei to become apparent. Additionally, condensin 
may be involved in restructuring of TAD boundaries, as has been shown for the dosage 
compensation complex (DCC) in C. elegans (Crane et al., 2015). The related complex 
cohesin is also thought to introduce TAD-like structures into fission yeast 
chromosomes (Mizuguchi et al., 2014). Investigations into whether condensin acts in 
this way in mammals would involve Hi-C analysis of the Caph2nes/nes genome.   
 
The work described here does not rule out the possibility that condensins carry out 
interphase functions in vertebrates independently of their role in cell division, rather 
that the single nucleotide change within condensin II in Caph2nes/nes animals mutates 
the protein to such a degree that mitotic processes are affected, but results in a change 
in confirmation or structure that is below the threshold required to affect interphase 
























6.3 Cell type-specific vulnerability and response to condensin II deficiency 
 
My work provides evidence that different cell types reveal differential susceptibility 
to condensin II deficiency. The consequences of the deficiency differ in two important 
ways. Firstly, some stages of differentiation (CD4+ CD8+ DP T cells and Stage 3 
erythroid cells) exhibit high levels of hyperdiploidy, whereas the B cells and 
fibroblasts do not. Secondly, of the two cell types that display abnormal ploidy, only 
T cell numbers are decimated, which occurs at least in part due to cell cycle arrest 
(Figure 4.5). In contrast, the erythroid cells do not appear undergo cell cycle arrest 
(Figure 4.8). The possibility that cell fate decisions following abnormal mitosis are 
cell type-specific is supported by several studies (Foijer et al., 2013; Gascoigne & 
Taylor, 2008; Wertz et al., 2011). It has been suggested that the cause of the variability 
in cell fates is due to two competing networks: one that promotes cell death, and the 
other preventing mitotic exit (Gascoigne & Taylor, 2008). Cell fate is determined by 
which of the networks passes its critical threshold first. If cyclin B1 levels fall low 
enough, the cell will undergo mitotic slip, exit mitosis and perhaps continue through 
the cell cycle. Conversely, if the critical threshold for cell death occurs first, the cell 
will undergo apoptosis.  However, this study does not provide a model for cell fate 
after mitotic exit.  
 
I found a substantial population of T cells arrested in a tetraploid state (Figure 4.4), 
but no equivalent population in the erythroid lineage (Figure 4.8), implying these two 
cell lineages are prone to undergo different cell fates following failed cytokinesis. It 
could be that the erythroid cells are likely to downregulate the retinoblastoma protein 
(pRb) more quickly, and upregulate the S phase promoting E2F transcription factors 
before sufficient signals have accumulated to activate P53 and cell cycle arrest. For T 
cells, however, the opposite may be true, with downregulation of pRb occurring much 
more slowly. 
 
Work carried out by other members of the Wood lab supports the observation that T 
cells and erythroid cells respond differently to abnormal cytokinesis. Prolonged 
exposure to nocodazole revealed that primary T cells cultured ex vivo are removed 






















from the cell cycle, shown using DAPI DNA content analysis and flow cytometry. 
Analysis of primary erythroid cell cultured ex vivo in the presence of nocodazole, 
however, revealed a high proportion of cells with greater than 4N DNA content and 
an accumulation of 8N cells. This indicates that, unlike the T cells, a proportion of the 
erythroid cells do not drop out of the cell cycle in the absence of spindles but re-
synthesize their DNA and continue on to a second mitosis (Taylor, unpublished data).  
 
Since my results indicate that cell cycle arrest is activated in a substantial fraction of 
Caph2nes/nes DP T cells but not erythroid cells, despite both cell types revealing 
increased frequencies of cells with abnormal DNA content, (Figures 4.1c and 4.6c) 
this raises the question of what signalling pathways operate downstream from mitotic 
failure to induce cell cycle arrest in thymic T cells, but not erythroid cells. Failure to 
arrest tetraploid cells often results in the acquisition of an aneuploid karyotype. 
However, tetraploid cells are usually prevented from becoming aneuploid by 
undergoing cell cycle arrest. Using transformed cell lines, this cell cycle arrest has 
been shown to be dependent on P53 (Andreassen, Lohez, Lacroix, & Margolis, 2001; 
Takeshi Fujiwara et al., 2005). 
 
  






















6.3.1 The CD4+ CD8+ DP stage of T cell development is vulnerable to transformation 
in P53-/- mice 
 
In an aging cohort of nine Caph2nes/nes individuals, all nine animals developed T cell 
lymphoma within the 15 month study. Five of nine animals became moribund within 
the study period (Wood, unpublished data). Lymphoma cells were typically CD4+ 
CD8+, indicating that they originated from the stage of thymic T cell differentiation 
during which I have shown tetraploidy arises in young animals. 
 
Interestingly, the DP stage of T cell development, which I have shown to be uniquely 
vulnerable to condensin II deficiency, is known to be vulnerable to transformation in 
P53-/- mice. Mice inheriting null mutations in P53 develop thymic lymphomas 
originating from CD4+CD8+ cells more rapidly than any other type of tumour 
(Donehower et al., 1992; Jacks et al., 1994). Like the Caph2nes/nes phenotype (Gosling 
et al., 2007), the vulnerability of P53-/- animals to thymic lymphoma is independent of 
VDJ recombination (Liao et al., 1998).  This suggests that the DP stage of thymic T 
cell differentiation is unusually susceptible to malignant transformation, and that the 
tumour suppressive properties of P53 are of particular importance at this stage of 
development. 
 
Work has therefore been carried out to test the involvement of P53-dependent 
pathways in the Caph2nes/nes phenotypes during development and aging. To achieve 
this, Caph2nes/nes mice were crossed with P53 null mice, generating double 
homozygous mutants. Kaplan Meier survival analysis of these mice revealed a marked 
reduction in survival of the Caph2nes/nes P53-/- double mutants in comparison to P53-/- 
single mutants:  the median survival of the double homozygotes was 76 days, in 
comparison to a median of 144 days for P53-/- mutants. Individual tumours were found 
to be comprised of either CD4+CD8+ or CD4-CD8+ cells (A. Wood, unpublished data).  
 
Further investigation was carried out into the role of P53 specifically at the DP stage 
of T cell development before lymphoma establishment, which partial rescue of the 
Caph2nes/nes-dependent block in both proliferation and differentiation during T cell 
development in Caph2nes/nes P53-/- mice aged 7 days post partum (pp) (Wood, 
unpublished data). Gene expression analysis revealed that known P53 targets 






















important for cell cycle arrest (CDKN1A) and apoptosis (NOXA, FASL) were 
upregulated in Caph2nes/nes T cells in a P53-dependent manner, which potentially 
accounts for the proliferative block. By 6 weeks pp, the thymus had been taken over 
by CD4+ CD8+ or CD4- CD8+ lymphoma cells (Wood, unpublished data). These data 
indicate that inactivation of the P53 pathway can drastically accelerate 
lymphomagenesis in Caph2nes/nes mice. In addition, Caph2nes/nes P53+/- became 
moribund within a decreased time frame in comparison with P53+/- cohorts (147 vs 
471 days) (Baker et al., 2009), and tumours consistently undergo loss of 
heterozygosity to lose the single wildtype allele of P53. Somatic loss of wildtype P53 
alleles is thus selected for in Caph2nes/nes tumours.  
  
6.3.2 The CD4+ CD8+ DP stage of T cell development progresses more rapidly from 
S to M phase in comparison to other cell types 
 
It is striking that a mutation that causes CIN and also one that protects against the 
negative effects of CIN manifest at the same point in differentiation, despite the 
mutations being present in every cell. Why should T cells at the CD4+ CD8+ stage 
show extreme vulnerability to reduced condensin II function and loss of P53? It is clear 
that the cell cycle role of condensin is relevant specifically between duplication (when 
catenations arise due to fork progression) and segregation. Therefore, as discussed 
previously, the stages that might be most vulnerable to condensin deficiency are S 
phase and M phase. 
 
Preliminary experiments (Chapter 4 Section 4.2.6) indicate that the increased 
requirement for condensin and the activation of the P53 checkpoint to maintain cell 
cycle arrest at the DP stage of T cell development may be due to more rapid 
progression from S to M phase at this specific stage of development. Replication fork 
velocity is known to change during development (Estefanía et al., 2012) and as a 
consequence of disease (Di Micco et al., 2006). As discussed previously, rapid 
progression through S phase could result in an increased incidence of replication fork 
collisions, resulting in more DNA catenations (Sundin & Varshavsky, 1980). 
Alternatively, catenations may persist into and beyond anaphase due to insufficient 
time for decatenation to occur. These two alternatives are not necessarily mutually 
exclusive. 























The hypothesis that the persistent catenation arise due to increased synthesis rather 
than reduced resolution is supported by experiments in yeast which indicate that 
although topoisomerase begins to resolve sister catenations as early as S phase, 
condensin’s role in positively supercoiling DNA to facilitate decatenation occurs 
between prophase and anaphase, specifically. Experiments carried out by Baxter et al. 
in which circular yeast plasmids treated with either nocodazole (a microtubule 
inhibitor, which blocks cells in prometaphase) or Cdc20 inhibitors (which prevent 
anaphase onset), revealed that the condensin-dependent transition from premitotic 
negatively supercoiled catenanes to positively supercoiled mitotic catenanes occurs in 
the absence of the anaphase promoting complex subunit Cdc20 (i.e. before anaphase), 
but not in the absence of microtubules. In addition, it was discovered that the transition 
from negative to positive supercoils does not take place in the absence of centromeres: 
i.e. spindles must be engaged with kinetochores (Baxter et al., 2011), implying that 
condensin’s role in decatenation is specific to metaphase. However, the extent to 
which the mechanism of condensin-dependent decatenation observed on circular 
plasmids can be extrapolated to the linear chromosomes of yeast, or indeed the much 
larger chromosomes of vertebrates, is not clear.  
 
As discussed above, work carried out by Ono et al. provides evidence to suggest that 
condensin is involved in the individualisation of sister chromatids of HeLa cells during 
S phase (Ono et al., 2013). If this is also the case in other cell types, then the increased 
frequency of persistent catenations in condensin mutants are just as likely to be a result 
of an inability to resolve the catenations due to limited time between S and M phase. 
The persistent mutations observed in Caph2nes/nes DP T cells may, in fact, arise due to 
a combination of these two possibilities. As discussed previously, (Section 4.3), 
analysis of the rate of progression from G2 to M phase would provide the opportunity 
to infer which of these alternatives is more likely: if the DP T cells progress more 
slowly from G2 to M phase in comparison to DN T cells, B cells or MEFs, then it 
would imply that S phase progression is quicker. A more direct experiment (although 
perhaps more challenging) would be to calculate the length of S phase in each of these 
cell types using a double labelling technique (discussed previously – Section 4.3). 
Finally, relative replication fork velocities could be analysed using DNA combing on 
these different cell types. 























I have discussed the possibility that DNA replication may introduce two different types 
of catenations: ones that are easily resolved by topoisomerase II, and more complex 
catenations that require condensin activity during early metaphase (Charbin et al., 
2014). It has been shown that in budding yeast, condensin is particularly important at 
the rDNA locus (Freeman, Aragon-Alcaide, & Strunnikov, 2000). This locus is very 
highly transcribed by RNA PolI, and is therefore vulnerable to collisions between 
DNA and RNA polymerases (Takeuchi, Horiuchi, & Kobayashi, 2003). Interestingly, 
despite condensin localization being dynamic throughout the cell cycle, it becomes 
enriched at the rDNA locus during anaphase (D’Amours, Stegmeier, & Amon, 2004). 
It is possible, therefore, that increased fork collisions results in an increase in 
topologically complex catenations, which condensin is required to resolve.  
 
Rapid S phase progression in higher eukaryotes may also introduce more of these 
topologically complex linkages. This raises the question: why do certain types of 
catenations persist into mitosis, and are only removed after kinetochore attachment in 
the presence of condensin (again, assuming that this is also true for higher eukaryotes) 
(Charbin et al., 2014). If these catenations are indeed more topologically complex and 
difficult to resolve (as discussed in Section 4.3), then it would make more sense to 
remove them as early as possible. Eukaryotic condensin II is nuclear throughout the 
cell cycle (Tatsuya Hirano, 2012; Ono et al., 2004), so would have the opportunity to 
begin to resolve catenations in collaboration with topoisomerase II as early as S phase.  
 
Could it be that these particular type of catenations are maintained in order to stabilize 
the cohesin-mediated linkages between sister chromatids? The hypothesis that sister 
chromatid catenations may act in concert with cohesion machinery to ensure close 
physical proximity of sister DNA strands has been suggested previously (Hirano, 
2000) and work carried out by Vagnarelli et al. indicates that catenations are able to 
maintain sister chromatid cohesion if topoisomerase is inhibited (Vagnarelli et al., 
2004). Additionally, Bickmore and Oghene revealed the presence of apparent 
catenations between sisters in alpha satellite DNA (Bickmore & Oghene, 1996). 
However, it is not known whether sister catenations act to maintain cohesion in vivo, 
when topoisomerases are uninhibited.  
 






















An alternative explanation could be that condensin-mediated decatenation, through the 
process of positively supercoiling DNA, is related to a series of tightly regulated 
compaction and expansion events throughout different stages of mitosis. Progression 
from mid to late prophase has been linked to a reorganization of chromatin structure, 
which includes an increase in chromosome width, sister individualization, 
topoisomerase axes splitting and reorganization of chromatin into a radial 
confirmation around a central topoisomerase axis. These conformational changes are 
consistent with removal of constraining topological linkages resulting in expansion of 
chromatin, and reorganization into a lower energy state. The removal of these 
constraints at late prophase was shown to be topoisomerase II dependent (Liang et al., 
2015). Topoisomerase II mediated decatenation during late prophase may represent 
the removal of the final linkages of the kind that are easily resolved, and do not require 
condensin. Following expansion during late prophase, Liang et al. demonstrated that 
rapid compaction of chromosomes occurs during metaphase (Liang et al., 2015). It is 
tempting to hypothesise that this compaction occurs due to condensin-mediated 
decatenation of sister chromatids, which locks in structural changes that were 
introduced as a consequence of chromosome expansion occurring in late prophase 
(Liang et al., 2015). However, firm conclusions cannot be drawn, since the 
experiments which indicate that condensin is involved in decatenation during 
metaphase were carried out in circular yeast chromosomes (Baxter et al., 2011), 
whereas the mitotic expansion and compaction cycles were investigated using 
mammalian cells (Liang et al., 2015). Therefore, theories developed to explain 
observations in one experimental system might not necessarily apply to other 
organisms. 
 
6.4 Concluding remarks 
 
In agreement with previous studies (Ono et al., 2003, 2013; Vagnarelli et al., 2004), I 
have shown that condensin II deficiency results in abnormal chromosome structure, 
with metaphase chromosomes revealing a wavy morphology. This supports the 
hypothesis that condensin II contributes to chromosome structural integrity. 
 
The experiments described in Section 4.2.6 indicating that the rate of progression from 
S to M phase varies between cell types, with faster progression resulting in an 






















increased dependency on condensin activity, provide an exciting explanation for the 
cell type specific phenotype observed in the Caph2nes/nes mouse. However, at present 
this data is correlative, and more work is required: initially to characterise which stage 
from S to M phase is accelerated, and secondly to rescue the phenotype. In the future, 
I would like to confirm that manipulation of S phase kinetics impacts the condensin-
deficient phenotype, as has been shown using drugs such as hydroxyurea (HU) in 
bacteria (Gruber et al., 2014).  
 
In addition, it would be interesting to characterise the rate of progression from S to M 
phase of erythroid cells: since the Stage 3 erythroid cells also reveal high levels of 
hyperdiploidy (albeit to a lesser extent than DP blast T cells) it could be that erythroid 
cells also progress more rapidly than B cells or fibroblasts. These experiments address 
the first level of complexity of the condensin deficient phenotype; i.e. that some cell 
types (T and erythroid) display increased hyperdiploidy, whereas others (B cells and 
fibroblasts) do not. The second level of complexity relates to the difference between 
those cells that undergo a higher frequency of cytokinesis failure (discussed above). 
As a consequence of increased levels of hyperdiploidy, T cells appear to undergo cell 
cycle arrest and cell number reduction, whereas erythroid cells do not. In order to better 
understand this process, single cell transcriptome profiling could be carried out, with 
comparisons made between tetraploid arrested versus tetraploid cycling T and 
erythroid cells. This may help to elucidate the different checkpoint activity operating 
in each of these cell types. 
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